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Our goal is to develop, optimize and demonstrate workflows that incorporate rapid 
Asp-selective chemical proteolysis into proteomic studies of complex mixtures.  This 
can be further divided into several specific aims.  The first aim is to develop and 
optimize the sample preparation, mass spectrometric, and bioinformatic methods 
required for complex mixture analysis of peptides resulting from acid digestion both 
in solution and in polyacrylamide gels. Second, the optimized methods will be 
applied to three model systems.  In the first application, the large peptides derived 
from microwave-supported acid hydrolysis of human ribosomes isolated from MCF-7 
breast cancer cells are analyzed.  Secondly, acid hydrolysis will be applied to 
characterize Lys63 linkages in polyubiquitins.  Finally, all the above methods will be 
  
combined for the analysis of extracellular vesicles shed by myeloid derived 
suppressor cells from a murine mammary carcinoma model. 
 After optimizing the mass spectrometric and bioinformatic methods required 
for analysis of peptides resulting from acid hydrolysis, the most comprehensive 
analysis using this digestion technique to date was achieved both for in gel and in 
solution analysis.  In gel digestion resulted in identification of over twelve hundred 
peptides representing 642 proteins, and in solution digestion via mass biased 
partitioning allowed identification of over 300 proteins.  Mass biased partitioning also 
resulted in two distinct peptide populations from the high and low mass analyses 
implemented.   
 Nearly 90% of the predicted human ribosomal proteins were identified after 
acid hydrolysis.  High resolution analysis of both precursor and product ions resulted 
in an average sequence coverage of 46% among identified proteins.  It was also 
demonstrated that microwave-supported acid hydrolysis facilitates a more informative 
method for analysis of Lys63 linked polyubiquitin.  After acid hydrolysis, ~629 Da 
mass shifts were found to be indicative of isopeptides.  These isopeptides were easily 
identified from complex mixtures using tandem mass spectrometry and diagnostic b 
ions.  Extracellular vesicles from a murine carcinoma model were then analyzed 
using in gel microwave-supported acid hydrolysis, mass biased partitioning after in 
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 Proteomic experiments can be divided into three distinct but equally important 
parts.  In the order in which they occur, those parts are sample preparation, mass 
spectrometry, and bioinformatic analysis.  This work will focus on sample 
preparation using microwave-supported acid hydrolysis, and the changes it requires in 
the mass spectrometric and bioinformatic parts of the experiment.  First, it will 
examine two methods to enhance analysis of microwave-supported acid hydrolysis 
produced peptides from complex mixtures.  In the first method, the acid hydrolysis 
reaction is coupled to polyacrylamide gel electrophoretically fractionated protein 
mixtures.  The second method enhances analysis of proteins digested in solution by 
partitioning the resulting peptides based on size, facilitating mass spectrometric and 
bioinformatic methods catered to the two distinct peptide populations.  The work will 
also demonstrate several important applications of microwave-supported acid 
hydrolysis.  It will demonstrate successful analysis of the human ribosome, a novel 




linked polyubiquitin, and finally, all of these methods will be combined for analysis 
of extracellular vesicles isolated from myeloid derived suppressor cells. 
Mass Spectrometry Based Proteomics 
 
 The word “proteome” was coined by Marc Wilkins in 19961 and can be 
defined as the entire protein complement of a given organism under specified 
conditions.  The study of the proteome, or “proteomics” is the natural next of kin of 
all the previously generated genomic sequencing data.  Unlike an organism’s genome, 
which is generally static, the proteome is ever changing in response to stimuli.  In 
addition to the changing expression levels that proteins demonstrate, there are myriad 
post translational modifications (PTM) that lead to specific consequences.  Despite its 
official definition proteomics has come to signify a specific type of experiment in 
which a protein or set of proteins is analyzed (and sometimes quantitated) using mass 
spectrometry.  Mass spectrometry (MS) is well suited for the task of identifying 
proteins and peptides since it characterizes molecular populations based on mass, a 
property that with sufficiently high accuracy can be directly indicative of empirical 
formula, and rather fortuitously, eighteen of the twenty commonly occurring amino 
acids have unique elemental compositions (and masses).  Proteomic analysis by MS 
offers a unique analytical perspective on biological problems.  It allows simultaneous 
analysis of a large number of proteins in a relatively unbiased manner.  Proteomic 
methods display an impressive degree of analytical versatility, allowing 
characterization of entire cell lines2 at one extreme to in depth analysis of single 




spectrometry and bioinformatic parts of a proteomic workflow in terms of two 
commonly used experimental approaches for proteomic analysis, termed “bottom up” 
and “top down”.   
Electrospray Ionization 
 
  Advances in ‘soft’ ionization methods have allowed introduction of 
large biomolecules into the gas phase without artefactual fragmentation.3, 4  The 
advent of these new technologies and their effect on allowing biomolecular analysis 
culminated in reception of the Nobel Prize in Chemistry in 2002 by Tanaka and 
Fenn.5  Electrospray ionization (ESI) and matrix assisted laser desorption ionization 
(MALDI) have facilitated rapid advancement in proteomic analytical technology, and 
are still the most widely used ionization techniques in biological mass spectrometry.  
Although both ionization methods were used in this work, this dissertation will focus 
on ESI because of its proclivity for complex mixture analysis when coupled with 
liquid chromatography. 
  
  Electrospray ionization is the method of choice for sample introduction into 
the MS following fractionation of a complex mixture by liquid chromatography (LC), 
which has long been known to offer simultaneous separation and concentration of 
analytes of interest with a wide variety of possible stationary phases.  In positive 
polarity ESI, a potential is applied between the inlet of the mass spectrometer and an 
acidified liquid sample (often directly eluting from an LC column), which is forced 




the acidic sample is desolvated en route to the MS inlet.  The electrosprayed peptides 
are multiply protonated during the desolvation process.  For small peptides this will 
often lead to doubly and triply charged ions, and the number of acquired charges 
increases proportionally with size (with some discrepancies observed due to gas 
phase protein structure).6 Neutral protein and peptide molecular weights can be 
determined from the observed mass to charge ratios based on the following formula: 
 
     (Equation 1) 
 
In the relationship above, the mass, m, is equal to the observed charge density 
multiplied by the number of associated charges, and subsequently the product of the 
charge and the elemental proton mass is subtracted.  Additionally, large species will 
produce a distribution of charge states that are representative of different gas phase 
conformations, which results in dilution of the total ion signal for a single polypeptide 
species.  The extent of this phenomenon is dependent on polypeptide length.   
 
 Coupling with High Pressure Liquid Chromatography 
 
 As mentioned previously, high pressure liquid chromatography (HPLC) is 
well suited for coupling with ESI.  In HPLC, analytes are partitioned between mobile 
and stationary phases depending on their affinity for each.  For proteomics 
applications, the most common stationary phases capitalize on hydrophobic 
interactions with proteins and peptides, often called reversed phase chromatography.  




particle (between 1.7 and 5µm) and pore (100-1000Å) size attached to a hydrocarbon 
of defined length (common lengths are butyl (C4), octyl (C8), and octadecyl (C18)).  
Liquid chromatography tandem mass spectrometry (LC-MS/MS) experiments are 
also made possible by the convenient solvent system used in reversed phase HPLC 
(RP-HPLC).  In positive ion mode LC-MS/MS experiments, peptides are loaded onto 
a RP column in a solvent that is nearly all aqueous.  Solvents are substituted with 
0.1% formic acid to aid in the ESI process.  Once on the column, peptides or proteins 
are eluted by steadily increasing the proportion of less polar organic solvent (usually 
acetonitrile (ACN)) going through the column.  Introduction into the MS via ESI 




 Electrospray has been used in conjunction with many types of mass analyzers, 
but this dissertation will focus on two that are often paired together.  Ion traps and 
Fourier transform based analyzers, specifically Orbitraps, have become a popular 
instrument configuration in recent years.  The two mass analyzers have duty cycle 
and resolution limitations that offset one another, but that function well when 
combined. 
 





 Wolfgang Paul was awarded the 1989 Nobel Prize in physics for inventing the 
ion trap (sometimes referred to as the Paul trap).7, 8 Ion traps function based on 
oscillating electric and radio frequency potentials applied in three dimensions to 
maintain ion populations in regions of high stability.  This method proves useful for 
MS/MS in which ions of interest (or more accurately m/z regions of interest) are 
isolated, fragmented, and their resulting product ions are detected upon collision with 
an electron multiplier.  Ions outside the m/z region of interest are ejected based on the 
principle of mass selective instability.9  This method allows coupling of a specific 
precursor ion with its associated product ions that form following collision induced 
dissociation (CID) with an inert gas, such as He.  The most common method used to 
produce the aforementioned fragment ions is CID, although there are alternative 
methods.10  The ion trap is filled with a bath gas, and by rapidly oscillating the end 
cap electrode potentials, the isolated peptide population undergoes multiple collisions 
with the bath gas molecules present in the trap, and acquires energy which is 
redistributed throughout the peptide.  Energetic redistribution following this slow 
heating method results in peptide bond cleavage, with the weakest bonds being 
cleaved in highest abundance. Figure 1 demonstrates commonly observed backbone 





Figure 1.  Location of bond cleavage resulting in b and y ions, and its associated 
nomenclature. 
Using CID, backbone cleavage occurs predominantly at the peptide bond, forming b 
and y ions that contain the amino and carboxy termini, respectively.  Using these 
specific cleavage patterns in conjunction with predicted ion populations from a given 
sequence it is possible to search precursor masses along with their resulting fragment 
ions against databases produced in silico in a high throughput fashion.11  Ion traps are 
specifically well suited for this type of analysis due to their rapid duty cycle.  This 
allows analysis of multiple peptides in a short time frame (on the order of tens of 
milliseconds), a prerequisite for complex mixture analysis. 
 
 The Orbitrap 
 
 The Orbitrap was invented by Makarov and coworkers12 and has since 




cyclotron resonance mass spectrometers (FT-ICR-MS), which also provide high 
resolution data, Orbitraps do not require a superconducting magnet to function.  
Similar to ion traps, charged molecules in the gas phase are confined between 
electrodynamic potentials. The unique shape of the Orbitraps inner and outer 
electrodes between which the ions are confined (Figure 2) forces them to oscillate 
about a central axis at a given frequency, ω, dependent on the mass (m), charge (q), 
and an instrument specific electric field constant, k, with the following relationship:13 
 
        (Equation 2) 
 
Frequencies are acquired in the form of a transient image current, and subsequently 
undergo a fast Fourier transformation (FT) to arrive at the observed mass spectrum. 
 
Figure 2.  Cutaway view of the spindle shaped inner electrode and the surrounding 




Like all methods that utilize FT, the resolution of the transformation product exhibits 
a linear dependence on the frequency transient acquisition time.  Additionally, 
resolution decreases with changes in charge density according to the following 
relationship:13 
 
       (Equation 3) 
 
In contrast to the high scan speed and unit resolution of the ion trap analyzer, 
Orbitraps achieve the high resolution required for large polyeptide analysis at the 





Figure 3. Simulated isotopic spacing at differing resolutions, R, of a randomly 
selected ribosomal peptide 
VNVPKTRRTFCKKCGKHQPHKVTQYKKGKDSLYAQGKRRY at charge state z 
= 7.  The time required for transient resolution, t, is shown at right. 
	  
Hybrid instruments have joined the two analyzers to optimize analysis by allowing 
high resolution and high mass accuracy precursor analysis (in the Orbitrap) with 
concomitant isolation, fragmentation, and detection of multiple ions of interest at low 









 Proteomic methods utilize the tools outlined above in several ways dependent 
on the system being interrogated.  Generally, there are two methodologies that differ 
in the presence or absence of a proteolytic step prior to introduction into the mass 
spectrometer.  Bottom up methods use trypsin, a protease that hydrolyzes peptide 
bonds C terminal to unmodified Arg and Lys residues unless they are followed by 
Pro, to produce a high number of small peptides that can be fragmented and detected 
in the mass spectrometer with high efficiency. After cleavage C terminal to basic 
residues and introduction into the gas phase, peptides are likely to sequester protons 
at each terminus (at the primary amine on the amino terminus and at the side chain 
primary amine on Lys or the guanidyl group on Arg).  The chemical result of this 
circumstance is that both b and y fragment ions produced during the CID process are 
likely to have an associated proton and be detected.  Tryptic digestion has become 
such an integral part of proteomics that some bioinformatic search methods will 
utilize predicted relative ion abundances based on well characterized fragmentation 
schemes of tryptic peptides rather than just observing the presence or absence of an 
expected peak.14, 15   Although the small peptide size is convenient for fragmentation 
using CID, the large number of peptides produced from most protein mixture samples 




identification of a relatively small percentage of a protein’s sequence.  The 
combination of low sequence coverage and high number of similarly sized peptides 
requires that confident protein identification be restricted to those in which two or 
more tryptic peptides are observed with high confidence.  Despite this stringent 
bioinformatic requirement, identification of thousands of peptides and hundreds of 




 Top down methods lack a proteolytic step, and introduce intact proteins into 
the mass spectrometer directly.  Analysis without prior proteolysis provides 100% 
sequence coverage of the identified protein automatically, and also provides 
information on relative abundances of post translationally modified isoforms.16 
The intact mass is analyzed at high resolution to obtain an accurate neutral mass, and 
subsequently the protein is fragmented with product ions also being detected at high 
resolution.  High resolution analysis is required due to the fact that large molecular 
weight species acquire a high number of charges in ESI-MS.   With isotopic 
resolution, charge state can be rapidly determined according to the following formula: 
 





The assumed difference between adjacent 13C isotope peaks is approximately 1Da; 
therefore, the inverse of the difference in m/z of adjacent isotope peaks is equal to the 
charge state (Figure 4). 
 
Figure 4.  Isotopic spacing of a peptide and the accompanying formula used to 
determine its charg state. 
Accurate charge state determination is required for attaining an ion’s neutral mass 
using Equation 1.  Bottom up experiments do not require high resolution since 
product ions are assumed to have charge states of z = 1 or z = 2, based on the 
relatively small size of the peptide precursors.   Top down analyses were initially 
limited to single protein infusion-type experiments, in which the protein is put in 
solution at higher concentration and electrosprayed into the MS directly without any 
LC fractionation.17  The time dependence associated with the FT-based mass 




chromatography (LC) for several reasons.  Primarily, chromatographic peak widths 
(in seconds or minutes) may be incompatible with the time required for high 
resolution accurate mass spectral acquisition.  In addition, the ESI process, as stated 
previously, produces multiple charge states of the same species with polypeptides of 
higher mass.  This phenomenon results in a dilution of total analyte signal across 
multiple charge states.18  Complex intact protein mixtures fractionated by LC 
beforehand are likely to have peaks with overlapping charge state distributions.  
Tandem mass spectrometry is additionally complicated for complex protein mixtures 
due to the fact that usually the most abundant peaks, where abundance is the criterion 
used for precursor selection in most data dependent MS/MS methods, are different 
charge states of the same precursor.  For these reasons, top down methods have not 
yet been adopted by the proteomics community for complex mixture analysis, barring 




 This work will focus, in part, on a compromise between the two methods 
outlined above, termed middle out (also known as middle down).  Middle out 
peptides are between 3 and 20kDa in mass,21, 22 and are usually produced using single 
residue specific proteolysis, although other methods have been employed.21   This 
hybrid method utilizes high resolution analysis, although not so high that it can only 
be performed using an FT-ICR instrument.  The method also uses proteolysis, but the 




therefore, provide higher sequence coverage.  The benefits and drawbacks of this 
method will be explored further in the following chapters. 
Bioinformatics 
Search Algorithms for Bottom Up 
 Bottom up proteomics experiments produce a large amount of data.  Hybrid 
instruments, like the LTQ-Orbitrap described above, routinely acquire tens of 
thousands of spectra over the course of a single LC-MS/MS experiment.  Datasets 
like this are too large for manual interpretation of each pair of precursor and 
associated product ion spectra, so high throughput bioinformatic search methods have 
become an integral part of proteomics experiments.  Proteomic search algorithms 
utilize a priori knowledge of the analyte and sample preparation methods for 
matching against predicted peptides from a set of protein candidates.23-25  For MS/MS 
experiments, inputting a product ion spectrum and the m/z of the ion from which it is 
derived will return a list of peptides likely to be in the sample based on observed 
fragment ions (Figure 5).  First, the specificity of the enzyme used in the proteolysis 
step is used to compile a list of peptides in silico from a set of candidate proteins, 
which are usually defined by translation of genomic sequences of a given 
phylogenetic taxon.  Subsequently, a precursor ion is searched against the in silico 
produced peptide masses within a user defined mass tolerance.  If there are candidate 
peptides within that mass tolerance, experimentally observed product ions are 
compared with predicted b and y fragment ions (for CID produced product ions).  






Figure 5.  Product ion spectrum matched to a peptide from histone H2B type-1 from 
M. musculus.  The nearly complete y ion series facilitated a high confidence 
assignment. 
 
A common metric for gauging the confidence of peptide identifications is the 
expectation value (Evalue).  Formulae that mathematically describe an algorithm’s 
Evalue differ from one search engine to another, but practically Evalues are the 
number of additional peptides that match a given precursor and product ion pair with 
equal or better scores by random chance alone.   This is used in conjunction with an 
additional parameter, the false discovery rate (FDR).  False discovery rates are 
calculated by searching mass spectral data against a database of intentionally false 
sequences, which are formulated by shuffling or reversing the individual protein 




defined, all ‘true’ matches in the forward database must have Evalues better than the 
Evalue of the highest confidence match in the reverse or shuffled database.  Applying 
these stringent parameters achieves a 0% FDR. 
 
Search and Decharging Algorithms for Large Peptides and Proteins 
 
 Large peptides and proteins, as stated earlier, require neutral mass 
determination of both precursor and product ions prior to database searching.  Search 
engines that can match large peptides and proteins to candidate sequences must first 
decharge all mass spectra.  For the large quantity of spectra in a given LC-MS/MS 
experiment this is performed rapidly by comparing experimentally observed isotope 
clusters for each MS peak with a cluster predicted from a polypeptide composed of 
Averagine, a theoretical amino acid weighted for the relative abundance of all twenty 
commonly occurring amino acids.26 After attaining the neutral mass of all peaks, the 
algorithms take advantage of the high mass accuracy measurements for highly 
specific matching to predicted product ions resulting in a low FDR.  The search 
program utilized for this dissertation, ProSightPC (ThermoFisher, San Jose, CA), was 
designed to accommodate post translational modifications, and therefore does not 
associate any additional confidence for high accuracy precursor mass measurement.  
This peculiarity was best demonstrated by Wynne and Fenselau in the assignment of 
a single amino acid substitution for DNA binding protein HU Alpha from Erwinia 





Figure 6. Product ion spectrum of a  z = 13  precursor at m/z 732.71.  The ion was 
matched to the DNA binding protein HU alpha with a ~14 Dalton mass difference 
(top sequence).  Applying the observed mass shift to a region lacking overlapping b 
and y ions resulted in an increase in confidence due to a higher number of 
overlapping b and y ions. Adapted from reference 27. 
In this example, the spectrum was matched to a sequence based on the high accuracy 
fragment ions, but with a precursor mass difference of ~14 Daltons (Da).  
Examination of the matched fragment ions shows that there are no ions overlapping 
the region containing “EGDAV”.  The authors then localized the ~14Da mass shift to 
this region.  Implementing a mass shift to the only amino acid that can accommodate 
this mass change (a Glu to Asp substitution) resulted in an increase in the total 









  The current permeation of proteomics in biological research is due largely to 
genomic sequencing.  Generally, there are a few categories that describe the 
evidential basis of a protein database.  They are either composed of translated 
genomic data, manually curated, or some combination of the two.  Genomic 
databases are characterized by a higher number of total sequences, but there are 
frequently redundant entries.  Manually curated databases typically have fewer 
sequence redundancies and a greater amount of functional and biological information 
per entry.  In this work, all final identifications were taken from sequences and entry 
specific information (cellular component, biological function, etc.) present in the 




 Scientists undertaking proteomic experiments are generally exposed to a 
single method for analysis.  The typical proteomic experiment employs tryptic 
digestion either in gel or in solution and low resolution mass spectrometric fragment 
ion analysis of small peptides providing little more than identification of the proteins 




efficient proteolytic reaction that has been shown to reliably produce peptide sets in 
which the expected cleavage sites predominate. To date, this method has not been 
successfully applied to mixtures of greater complexity than the yeast ribosome.  The 
primary aim of this dissertation is to demonstrate, through two methods development 
experiments applied to complex mixtures and several novel applications, that 
alternative methods to the tryptic standard, in this case, microwave-supported acid 
hydrolysis, can provide a comparable amount of information and are sometimes better 









Chapter 2: Microwave-supported Acid Hydrolysis 
 
 
Single Residue Specific Proteolysis 
 
 Bottom up methods have provided an extensive and solid foundation for 
proteomic analysis.  These methods rely on the enzyme, trypsin, which cleaves C 
terminal to Arg and Lys residues unless they are modified or followed by Pro.  
Despite the ease of use and reliability of bottom up methods, there are numerous 
benefits to using single residue specific methods that cannot be achieved using 
trypsin.   The most obvious is an overall increase in average peptide length. The 
extent of the change in average peptide length is dependent on the specificity of the 
enzyme or chemical used.  There are several readily available options that will cleave 
at a single residue; cyanogen bromide (CNBr) (C terminal of Met), and the enzymes 
GluC, AspN, ArgC, LysC, and LysN.  The relative abundance of each one of these 
amino acids, as determined by an in silico digest of the human proteins present in the 
UniprotKB shows that of the above options, Met is the least abundant followed by 





   
Figure 7. Shown above is a histogram demonstrating the relative abundance of the 
twenty essential amino acids present in human proteins in the UniProtKB.  The 
abundances of residues commonly exploited for single residue specific proteolysis are 
denoted by an asterisk. 
 
Despite its theoretical promise, widespread use of CNBr hydrolysis at Met residues 
for proteomics is marred by several factors.  Primarily, the reagent is toxic and 
requires specialized accommodation for safe use and disposal.  Additionally, there are 
possible undesirable side reactions in which peptide bond hydrolysis does not occur.  
Despite these drawbacks, several investigators have found CNBr to be a worthwhile 
method for proteomic analysis.  Few methods use CNBr alone, but it is frequently 
paired with another enzymatic or chemical cleavage method.  The high concentrations 
of acid used in CNBr digestion seem to invite dilution and subsequent acid 
hydrolysis.  Indeed, Baek and co-workers observed a nearly 3-fold increase in the 
number of proteins identified using this method as well as an increase in average 
sequence coverage when compared to analysis of the same membrane enriched 




the human proteome makes CNBr an attractive option in middle out proteomics, the 
safety hazards and possible undesirable side reactions associated with its use often 
outweigh the benefits. 
 
 The enzymes AspN, LysC , LysN, and ArgC  all produce similar average 
length peptides to one another based on their respective amino acid distributions.  
Some enzymes, including the AspN protease isolated from Pseudomonas fragi, are 
metalloproteases, meaning that they require a metal cofactor to cleave proteins.29  
This circumstance makes them incompatible with workflows that utilize metal 
chelators like EDTA, a commonly used blood anti-coagulant, in their buffers.30 
Despite the drawbacks mentioned above, all of these enzymes have their respective 
places in the proteomics toolkit.  The common theme among all of them, however, is 
that they are enzymes.  All of these enzymes have conditions under which they 
perform optimally, usually near neutral pH and little to no denaturant.  Once optimal 
conditions are achieved, catalysis is allowed to proceed typically overnight. 
   
 The increase in average length displayed by single amino acid specific 
enzymes and chemical proteolytic methods is accompanied by a decrease in the total 
number of peptides produced from a complex protein mixture.  A reduction in sample 
complexity facilitates more efficient chromatographic fractionation prior to 
introduction into the mass spectrometer.  Karger and colleagues first alluded to this 
fact in their extended range proteomic analysis publications using single residue 




of the idea was later underscored by Mechtler and co-workers, when they 
demonstrated a linear relationship between chromatographic peak capacity and the 
number of proteins identified in a given LC-MS/MS experiment.34  The significance 
of a decreased number of peptides for such a complex sample is obvious, but previous 
work by Swatkoski and co-workers demonstrated that fewer peptides from an 
equivalent sample will benefit even samples of low to moderate complexity using the 
S. cerevisiae ribosome as a model system.35  The same publication utilized in silico 
digestions to show a high number of peptides with similar size and chemical 








Figure 8.  Comparison of peptide lengths of S. cerevsiae ribosomal proteins following 
digestion with trypsin (top) and Asp specific digestion (bottom).  Note the difference 
in Y axis. Reprinted with permission from reference 35. 
 Longer peptides also benefit proteomic analysis by their size alone.  An 
increase in sequence coverage provides more information on a given sequence of a 
protein.  This is particularly well suited for proteins that display multiple 
modifications that work in concert.  Histones, which are extensively post 
translationally modified proteins responsible for packaging chromatin within a cell’s 
nucleus, are a perfect example of this phenomenon.  According to the UniProtKB, 
histone H2A.X (accession number P16104) from H. sapiens, can contain up to six 




similarity.  This ~15kDa protein contains only two internal Asp residues, resulting in 
three peptides following Asp specific acid hydrolysis.  The high number of post 
translational modifications working in concert with one another require an analytical 
method that can observe as many PTMs as possible on a single peptide.  Additionally, 
Histones are DNA binding proteins, and in order to perform their required function 
they must contain a high occurrence of basic residues.  The relative abundance of Lys 
and Arg residues in DNA binding proteins is increased significantly compared to the 
entire human proteome.  These two reasons, the ability to observe long peptides 
containing multiple PTMs that work cooperatively, and a high incidence of basic 
residues that would result in peptides too small for analysis following tryptic 
digestion, make Asp-selective hydrolysis an attractive option.  An additional model 
system of nucleotide binding proteins, the human ribosome, will be examined later in 
this work. 
 




High temperature incubation in acidic solutions has been employed for 
indiscriminate protein hydrolysis into their individual amino acids. Schultz and co-
workers observed in 1962 that under acidic conditions used for total protein 
hydrolysis, lone Asp residues were produced at a rate at least 100 times greater than 




led to the hypothesis that hydrolysis proceeds via two different mechanisms where the 
bond is cleaved between Asp and the adjacent N- or C-terminal amino acid.37  At 
temperatures greater than 108°C, the reaction will proceed indiscriminate of the acid 
used as long as the pH is below the pKa of the beta carboxyl group of the Asp side 
chain. Li and co-workers demonstrated in 2001 the utility of Asp specific acid 
cleavage for proteomics experiments.38 Using a heating block to keep the temperature 
at 108°C, the reaction was allowed to proceed for up to 4 hours in 2% formic acid. 
Laboratories later demonstrated the temperature could be easily maintained with a 
microwave oven, a technique already adopted in the synthetic organic chemistry 
community. Microwave irradiation was found to allow selective protein hydrolysis to 
be achieved in minutes, instead of the hours previously required.39, 40  
 
Two mechanisms are illustrated in Figure 9, which allow proteolysis to occur 
C-terminal and N-terminal to Asp residues. The Asp side chain cyclizes, forming 6- 
or 5-membered rings with carbonyl groups on either side.  Model systems favor 
hydrolysis of the 5-membered ring,41, 42 supporting previously observed results from 






Figure 9.  Mechanisms of Asp-selective acid hydrolysis. Adapted from reference 38. 
Acid hydrolysis has been demonstrated using several acids,43-45 consistent 
with the idea that Asp side chain protonation is a requirement.  Inglis’ initial 
characterization defined pH 2.0 (achieved with both HCl and formic acid), at a 
temperature of 108°C over the course of a 2 hour incubation period as optimal 
reaction conditions.37  Hydrochloric and formic acid are also known to denature 
proteins, facilitating protonation and proteolysis.  Formic acid and acetic acid are 
employed by most laboratories at concentrations ranging from 0.05% to 12.5%.22, 30, 
35, 39, 40, 43, 44, 46-51  Low abundance side reactions include N-terminal pyroglutamate 
formation, formylation, and presence of the dehydrated cyclic intermediates. 
Proteomics search engines will readily allow for all of which.  Fenselau and co-




short incubation times with simple mixtures, a phenomenon not observed using acetic 
acid.47  Koomen and co-workers demonstrated that selective acid hydrolysis can even 
be implemented with the acidic matrices used for MALDI-MS.52 Hydrolysis with 
stronger acids like trifluoroacetic acid at higher concentrations leads to non-specific 
cleavage, likely due to a higher proportion of hydronium catalyzed hydrolysis.53, 54  
 
In general, incubation time increases with sample complexity. The best results 
have been obtained when total protein concentration does not exceed 0.1mg/mL, 
irrespective of sample complexity.  Protein disulfide bond reduction has been 
demonstrated by the addition of dithiothreitol (DTT) to the reaction vessel.44, 46  The 
high temperature acidic conditions hydrolyze both O-linked glycans and 
phosphorylations.38, 43 
 
Microwave-supported Acid Hydrolysis 
 
 Microwaves lack sufficient energy for molecular rearrangement, and are 
therefore non-ionizing.  In an electromagnetic field, dipoles will attempt to constantly 
align themselves with the electric field.  This frequent dipolar rotation provides 
dielectric heating.  In addition, microwave absorption and heating is solvent 
dependent.55  The physics governing microwave energy absorption are beyond the 
scope of this dissertation; however, Lidstrom, et al can provide a comprehensive 





 Microwaves are a type of electromagnetic radiation with a wavelength 
between 1 and 1e-3 meters.   The specific frequency of 2.45 GHz is commonly used to 
support chemical reactions. Initial experiments in this laboratory utilized a domestic 
microwave oven operated at 745W;39 however, subsequent attempts from this 
laboratory as well as others progressed to research grade microwaves with tunable 
power settings.30, 35, 43, 44, 46-48, 50 Asp-selective acid digestion has been performed in 
domestic microwaves, and with non-microwave induced heating,38, 40, 45, 52 but 
microwaves specifically made for chemical reactions have convincing benefits.  
Kitchen microwaves irradiate non-uniformly.  While this is a non-issue for food 
preparation, which takes up significant space in a domestic microwave, the 
microscale sample volumes typically used in proteomics experiments necessitate 
more focused exposure.  Commercial microwaves offer focused irradiation in a 
confined area with uniform energy distribution.  As an added benefit, research grade 
microwaves facilitate temperature regulation to within ±5 o C.   
 After demonstrating that microwave-supported acid hydrolysis works on 
standard proteins and bacteria, Swatkoski et al appraised its effectiveness for complex 
mixtures using both MALDI and ESI approaches,35  Ribosomes were purified from S. 
cerevisiae and digested for 20 minutes in 12.5% acetic acid at 140  ±5o C. Using an 
automated bottom up approach, 247 peptides were confidently observed, representing 
58 of the 78 expected ribosomal proteins.  Ribosomal and other nucleotide binding 
proteins contain high numbers of Arg and Lys residues in their primary sequences. 
This makes them poorly suited for proteomic analysis with tryptic digestion, because 




smaller (red) and large (green) peptides predicted for each protein from the ribosome, 
and the sequence coverage provided. The bottom graph shows peptides produced by 




Figure 10. Predicted peptides resulting from Asp specific (top) and tryptic digestion 
of the S. cerevisiae ribosome.  Peptides in green are outside the 500-5,000Da mass 
range.  Individual proteins are shown on the X axis and the relative sequence 
coverage provided by each peptide is shown on the Y axis. Reprinted with permission 





The chemical properties of acid hydrolysis produced peptides are distinct from 
those produced with trypsin.  Trypsin’s specificity for the C terminal side of Lys and 
Arg provides a basic site on the C terminus of every product.  Protonation of the C-
terminal amino acid side chain and amino terminus, typically gives product ion 
spectra ideally suited for high throughput database searching.15  Swatkoski and 
Fenselau demonstrated product ion spectra of peptides without a C terminal basic 
amino acid could be interpreted and searched against databases.35 Interestingly, the 
majority of peptides from the S. cerevisiae ribosome had two or greater internal basic 
residues, which aided in sensitivity for nanospray MS analysis.  Swatkoski and co-
workers evaluated the hydrolysis reaction by searching the observed data without 
designating any enzyme specificity.  This step allowed evaluation of cleavage 
specificity based on fragmentation data, a stronger basis for identification compared 
to peptide mass fingerprinting, applied previously.  In agreement with Li et al,38 70% 
of the peptides adhered to the expected cleavage either side of Asp. Mascot, a popular 
proteomics search algorithm, now offers acid cleavage (“formic acid” in Mascot) as a 
parameter for enzymatic specificity.  
 Basile and co-workers have implemented microwave-supported acid 
hydrolysis in line with chromatographic separation.44  Proteins were subjected to 
microwave irradiation for 5 minutes in 12.5% formic acid at 130 o C via a 5 µL fused 
silica reaction loop.  The method was used to analyze an E. coli lysate in which ten 
proteins were successfully identified by LC-MS/MS.  The same laboratory later 
demonstrated combining microwave-supported acid hydrolysis with electrochemical 





The previously outlined experiments demonstrate that acid hydrolysis, 
whether supported by microwave irradiation or not, can reliably and quickly produce 
peptides that are the result of hydrolysis on either or both sides of Asp residues.  
Additionally, despite lacking a C terminal basic site to aid in ion trap and quadrupole 
fragmentation, acid hydrolysis peptides are amenable to high throughput 
bioinformatic search algorithms.  The most compelling results from these 
experiments have been from standard proteins or with simple mixtures.  This 
dissertation will go over several methods development and optimization type 
experiments aimed at extending the benefits of microwave-supported acid hydrolysis 
to more complex mixtures. 
 




 Denaturing polyacrylamide gel electrophoresis has become a mainstay for 
fractionation of complex protein mixtures based on molecular weight. Arguably the 
most applied technique in proteomics couples tryptic digestion with electrophoretic 
separation.  Microwave-supported acid hydrolysis has been shown to be an effective 
method for rapid proteolysis in proteomic workflows in solution, and has even been 
applied on pure proteins in gel and molecular weight standards.   Despite its rapid 




used on truly complex mixtures, whether in gel or not.  Presented here is a 
demonstration of in gel microwave-supported acid hydrolysis on a whole cell lysate 
from RPMI-8226 multiple myeloma cells. 
 Currently, comprehensive proteomics employs almost exclusively 
workflows that utilize a two-residue specific enzymatic proteolysis step coupled with 
some method of fractionation at either the protein or peptide level.  Proteolysis is 
usually performed with trypsin, a protease that cleaves C terminal to Arg and Lys, 
unless followed by Pro.  While this method has proven to be quite reliable and 
effective, there is still a need for alternative options in the proteomics toolkit.   
In gel digestion using trypsin for protein identification has become a standard 
procedure for many labs.  The ease of applicability of this method has made it readily 
available even for scientists that normally work outside the proteomics arena.  
Despite its simplicity, few methods can rival the protein level separation efficiency of 
electrophoresis   A recent publication from this laboratory demonstrated a higher 
number of identifications using in gel tryptic digestion when compared to other easily 
implementable methods that have garnered recent acclaim.56, 57  As of yet, there are 
few examples in the literature of in gel digestion being performed using microwave-
supported acid hydrolysis.38, 40, 45  While these works are important to show the 
feasibility of in gel microwave-supported acid digestion, they do not demonstrate the 
potential of the reaction for applications analyzing complex mixtures.  Additionally, 
there are only a few examples of this proteolytic method being used successfully for 




demonstrate the feasibility of using microwave-supported acid digestion on complex 
mixtures in gel using a whole cell lysate from RPMI-8226 multiple myeloma cells. 
 
Materials and Methods 
 
 Cell Growth, Harvesting, and SDS-PAGE Fractionation.  RPMI-8226 
cells and RPMI-1640 media were purchased from ATCC (Manassas, VA).  Cells 
were grown in suspension in RMPI-1640 media supplemented with 10% fetal bovine 
serum (FBS) and antibiotics.  The cells were maintained in a 5% CO2 atmosphere.  
RPMI-8226 cells were incubated at 4°C for 30 minutes in hypotonic buffer (2.5mM 
imidazole, pH 7.0) prior to lysis using N2 cavitation.  The lysate was spun at top 
speed in a benchtop centrifuge for 10 minutes to pellet insoluble cellular debris, and 
the supernatant recovered.  Soluble protein was precipitated using the method of 
Wessel and Flugge58 and concentration was estimated using the RC/DC Protein 
Assay (BioRad, Hercules, CA) post resolubilization in gel loading buffer.  
 Four 170µg aliquots were diluted in Laemmli loading buffer (BioRad, 
Hercules, CA) and fractionated electrophoretically on a 8-16% gradient Tris-HCl 
polyacrylamide gel (BioRad, Hercules, CA).  The gel was then fixed and stained.  
Eight bands were excised from the gel with each band composed of equivalent 
molecular weight regions from each of the four lanes (32 bands total).  The bands 
were then pooled and destained according to the method of Shevchenko and co-
workers.59 The pooled gel bands were macerated to aid in solvent uptake and eventual 




rehydrated in 12.5% (v/v) acetic acid in water for 30 minutes.  Just prior to digestion 
additional solvent was added to ensure the gel pieces were completely submerged. 
 
 Microwave-supported Acid Hydrolysis.   For in gel digestion the destained 
gel pieces were digested for 30 minutes at 140°C while irradiating with 300W of 
microwave energy.  The post digestion supernatant was recovered and the peptides 
were recovered following the previously referenced protocol.59  Briefly, peptides 
were extracted by adding a 1:2 solution of 5% formic acid:ACN and incubating at 
37°C on a shaker for 30 minutes.  The post digestion supernatant and extraction 
solution containing the acid proteolysis peptides were combined and lyophilized to 
near dryness.  The solution was diluted to ~100µL prior to LC-MS/MS analysis. 
 
 LC-MS/MS.  For each of the eight pooled gel samples, 95µL of the digested 
mixture were injected and fractionated via RP-nLC prior to MS analysis.  Peptide 
solution was injected via a Shimadzu Prominence NanoLC (Columbia, MD) and 
autosampler.  The sample was concentrated online at 5µL/min in 100% solvent A 
(97.5% water/2.5% ACN/0.1% formic acid) for 20min.  Subsequently, the peptides 
were fractionated on a 0.15mm x 150mm C18 column (Grace Vydac, Deerfield, IL) 
using a linear gradient that declined from 100% solvent A to 65% solvent A over the 
course of ninety minutes with a flow rate of 500nL/min.  Mass spectrometric analysis 
was performed using a Thermo LTQ Orbitrap XL (San Jose, CA).  Precursors were 
acquired at high resolution (30,000) and the top nine most abundant multiply charged 




following CID settings: normalized collision energy was set to 35, activation time 
was set to 30ms, activation Q was set to .250, and isolation width was set to 3Da.  
 
 Bioinformatics.  All spectra were searched and combined using the PepArML 
combiner provided by Dr. Nathan Edwards 
(htts://edwardslab.bmcb.georgetown.edu/PepArML/).60  Acid digested peptides were 
searched against the IPI Human database.  Dehydration at Asp, pyro-glutamic acid 
formation from N terminal Glu and Gln, and oxidation of Met were added as variable 
modifications.  These parameters were searched against six different search engines 
and the results were combined and an estimated peptide specific false discovery rate 
was generated.  Peptides with FDR less than 10% were included in the list of 
identified peptides and therefore proteins.  The raw data was also searched against the 
IPI Human database without designating enzymatic specificity using the Mascot 
search engine (MatrixScience, Manchester, UK).  Mascot searches used a 10 part per 
million (ppm) precursor mass tolerance and 0.6Da fragment ion mass tolerance. 
Charge states +2, +3, and +4 were interrogated using the same variable modifications 
listed above. 
 
Results and Discussion 
 
 The proteomics community has accommodated the fact that polyacrylamide 
gel electrophoresis permeates nearly all aspects of in vitro biological research by 




Similarly to in solution digestion methods, microwave-supported acid hydrolysis is 
catching up to the tryptic standard.  Although acid hydrolysis has been used on gel 
fractionated samples previously,38, 40, 45 there have yet to be any successful analyses of 
complex mixtures.  In this report, a gel fractionated whole cell lysate from multiple 
myeloma cells resulted in 1241 distinct peptides representing 642 proteins (Appendix 
Table 1 and Appendix Table 2).  The average sequence coverage per protein was 
8.25%.  Despite the higher protein concentration required for in gel acid digestion, the 
efficiency of electrophoretic fractionation is maintained (Figure 11).  The resulting 
data validates this conclusion by observing greater than 75% of all proteins identified 
were confined to a single band. 
 
 
Figure 11.  Coomassie stained gel demonstrates lowered stain resolution due to high 
protein concentration.   Excised bands are outlined in red.  Despite lower resolution, a 






Microwave-supported Acid Digestion for Bottom Up Proteomics.  In both of the 
experiments outlined above it can be concluded that microwave-supported acid 
hydrolysis in gel is a viable method for proteomic analysis of complex mixtures.  
When compared to the standard tryptic methods used by most laboratories, acid 
hydrolysis provides a faster alternative, albeit at lower sensitivity. Since the result of 
kinetic selectivity is a distribution of peptide products regardless of digestion time, 
there is an inherent decrease in the absolute quantity of any single peptide ion of 
interest.  Practically, this means that a given portion of a protein’s sequence will be 
observed in at least one specific ion and at most four (DXXXXXXD, DXXXXXX, 
XXXXXXD, and XXXXXX) due to the dual terminal specificity.30  It is also likely 
that the decrease in sensitivity can be attributed to the peptide mass distribution 
resulting from microwave-supported acid digestion.22  Contrary to the ease of 
implementation of in gel bottom up proteomics, top down methods have not enjoyed 
the same widespread success despite significant effort.61, 62  This is due to a decrease 
in extraction efficiency from the polyacrylamide gel matrix as the length of the 
polypeptide increases.   
 In this work we demonstrate that microwave-supported acid digestion is a 
viable workflow for the analysis of complex mixtures in gel.  Specifically, we show 
that this method is applicable to a complex mixture such as a whole cell lysate and 
will provide results in a small fraction of the time used for the current tryptic 
standards. In gel microwave-supported acid digestion has been shown to provide a 
more comprehensive analysis than previously shown, albeit with lower sensitivity 




the benefits of electrophoretic fractionation are still observed.  Proteins can be 
effectively denatured and fractionated, cleaned of interfering non-proteinaceous 
materials, and visualized prior to rapid chemical digestion well suited for LC-MS/MS 
analysis.  
 




 All of the previously mentioned methods take advantage of acid hydrolysis 
produced peptides that are similar in size to those produced using trypsin.  Although 
this strategy has a clear advantage over enzymatic methods due to the increase in 
speed of analysis, it ignores additional benefits provided by single residue specific 
proteolysis methods. A strategy is presented for enhancing the middle-out analysis of 
higher mass peptides recovered from a complex protein mixture.  Following a 30 min 
digestion of multiple myeloma cell lysate by an acid cleavage reaction that is 
selective for aspartic acid, a 3,000Da membrane filter is used to bifurcate the peptide 
product mixture, and the heavier fraction is subjected to collisional activation with 
precursor selection that excludes charge states below +4. Filtration and charge state 
selection are shown to provide significant increases in the number of peptides 






 Middle-out proteomic strategies exploit the advantages of analyzing heavier 
peptides (3,000-20,000Da) in proteomic analyses.64, 65 These include improved 
chromatographic fractionation, higher sequence coverage, and characterization of 
cohabiting and potentially interactive modifications.32, 66 Experimentally, analysis of 
peptides in the mass range 3,000 to 20,000Da simplifies the complex mixtures offered 
by bottom up strategies, while avoiding the diminished performance of top down 
experiments.21, 67   Most often, single-residue specific enzymatic reactions are used to 
produce mid-range peptides. Previously we have demonstrated the use of a chemical 
method that cleaves proteins selectively at aspartic acid in less than 30 min.22 Like 
other proteolytic agents, microwave-supported acid cleavage of complex protein 
mixtures produces complex peptide mixtures that contain lower mass peptides as well 
as heavier peptides. During automated analysis by LC-MS/MS, an abundance of low 
mass peptides in the mixture can suppress or obscure precursor selection and 
activation of the mid-range peptides. Here we report the use of molecular weight 
cutoff filters to separate a complex peptide mixture into high mass and low mass 
fractions. In addition, we limit precursor selection in high resolution tandem mass 
spectrometry experiments to charge states of 4+ or greater in order to optimize high 
throughput analysis of mid-range peptides. The combination of these two 







Materials and Methods 
 
 RPMI-8226 Cell Culture, Isolation, and Lysis.  RPMI-8226 multiple 
myeloma cells were grown and harvested as published.68 The cells were lysed in 
2.5mM imidazole, pH 7, using N2 cavitation at 1250psi (Parr Instrument Co, Moline 
IL).   Following centrifugation at 10,000rpm for 10 minutes, the supernatant was 
collected and stored at -80°C until digestion. 
 
 Microwave-supported Acid Hydrolysis and Mass Biased Partitioning.  
Protein was precipitated from solution using the method of Wessel and Flugge.58  The 
pellet was redissolved in buffer and the concentration was determined by RC/DC 
assay (BioRad).  A 50µg aliquot was diluted to 0.1µg/µL with acetic acid and water 
to arrive at a final solvent concentration of 12.5% (v/v) acetic acid.  The acidified 
sample was digested in a CEM Discover Microwave (Matthews, NC) at a maximum 
temperature of 140°C for 30 minutes while irradiating with 300W.   Following 
digestion the samples were allowed to cool to room temperature. Amicon 3kDa and 
10kDa molecular weight cutoff (MWCO) filters (Millipore, Billerica, MA) were 
equilibrated with 12.5% acetic acid prior to use.  The acid digestion products were 
then fractionated through the filter according to the manufacturer’s instructions.  The 
high mass fraction retained above the filter was diluted with 200µL of Milli-Q water, 




approximately 100µL.  The low mass filtrate was also collected and reduced to 100 
µL.  
 
 LC-MS/MS. For the low mass peptide sample, 1/20th of the total volume was 
injected for LC-MS/MS analysis.  Reversed phase chromatography was carried out 
using a Shimadzu Prominence LC and Autosampler (Columbia, MD).  Following 
injection, the peptides were desalted and concentrated online for 20 minutes at a flow 
rate of 10µL/min with 100% Solvent A (97.5/2.5/0.1 H2O/ACN/formic acid).  The 
peptides were then fractionated using a 0.150mm x 150mm Grace Vydac Everest C18 
column packed with 5µm particles with 300Å pores (Deerfield, IL).  The flow rate 
was set to 300 nL/min and the concentration of Solvent B (97.5/2.5/0.1 ACN/H2O 
/formic acid) was increased in a linear fashion from zero to 35% over the course of 
180 minutes.  Low mass peptides were introduced into an LTQ-Orbitrap XL and MS1 
scans were acquired at 30,000 resolving power.  Precursor peaks were limited to the 8 
most abundant multiply charged peptides.  Product ion spectra were recorded in the 
LTQ at unit resolution. 
 For the high mass portion, 100µL of sample was injected for each analysis.  
Chromatographic conditions were identical to those outlined above.  Survey scans 
were acquired at 30,000 resolving power and the three most abundant multiply 
charged precursors were isolated and fragmented in the ion trap, and subsequently 





 Charge State Inclusion and Rejection.  For mass biased partitioned samples 
chromatographic conditions were identical to those outlined above.  For the low mass 
fraction, MS parameters were identical aside from charge state selection.  Data 
dependent analysis was set to only isolate and fragment precursors with charge states 
of +2 or +3.  For higher mass peptide analysis, only precursors with charge states 
greater than +4 were selected for isolation and fragmentation.   Automated gain 
control targets were set to 5 x 105 and 5 x 106 for the survey and product ion scans, 
respectively. Isolation width was set to 10Da.  
 
 Bioinformatics.  Mid-mass peptides were identified using ProSightPC2.0, 
which incorporates the Xtract algorithm for precursor and product ion neutral mass 
calculations (ThermoFisher).  Precursor mass tolerance using ProSightPC was set to 
250Da. The large mass window allows for the identification of the N- or C-terminal 
Asp-cleavage products observed in microwave-supported acid hydrolysis with 
ProSightPC’s AspN in silico digest option.   In addition, the large window allows for 
the identification of dehydrated and oxidized species.  Fragment mass tolerance was 
set to 15ppm.  Mid-mass spectra were searched against a database of reviewed human 
proteins from the UniProtKB digested in silico using ProSight’s Database Manager 
utility, with a maximum of 9 missed cleavages and maximum peptide mass of 20kDa.  
Spectra were also searched against a shuffled version of the same database.  
Identifications were assigned automatically with E-values less than or equal to 10-8, 
the threshold at which no peptides were matched in the shuffled database search.  




were validated manually. RAWmeat (Vast Scientific, Cambridge, MA) was used to 
obtain scan and charge statistics from data files.  
The low mass peptide fraction was searched using the PepArML search engine.10 
PepArML combined results from 6 search engines against the IPI Human database 
incorporating cleavage specificity at either side of Asp residues.  Dehydration at Asp, 
pyro-glutamic acid formation from N terminal Glu and Gln, and oxidation of Met 
were added as variable modifications. In silico digestions were performed using ad 
hoc software developed in house. 
 
Results and Discussion 
 
 In order to prepare a sample enriched in mid-range peptides, fractionation of 
the peptide mixture was evaluated using both 3kDa and 10kDa filters. The heavier 
fraction of peptides recovered from each filter was analyzed by LC-MS/MS, 
excluding selection of  +2 and +3 precursor ions and implementing 7500 resolution 
for product ion analysis as described in the experimental section.  Increasing the 
resolution for product ion spectra improves product ion charge-state determination 
and boosts the specificity of product ion matching, however, at the expense of 
increased duty cycle.  A larger proportion of the 10kDa filter’s peptides were heavy 
(≥ 3kDa), compared to the 3kDa filter’s peptides, although the absolute number of 
heavy peptides was greater for the 3kDa filter. Consequently the 3kDa filter was 




 A combined total of 349 proteins were identified from 624 peptides when both 
the heavy and light peptide fractions were analyzed using optimal conditions as 
described in Materials and Methods.  Fifty-six peptides were identified in the high 
mass fraction (3kDa filter) from 38 proteins, whereas 568 peptides were observed in 
the low mass portion, from 333 proteins. Figure 12 shows the molecular masses of 
peptides identified from injections of the heavier retentate and the lighter filtrate. In 
this figure, the proportion of each fraction’s identified peptides in each of 500Da bins 
is plotted side-by-side. The masses of the peptides identified from each injection 










Figure 12.  Peptide mass distributions of high (red) and low (blue) mass peptide 
fractions resulting from mass biased partitioning after microwave-supported acid 
hydrolysis. 
Of the total, only 9% of the peptides identified have masses > 3,000Da. To some 
extent, this reflects the smaller number of heavier peptide products that can be 
formed.  A theoretical analysis of AspC cleavage of the proteins identified indicates 
that 27% of the peptide products would be expected to weigh more than 3,000Da 
(with 0 missed cleavages and a maximum peptide mass of 20kDa). By contrast, 91% 
of the peptides identified had masses below 3,000Da, while 73% were predicted. 
Experimental under-sampling clearly occurs in our experimental analysis of the mid-
range peptides.  
 The distribution of experimental peptide identifications was also compared to 




and analyzed twice, first using the LC-MS/MS parameters optimized for the lighter 
filtrate and also those optimized for the heavier peptide mixture. One hundred and 
ninety-eight peptides were identified when product ion characterization was carried 
out with unit mass resolution in the ion trap (our low mass mode). Fifteen of these 
peptides had masses exceeding 3,000Da, however the use of low resolution 
compromised their identification. Twenty-eight peptides were identified using the 
higher resolution Orbitrap analysis, of which thirteen had masses exceeding 3,000Da. 
The more complex mass biased sample preparation appears to provide more peptide 
identifications overall, and, more to the point, a nearly four-fold increase in 
identifications of mid-range peptides with high reliability. 
 We have reported previously, in a study of human ribosomal proteins, that 
analysis of heavier peptides obtained using Asp-selective acid cleavage provides 
higher sequence coverage than the shorter peptide products of tryptic proteolysis.22  
The advantageous coverage offered by longer peptides is confirmed in the present 
study of whole cell lysate. Thirty-three per cent of singlet peptide identifications in 
the high mass fraction provided greater than 10% sequence coverage of their parent 
proteins, while only 10% of the individual peptides identified in the low mass fraction 
provided greater than 10% coverage. Overall, the average protein coverage for the 
high mass peptide fraction is 9.4%, and for the low mass peptides is 4.6%. This trend 
for Asp-selective acid cleavage is in agreement with the general view of single-
residue middle-out analysis of protein.21, 22, 67     
 The proportion of peptides produced by a proteolytic reaction that fall into the 




frequency of the targeted residue(s) and experimental control of missed cleavages. Of 
particular interest is the distinction between the products of trypsin, which cleaves at 
two amino acid residues--lysine and arginine, and methods that cleave at a single 
amino acid. Karger and co-workers have suggested that the false discovery rate 
decreases with larger peptides.32 Goodlett and co-workers have examined the notion 
that precursor ion densities are not distributed uniformly across the m/z landscape in 
their gas phase fractionation experiments.69, 70  To explore the density of overlapping 
peptide masses in our experiment, human proteins in the UniProtKB were digested in 
silico based on cleavage with trypsin, and also on cleavage at the C-terminal side of 
aspartic acid, and duplicate peptide sequences were removed. For each in silico 
peptide, the number of additional peptides within 10ppm of its mass was counted, and 
the peptides tabulated in various non-specificity bins. The results are summarized in 
Figure 13, where it can be seen that 70% of all Asp-C peptides in the mass range 500 
to 1000 share their 10ppm window with 5 or fewer additional peptides, while 19% of 
the tryptic peptides 500 to 1,000Da have this advantage. The 70% precursor 






Figure 13. The proportion of peptides with masses that overlap within 10ppm, 
produced by in silico digestion of a subset of human proteins in UniProtKB using 
trypsin (top) and Asp C (bottom).  Portions in blue indicate regions with 0-5 
additional peptides, regions in red have 6-10, in green have 11-20, and in yellow have 
greater than 20. 
 
Consideration of Figure 13 indicates that the molecular masses of peptides in the 




Theoretically, Asp-specific proteolysis (and likely any single residue proteolysis) 
produces a higher proportion of peptides with nearly unique masses than trypsin. This 
allows more reliable identifications with lower false discovery rates due to the lower 
number of searchable peptide candidates within a given precursor mass tolerance.  
 In summary, we have demonstrated that microwave-supported acid hydrolysis 
is a viable method for rapid proteolysis of complex protein mixtures, and that mass 
biased partitioning, comprising both membrane cut-off filtering and precursor charge 
state selection, provides enhanced access to, and identification of, mid-sized peptides. 
Care must be taken with the analysis of the larger peptides. In our experience there is 
often just one identified per protein.  The use of high resolution in the determination 
of both precursor and fragment ion masses, and the reduced probability for 











 Despite tremendous advances based on Fourier transform ion cyclotron 
resonance mass analyzers, there are still technical barriers to the implementation of 
top-down tandem mass spectrometry as the method of choice for automated analysis 
of complex protein mixtures. In addition to the challenge to continue to extend the 
mass range to accommodate protein requirements,71, 72 the resolution and mass 
accuracy required for deconvolution of very high charge state species are achieved on 
many Fourier transform ion cyclotron resonance analyzers at ion accumulation times 
incompatible with interfaced chromatographic flow rates. In the meantime, real 
advantages have been recognized for the analysis of long polypeptides, so-called 
middle-out analysis, in the mass range 3,000 to 20,000Da. Such proteolytic products 
are reported to provide valuable information about the cooperative occurrence of 
PTMs.71, 73-75 Midrange peptides are reported to be fractionated with improved 
resolution by HPLC.32 Longer peptides carry higher numbers of charges when 
electrosprayed, which enhance both CID and ETD.35, 48, 76 
 These polypeptides are usually produced from protein mixtures by enzymatic 
or chemical methods that cleave with selectivity for a single residue.32, 35, 75, 77, 78 One 
of these, microwave-supported acid hydrolysis, has been consistently shown to cleave 
polypeptides on one or both sides of Asp residues. This method has the advantage 




residues; however, its major advantage is the speed with which it provides proteolysis 
in a variety of solvents. 
 Without requiring customized modifications, the Orbitrap mass analyzer has 
been shown to provide resolution sufficient to decharge midsized polypeptide 
precursors in a time frame compatible with capillary HPLC peak widths. 
Additionally, the Orbitrap is able to analyze the multiply charged fragments resulting 
from collisional or electron transfer activation of highly charged precursors with high 
resolution (15,000 and up) at a duty cycle compatible with chromatography. The 
Orbitrap used in this work was coupled to a linear ion trap, whose trapping capability 
maintains sensitivity while providing robust multicollision activation. The longer duty 
cycle that results from measuring both precursor and product ions with high 
resolution means that fewer peptides can be analyzed in a given elution time and 
recommends the use of mixtures of fewer peptides such as those provided by the 
middle-out strategy. 
The computational requirements include the capability to extract and 
deconvolute charge states from isotope patterns of precursor and product ions and to 
search the resulting fragmentation patterns against predictions from databases of 
protein sequences. In the present work, ProSightPC 2.0 was used, which also provides 
the option to specify acid cleavage at Asp. 
 The ribosome is an important multiprotein complex, currently under intense 
scientific scrutiny.79 Pulse chase experiments have shown that the half-life of the 
eukaryotic ribosome exceeds that of the cell,80 and modest protein modifications have 




treatment. In the human ribosomal database, Asp residues account for 3.81% of total 
residues. By comparison, Arg, Lys, and Arg-plus-Lys account for 9.30, 12.36, and 
21.65% of total residues, respectively. Figure 14a-c shows the distribution of 
peptides of various residue lengths predicted for molecular weights greater than 
500Da with at most 1 missed cleavage, with respect to (a) tryptic digestion (3,397 
total), (b) Lys-C digestion (2,406 total), and (c) acid digestion (991 total). We use an 
in silico Asp-C cleavage for this figure, instead of the total acid digest, to eliminate 
double counting of sequences that differ only in the presence of an Asp residue. 
Observed acid cleaved peptides have also been filtered throughout to eliminate 
peptides differing only in terminal Asp residues. In the small ribosomal proteome, 
comprising mostly basic proteins, Asp-selective cleavage is expected to provide a 
peptide set of limited size with molecular masses (lengths) across the middle-mass 
range. The present evaluation of a novel middle-out workflow has been carried out on 
the ribosomal proteome with the expectation that it will be applied in future studies of 






Figure 14. Distribution of peptide products by length, predicted from the 84 proteins 
in the human ribosome cleaved by (a) trypsin, (b) Lys-C, and (c) Asp-C acid 
cleavage. (d) Distribution of Asp-C peptides identified experimentally in an acid 
cleavage digestion. Reprinted with permission from reference 22. 
 
 
Materials and Methods 
 
 Cell Culture and Ribosome Isolation. MCF7 breast cancer cells were grown 
to confluence in Improved Minimal Essential Media (IMEM) with L-glutamine 




inactivated FBS. Cells were maintained at a temperature of 37 °C in a 5% carbon 
dioxide atmosphere until confluence. 
 Ribosomes were isolated from confluent cells. All procedures were carried out 
on ice unless otherwise indicated. Homogenization of the cell pellet with a 
Kinematica mechanical homogenizer (Littau, Lucerne; Switzerland) in two volumes 
homogenization buffer (50mM Tris-HCl, pH 7.5; 5mM MgCl2, 25mM KCl, 200mM 
sucrose) was followed by centrifugation at 10,000g for 10 minutes at 4°C in a 
benchtop centrifuge. The supernatant was collected and the remaining pellet 
rehomogenized on ice and centrifuged. The supernatant was layered 1:1 over a 
sucrose cushion buffer (50mM Tris-HCl, pH 7.5; 5mM MgCl2, 25mM KCl, 2 M 
sucrose) and the ribosomal pellet isolated by centrifugation at 260,000g at 4°C for 2 
hours in a swinging bucket rotor. 
 Protein Extraction.  Ribosomal proteins were extracted from a 500µL 
suspension following a variation of the method described by Hardy et al.81 In brief, 
one volume of the ribosomal suspension was mixed with 0.25 volumes of 1M 
Mg(OAc)2 followed by the addition of 1 volume glacial acetic acid. Each solution 
was incubated for 1 hour and the precipitated rRNA was pelleted by centrifugation at 
10,000rpm at 4°C for 10 minutes in a benchtop centrifuge. The supernatant was then 
collected. Molecular weight cutoff filters (Microcon Ultracel YM-3, Millipore, 
Billerica, MA) were used to concentrate the samples and reduce the acid content. 
After desalting and concentrating the samples, the protein concentrations were 




concentrations were prepared for each sample. To each of these samples acetic acid 
and dithiothreitol were added to achieve 12.5% acetic acid and 5mM dithiothreitol. 
 
 Microwave-supported Acid Hydrolysis.  The method optimized and 
reported by Swatkoski et al35 for digestion of ribosomal proteins was used. Fifty 
microliters of each solution was irradiated at 300W for 20 minutes in SPS mode in a 
Discover Benchmate microwave (CEM) at 140°C. Samples were collected and 
injected directly into the nanoLC through an autosampler.  
 
 LC-MS/MS.  Seven injections were made into a Shimadzu Prominence 
NanoLC (Shimadzu, Columbia, MD) interfaced to the LTQ Orbitrap mass 
spectrometer (ThermoFisher, San Jose CA) via an Advance CaptiveSpray Plug-and-
Play source (Michrom Bioresources, Auburn CA). The samples were loaded onto a 
0.3mm x 5mm Peptrap 300 C18 pre-column (Dionex, Sunnyvale, CA) in 5% Solvent 
A (97.5% water/2.5% ACN/0.1% formic acid) and desalted for 15 minutes. Peptides 
were eluted into a 0.1mm x 150mm C18 analytical column (Grace Vydac) and 
separated with a linear gradient of 5−15% solvent B (97.5% ACN/2.5% water/0.1% 
formic acid) in 5 min, then to 69% B in 115 min. Flow rate was 500nL/min.  
Automated gain control settings were optimized using replicate injections of the 
human ribosome digest.  Survey scans were acquired in the Orbitrap with resolving 
power of 30,000 at m/z 400 and an automated gain control (AGC) target level of 5 x 
105. The three most abundant ions were selected for fragmentation using CID in the 




with He gas for 30ms with a normalized collision energy of 35. The product ion AGC 
target level was set to 5 x 104 and fragment ion scans were acquired in the Orbitrap 
with resolving power of 15,000 at m/z 400. Dynamic exclusion parameters were set 
to exclude ions previously selected for fragmentation for 3 minutes. All data were 
acquired in reduced profile mode to accommodate further downstream processing. 
 
 Bioinformatics.  Following spectral acquisition .RAW files were processed 
using ProSightPC 2.0 provided by Professor Neil Kelleher, University of Illinois.65 
Each .RAW file was processed in High Throughput mode. Spectra were decharged 
with cRAWler using the THRASH algorithm. A FASTA format protein sequence 
database of 79 human ribosomal proteins was extracted from the Ribosomal Protein 
Gene Database82 and configured for acid-cleavage analysis with ProSightPC 2.0. 
Spectra were searched in Absolute Mass mode using a 2.5Da precursor window based 
on the peptide monoisotopic mass. An additional search, using a loose precursor 
window of 250 Da, was carried out to search for evidence of PTMs and peptide 
isoforms. Significant identifications, when sufficient b and/or y ions were matched 
despite discrepancies between the predicted precursor mass and the observed mass 
were manually checked using ProSightPC’s Sequence Gazer tool. The sequence 
positions of the b and/or y ions matched help to localize the mass-shift from putative 
PTMs and single amino acid substitutions.19, 27 Mass tolerance for fragment ions was 
set at 15ppm. False discovery rates (FDR) were calculated using a randomly shuffled 
version of the ribosomal protein sequence database previously described.  Mascot 




out specifying “no enzyme.” Up to 9 missed cleavages were allowed, with precursor 
tolerance of 10ppm and product ion tolerance of 0.05 Da. Variable modifications 
were selected to include N-terminal acetylation, N-terminal pyro-glutamate formation 
from Gln and Glu, Met oxidation and Ser/Thr/Tyr phosphorylation. 
 
Results and Discussion 
 
 Since resolution attained with Fourier transform based mass analyzers is 
linearly dependent on transient acquisition time, it is important to optimize the duty 
cycle to acquire the maximum number of high resolution product ions scans per unit 
time, particularly with complex mixtures containing coeluting peptides throughout the 
chromatographic separation.  Automated gain control (AGC) is a user tunable 
parameter designed to prevent space charge effects, a phenomenon in which high 
concentrations of ions in the confined space of the ion trap coulombically repel one 
another and decrease resolution during analysis.  Optimization of the AGC settings 
was based on several important assumptions associated with the chemical nature of 
ribosomal proteins and peptides.  Importantly, all proteins present in the mixture are 
assumed to have stoichiometric abundance.  This allowed optimization to be carried 
out without any concern for acquiring spectra of low abundance peptides.  
Additionally, the ribosomal peptides are highly basic and thought to sequester 
protons15.  The high gas phase basicity of Arg and Lys residues (which exhibit 
increased abundance in ribosomal proteins when compared to the rest of the human 




fields within the mass spectrometer.  These assumptions allowed a decrease in the 
maximum number of ions used to fill the trap in each product ion scan (based on the 
increased stability in the gas phase), and an additional decrease in the total ion trap 
fill time in the event there is an insufficient number of ions to fill the trap (based on 
the assumed stoichiometric abundance of all proteins and peptides). Figure 15 
demonstrates the increase in the average number of scans per unit time after applying 
the optimized settings. 
 
 
Figure 15.  Product ion spectra of the same precursor ion acquired using default (top) 




The changes implemented in the AGC parameters allowed an approximately 1.3 fold 
increase in the total number of acquired scans, which in turn, resulted in an increase 
in the total number of identified peptides using an identical chromatographic 
separation. 
 
 Peptide identifications were accepted at E-values of 1 × 10-3 or less, 
corresponding to a FDR of <1%. Three hundred sixty-six distinct peptide sequences 
were identified using ProSightPC 2.0, including a number of peptide sequences 
differing only in the addition or removal of N- or C-terminal Asp. Two hundred 
seventy-six unique peptides remain after accounting for this redundancy. Forty-four 
percent of the peptides had masses greater than 3kDa. Twenty-eight percent of the 
predicted peptides were identified experimentally. Figure 14d indicate that 
microwave-supported acid cleavage produces peptides from ribosomal proteins that 
span a range of lengths, including significant representation in the range 3000 to 
10  000 Da. It should be noted that the full range of charge states could not be 
explored at the resolution used in this study. We are working to extend the range of 
middle-out analysis on the LTQ-Orbitrap at higher resolution. 
 Microwave-supported acid hydrolysis exhibits kinetic selectivity (not binding 
specificity) for cleavage at aspartic acid.43  In a previous study of yeast ribosomal 
proteins we reported that acid cleavage occurred with fidelity at Asp at 83% of the 
termini in peptides identified. Mascot was used with “no enzyme” specified to make 
this analysis. The present data set was also searched with Mascot, specifying “no 




identified in the ProSight search. Among the 376 peptide termini analyzed, 34 
comprised protein termini and 19 (5%) carried termini produced by cleavage at 
residues other than Asp. The majority of these occurred next to Pro,(4) Asn,(5) and 
Glu(6). 
 The 366 peptides identified represented 70 of the 79 human ribosomal 
proteins present in the ribosomal database with at least one significant peptide 
identification, and 65 of the 79 ribosomal proteins were identified with at least two 
distinct significant peptide identifications. The average sequence coverage observed 
for these 70 proteins was 46.2%. Figure 16 illustrates the coverage accumulated from 




Figure 16. Sequence coverage of seventy proteins by the peptide products of acid 




 The present analysis allows us to test the hypothesis that larger acid digestion 
products provide an increase in sequence coverage.  Ribosomal protein L21 is 
represented by just two unique peptides. However, as Figure 16 indicates, those 
peptides account for 61% of the total sequence. Figure 17 provides a comparison of 
the sequence coverage for 70 proteins provided by the peptides with molecular 
masses above 3,000Da identified using ProSight, and coverage provided by peptides 
identified with molecular masses below 3,000Da. The set of peptides with masses 
below 3,000Da comprises 205 peptides, whereas the set with masses above that 
threshold contains 161. The more limited set of longer peptides provides higher 
coverage, 36% on average, while the average coverage provided by the more 
abundant shorter peptides is 21%. 
 
 
Figure 17. Sequence coverage of seventy proteins by subsets of the peptides in 
Appendix Table 5. 
Another positive byproduct of acid digestion is the presence of multiple basic 




cleave at basic sites create peptides with sequences that localize positive charges at 
the termini and must rely on proton transfer for backbone fragmentation.15 Peptides 
produced from acid digestion, on the other hand, usually contain multiple internal 
basic sites and readily produce multiply charged precursor and fragment ions. Figure 
18 illustrates the formation of highly charged fragment ions by collisionally induced 
dissociation of a polypeptide containing 14 Arg and Lys residues. Although no long 
series of sequence ions is produced, the fragment ions observed, used in conjunction 
with accurate mass measurements of precursor and product ion masses, are sufficient 
to allow the search program to identify the polypeptide with high reliability. 
 
Figure 18. Product ion spectra of a peptide with a calculated monoisotopic mass of 




fragmentation assigned by ProSightPC 2.0; (bottom) decharged product ion scan. 
Reprinted with permission from reference 22. 
The largest polypeptide observed has a neutral mass of 9174.51Da and carries 12 
charges on ions at m/z 765.01. This charge state was determined readily at the 
resolution used. 
Evidence for a number of modified peptides was collected in the course of this study 
using the loosely constrained precursor search.27 One example (Figure 19), curated 
and localized manually using ProSight’s Sequence Gazer tool, involves a mass-shift 
in an acid digest product of ribosomal protein L10. Initially identified with E-value 
1.672 × 10-7 based on 4 b and y ions, its E-value improved to 1.31 × 10-25, from 12 b 
and y ions, after application of an ~27 Da mass shift indicative of a single amino acid 






Figure 19. Comparison of the observed (top) and theoretical (bottom) isotope clusters 
from peptide [194-206] from ribosomal protein L10.  Also shown are the sequences, 
matched fragment ions, and corresponding Evalues.  The single amino acid 
substitution is highlighted in green in the theoretical sequence and satisfies the 
observed precursor mass difference. 
The substitution was later confirmed as a naturally occurring variation.83 
 
 Conclusions.  The novel middle-out workflow presented here demonstrates a 
rapid automated method for analysis of a small protein mixture, allowing high 
confidence identifications of nearly 30% of the expected peptidome, recognition of 
protein modifications and an average of 46% sequence coverage of 70 of 79 possible 




notably the use of still higher resolution on the LTQ-Orbitrap instrument to permit 





































 Ubiquitin is a 76 residue protein conserved among all eukaryotes that most 
famously targets substrate proteins for proteasomal degradation.  Many ubiquitin 
monomers are joined to one another and to the substrate protein of interest via 
isopeptide bonds that join the C terminal glycine residue to one of seven possible 
lysines on ubiquitin, and a solvent accessible lysine on the substrate.  Although 
proteasomal degradation is the most well known outcome of ubiquitination, there are 
many more that are directly linked to the length and linkage pattern of the modifying 
ubiquitin moiety.   In particular, Lys63-linked polyubiquitin is thought to affect at 
least four different non-degradative pathways within the cell; DNA damage repair, 
cellular signaling, intracellular trafficking, and ribosomal biogenesis.84 
 Proteomics has become an integral tool for studying ubiquitination and its 
effects in a high throughput manner.  Typically, ubiquitinated proteins are 
immunoprecipitated and subsequently digested using trypsin.  Cleavage with trypsin 
displays a convenient GlyGly tag on isopeptide bonded lysines, which is easily 
accommodated as a variable post translational modification through nearly all 




immunoprecipitated using an anti-GlyGly antibody for identification of the site 
containing peptides only.85  Using these methods, the data provided will reveal solely 
the site of ubiquitination.  There is no information provided about the nature of the 
modification, itself.  Currently, methods used for determining the length of a 
modifying ubiquitin moiety require observation of the intact mass of the substrate 
protein in addition to the polyubiquitin chain.  Due to the large size of the monomer 
(~8.5kDa), addition of only a few ubiquitins to all but the smallest proteins will likely 
render them unsuitable for top down mass spectrometric analysis. Denaturing 
polyacrylamide gel electrophoresis has become a standard method used to formulate 
ubiquitin ladders, where the protein of interest is observed in several bands separated 
by electrophoretic shifts indicative of the addition of a single ubiquitin monomer.  
These ladders allow one to accurately tell how many ubiquitins are on a given 
substrate, but fail to establish the linkage pattern between each unit, or even 
distinguish whether there is, in fact, a polyubiquitin chain or multiple 
monoubiquitinated sites.  Even immunoblotting with linkage specific antibodies only 
confirms the presence or absence of a given linkage type at one isopeptide bond in a 
potentially extensively branched molecule which could contain several. 
 Serendipitously, the primary sequence of ubiquitin contains no Asp residues 
between the C terminus and Lys63.  This means that if there is a polyubiquitin species 
containing only Lys63 linkages that is cleaved using Asp specific hydrolysis, the sum 
of the C terminal peptide masses (minus the loss of one water molecule for every 
isopeptide bond formed) is a direct indicator of the length of the polyubiquitin chain.  




of the C terminal peptide (DYNIQKESTLHLVLRLRGG) mass multiplied by the 
number of contributing monomer units minus 1 water molecule per isopeptide bond. 
 
 
Figure 20.  A schematic representation demonstrating the unbroken chain of C 
terminal ubiquitin following Asp specific hydrolysis.  Shown is a Lys63 linked 
tetramer conjugated to a ubiquitin substrate (the mass is equal to that of the 
pentamer).  Neutral mass of the resulting peptide is equal to the mass of the C 
terminal peptide (2211.21Da) multiplied by the number of monomeric units (5) minus 
one water molecule per isopeptide bond (4*18.01). 
 





 This method is clearly well suited to ubiquituin polymers that are not 
conjugated to a substrate, but it can also be useful for ubiquitin oligomers that are 
acting as protein modifiers.  A prerequisite for using this method in a discovery type 
way would be to have a priori knowledge of the actual sites of ubiquitination or of 
which proteins are modified.  This is a task for which trypsin has proven quite 
successful.  Once the ubiquitination sites are identified, one can confirm the number 
of Lys63 linked ubiquituins on it based on the change in observed mass from the 
unmodified peptide alone.  In a typical complex mixture proteomics experiment, the 
sample would contain far too many peptides for this type of analysis, but the added 
constraint of having a known ubiquitination site on the peptide of interest 
significantly decreases the number of molecular weight possibilities.  Of particular 
importance is that the peptide that also contains Lys63 following Asp specific 
proteolysis is the most C terminal on ubiquitin, meaning that it will be conjugated to 
the substrate regardless of any type of further linkage.  In the least informative 
scenario, high resolution accurate mass analysis with this longer “tag” will provide a 
higher level of confidence for previously arrived at tryptic digestion results. In 
situations in which there are multiple consecutive Lys63 linkages on a substrate it 
will provide an unprecedented look at the length of the ubiquitin moiety associated 
with a specific protein substrate under given cellular or in vitro conditions. 
 Polyubiquitin chains have been examined mass spectrometrically with the 
goal of distinguishing specific linkages before.  Aebersold and co-workers were able 




concerning the overall character of ubiquitin linkages from a complex mixture.86  
This method provides statistical information on the abundance of different linkages in 
the complex mixture, but fails to offer any information on the ubiquitin moiety 
associated with a specific substrate protein, a relationship that would be greatly 
beneficial to characterize.   In a work that utilized non-tryptic enzymatic digestion 
methods for linkage specific analysis, Goldberg, Gygi, and co-workers were able to 
observe evidence for the formation of at least di-ubiquitin for all seven possible Lys 
residues.87  Clemmer and co-workers were able to distinguish Lys63 and Lys48 
linked dimers of intact ubiquitin using differences in collisional cross section with ion 
mobility mass spectrometry.88  Oldham and co-workers demonstrated the successful 
linkage specific analysis of diubiquitin using a top down approach.89   These analyses 
demonstrated the untapped versatility offered by non-tryptic methods, with the two 
more recent approaches using higher molecular weight species that can define linkage 
patterns.  Unfortunately with most commercially available mass spectrometers, the 
resolution required for confident observation of intact species composed of more than 
a few ubiquitins is not yet attainable.  The same problem occurs when a ubiquitin 
chain is conjugated to a substrate protein.  
 
Materials and Methods 
 
 Ubiquitin Expression.  All expression, purification, and chain ligation was 
performed in the lab of Dr. David Fushman by Mark Nakasone. Competent E. coli 




K63 (where all Lys other than Lys63 are mutated to Arg), K0 (where all seven Lys 
are mutated to Arg), and an additional mutant form of ubiquitin in which an extra Asp 
residue is present on the C-terminus to prevent chain elongation (D77).  Following 
expression cells were lysed by sonication, and the lysate was cleared via 
centrifugation at 22,000rpm.  The supernatant was precipitated by the addition of 
1.5%(v/v) perchloric acid, and again centrifuged.  The ubiquitin containing 
supernatant was then dialyzed using a 3kDa molecular weight cutoff membrane 
against 2L of 50mM ammonium acetate (pH 4.5).  The ubiquitin containing solution 
was then loaded onto a 5mL cation exchange column (GE Life Sciences, Pittsburgh, 
PA) and eluted over a 22 column volume gradient from 0-40% solvent B (50mM 
ammonium acetate, 1M NaCl, pH 4.5).  Ubiquitin containing fractions were pooled 
and the purity was confirmed using SDS-PAGE. 
 
 Formation of Dimeric and Trimeric Ubiquitin. All polyubiquitin chains 
were synthesized enzymatically from the monomers described above using the 
method of Pickart and Rassi90 and Dong91 et al with slight modifications.  After 
expression in E. coli cells, UBE1 (E1 activating enzyme), Ubch5b (used as substrate), 
and MMS2 (necessary for UBC13 E2 activity) were purified using a 5mL His Trap 
column (GE Life sciences). The Lys63 specific E2, UBC13, was expressed as a 
fusion protein in BL-21(DE3) cells.  Yeast ubiquitin C-terminal hydrolase (YUH1) 
was expressed without a tag and purified according to the method outlined by 
Johnston and co-workers.  To generate dimeric K63 linked chains D77 and K63R 




and ATP.  Trimeric K63-linked chains were synthesized by removing D77 from the 
Lys63 dimer, and then using the same reaction conditions with the D77 monomer 
(2+1) to obtain the trimer.  After a period of twenty-four hours ubiquitin chain 
reactions were stopped by the addition of 10mL of cation buffer A (50mM 
ammonium acetate, pH 4.5), the solution was spun at 13,000rpm to remove 
precipitated E1 and E2 enzymes, then slowly injected on a 5mL cation exchange 
column at 0.2mL/min using an FPLC.  Once no absorbance was detected the attached 
ubiquitin and polyubiquitin species were eluted with 50mM ammonium acetate 
containing 1M NaCl, pH 4.5.  The eluted ubiquitin was then exchanged into PBS 
pH7.4, concentrated to volume of 1mL and the dimeric and trimeric species were 
resolved by size exclusion chromatography (SEC).  The purity of the SEC fractions 
were confirmed using 15% SDS-PAGE and MALDI.         
 
 Mono and Polyubiquitinated UbcH5b. Ubiquitinated Ubch5b was created 
using the same reaction conditions as the chains with the exception of the 
concentration of monomeric ubiquitin and Ubch5b.   To create mono-ubiquitinated 
Ubch5b, the same reaction outlined above was performed with 75µM Ubch5b and 
1mM of K0 ubiquitin in a 2mL volume.  The Lys63 polyubiquitinated UbcH5b92 was 
created under similar conditions with 75µM Ubch5b and 1.5mM Lys63 ubiquitin.  
After twenty-four hours each reaction was diluted with 10mL of PBS with 0.5M 
NaCl, pH 7.4, then loaded on a 1mL His-Trap column.  The elution, which contained 
a mixture of Ubch5b and Ubch5b with a varying number of ubiquitins, was 




volume of 1mL.  This was fractionated by SEC, and different oligomeric states of 
ubiquitinated Ubch5b were detected using 15% SDS-PAGE.     
  
 In Gel Acid Digestion of Dimeric and Trimeric Ubiquitin.  Once in our 
hands, electrophoretically separated ubiquitin dimers and trimers were excised using 
a transfer pipette from a polyacrylamide gel and destained in 50/50 ACN/water.  
After destaining the gel pieces were dehydrated in ACN and subsequently rehydrated 
in 12.5% acetic acid solution for 30 minutes.  Just prior to digestion additional solvent 
was added to ensure the gel pieces remained saturated.  Gel pieces were digested for 5 
minutes at 140ºC using 300W of microwave energy to maintain temperature in a 
CEM Discover microwave (Matthews, NC).  After digestion the peptides were 
extracted directly and desalted using Millipore C18 ZipTips (Billerica, MA) 
according to the manufacturer’s instructions.  Mass spectra were acquired in linear 
mode on a Kratos Axima CFR MALDI-TOF MS (Shimadzu, Columbia, MD). 
 
 In Solution Digestion of Di- through Hexa-Ubiquitin. Lys63 linked 
polyubiquitin (n = 2-7) was formulated as indicated above.  The protein was purified 
by SEC and confirmed by SDS-PAGE.  The resulting protein solution was 
precipitated58 and redissolved in 12.5% acetic acid.  Digestion was carried out at 
140°C in a CEM Discover microwave for 20 minutes while irradiating with 300W of 
energy.  The resulting peptides were then cleaned up using C18 Ziptips (Millipore) 





 Immunoprecipitation and LC-MS/MS.  Enzymatic digestion was performed 
using sequencing grade trypsin acquired from Promega (Madison, WI), and digestion 
was conducted according to the supplied protocol.  Lysine63 specific antibody 
(Millipore, Billerica, MA) was conjugated to agarose beads using the ThermoPierce 
Direct IP kit (Rockford, IL) according to the manufacturer’s instructions.  All IP 
reactions were performed according the manufacturer’s protocol.  High resolution 
mass spectrometry was performed using a Thermo LTQ-Orbirap XL.  Intact peptide 
masses were acquired at maximum resolution and product ion measurement was 
performed at 15,000 Rp (at m/z 400).  Prior to acquisition of mass spectra, peptides 
were separated using reversed phase chromatography with either an Agilent Zorbax 
C3 column or a GraceVydac C18 column at a flow rate of 500nL/min.  Data acquired 
from tryptic digestion was searched with the MASCOT (Manchester, UK) search 
engine against human proteins from the UniProtKB.  Precursor mass tolerance was 
set to 10ppm and fragment ion mass tolerance was set to  .05Da.  The diglycine tag 
was used as a variable modification for Lysine residues. 
 
Results and Discussion 
 
 MALDI Characterization and In Gel and In Solution Digestion of 
Oligoubiquitin. Due to the rapid nature of microwave-supported acid digestion in 
conjunction with its kinetic selectivity, short digestion times  (<90 seconds) were 
tested initially in solution to confirm that the expected cleavage sites were observed 






Figure 21.  Shown on the top left of the figure is the amino acid sequence of ubiquitin 
with lines shown at possible microwave-supported acid cleavage sites.  An asterisk 
and a diamond show the sites of cleavage for the most abundant (1 missed cleavage) 
and second most abundant (0 missed cleavages) peaks of the C terminus containing 
peptides, respectively.  Also shown are the corresponding sites on an NMR solution 
structure (PDB ID: 1d3z).93   
 
Interestingly, the peptide with the highest relative abundance is the segment from 
Gly53 to the C terminus.  This peptide contains 1 missed cleavage site.  Typically, the 




result that generally agrees with the idea of a globular protein in solution as a wound 
up ball of spaghetti with the termini exposed.  At the molecular level, microwave-
supported acid hydrolysis must have some dependence on solvent accessibility to 
potential cleavage sites.  This inference is underscored by the mechanisms proposed 
by Inglis and coworkers, which require cyclization of the carboxylic acid side chain 
of Asp to adjacent residues.37  Hydrogen bond donation to and from the adjacent 
backbone nitrogen atoms makes it unlikely the cyclization process would occur, 
inhibiting the formation of the proposed cleavage products.  Nuclear magnetic 
resonance and X-ray crystal structures display considerable evidence that the most C 
terminal Asp residue on ubiquitin is in involved in hydrogen bonding in a 3-10 
helix,93 which could explain the lack of abundance of the C terminal peptide without 








Figure 22. Zoomed in region containing Asp58 from the NMR solution structure of 
monoubiquitin.93 Measurements of the backbone nitrogen (on Tyr59) and backbone 
oxygen (on Ser57) to nearby hydrogen bonding partners are shown. 
Strong correlation between the majority of peaks from two dimensional (15N, 1H) 
heteronuclear single quantum coherence (HSQC) spectra acquired by Mark Nakasone 
for monoubiquitin in water and in 12.5% (v/v) acetic acid at room temperature 
supports this conclusion. Even under the harsh conditions of microwave-supported 
acid digestion, the low abundance of the most C terminal peptide suggests that some 
semblance of secondary structure is maintained prior to complete thermal 




 Initial analysis was simplified by the fact that the expected intact protein 
products were isolated by SDS PAGE into distinct gel bands at high concentrations.  
This allowed for effective in gel acid digestion and subsequent extraction of the large 
oligomeric state specific peptides.  Observation of the C terminal inclusive peptide 
was paramount since it contains the site of conjugation to the substrate and/or 
preceding ubiquitin moiety.  Two particular doublets of peaks were found close to the 
expected masses from the calculation described in Figure 20.  The two most 
abundant peaks in the region of interest were found to be the result of C terminal Asp 
cleavage as expected, and they were each accompanied by a peak 115Da lower, 
indicating the loss of one Asp residue (Figure 23).  The two doublets were separated 
by ~629 Da, which correlates to the mass difference between the C terminal peptide 
with one missed cleavage and that with zero missed cleavages (DGRTLS).  This same 
pattern of increasing by one missed cleavage was observed in the spectrum of the acid 
digested trimer (where one branch contained a K63R mutation), with an additional 





Figure 23.  Shown above are regions of interest from MALDI spectra of in gel 
microwave-supported acid digestion products of di- (top) and tri-ubiquitin.  The 
characteristic 115Da pairs are observed as well as mass differences that correlate to 1 
(top) and 2 additional missed cleavages (bottom).   
 
 LC-MS/MS and Diagnostic B ions.   Following the initial characterization of 
the reaction products by MALDI, it was essential to demonstrate that this method is 
compatible with LC-MS/MS methods.  Indeed, it could be expected that the increase 
in sensitivity provided by chromatographic separation would benefit the analysis of 
larger peptides that have higher ionization energy requirements in MALDI.  To 
confirm the expected results, multiply-ubiquitinated species engineered in the same 
manner were digested and subsequently separated chromatographically prior to high-




introduction, current methods in ubiquitin proteomics allow for identification of the 
ubiquitinated peptide, but fail to provide any information on the PTM itself.  This is 
achieved by digesting with trypsin and observing a GlyGly tag from the C terminus of 
ubiquitin on the Lysine of the conjugated peptide.  Due to the length of the tag left 
behind on the conjugated peptide using acid digestion (at least 17 residues), it is 
impossible to carry over this methodology.  Asp selective digestion, however, does 
allow for highly specific analysis by capitalizing on high resolution accurate mass 
measurements of diagnostic b ions from the N terminus of the conjugated ubiquitin 
peptide.  It was previously demonstrated using peptide mass fingerprinting that the 
most likely cleavage site for observing the C terminal peptide of ubiquitin occurred at 
Asp52.  From this point forward (toward the N terminus), it is possible to formulate 
reconstructed ion chromatograms for each individual b ion up until the isopeptide 
bonded Lys63 (Figure 24).  These ions prove to be diagnostic for isopeptides due to 
the fact that they are present from each possible C terminal peptide regardless of its 
position in the ubiquitin oligomeric species, whereas this is not the case with any 






Figure 24.  Shown above is a primary sequence representation of a Lys63 linked 
pentaubiquitin peptide resulting from Asp-specific proteolysis (each constituent 
peptide has 1 missed cleavage at Asp58). The b ions stemming from the residues 
highlighted in green plus any additional ions toward the next possible cleavage site 
from the C terminus are unchanged regardless of the oligomeric unit of Lys63 linked 
ubiquitins. 
 Especially with branched peptides, as the peptide gets larger and contains 
more branches the product ion spectral complexity increases, and so does the number 
of possible product ions – most of which are likely to be internal and unmatchable to 




the identification of these branched oligomers.  Ubiquitin is a small protein that 
produces a small number of peptides under the previously outlined conditions with 
Asp selective hydrolysis.  This number is sufficiently small that with high resolution 
accurate mass measurement of modified precursor masses and known sites of 
ubiquitination from tryptic digestion experiments run in parallel, manual 
interpretation of the changes in precursor mass should be attributable to a previously 
identified peptide in simple mixtures.  
 
 Lys63 Linkage Specific Protein and Peptide Immunoprecipitation. 
Immunoprecipitation has been used extensively in biochemistry for the purification 
and analysis of individual proteins and protein complexes.  Analysis of ubiquitin, 
specifically, has benefited greatly from the production of antibodies that are specific 
to oligomeric states of ubiquitin, and more recently, specific ubiquitin-ubiquitin 
linkages.  Lys63 linkage specific peptides have been formulated in two different ways 
using intact diubiquitin and a synthetic branched peptide as immunogens.  In this case 
the branched peptide derived antibody is better suited for analyzing oligomeric state 
specific peptides since it can be used at both the protein and the peptide level.  The 
enhanced specificity can be exploited for immunoprecipitating Lys63 linkage 
containing (poly)ubiquitinated proteins as well as for pulling down Lys63 linkage 
containing peptides that result from Asp specific digestion of the complex mixture. 
This process proves to be crucial for successful analysis of the oligomeric state 
specific peptides due to an inherent increase in dynamic range associated with 




specific ubiquitin peptide, there is only one informative peptide per polyubiquitin.  In 
addition to the one peptide of interest, there are four peptides that are of no interest 
per constituent monomeric unit.  This phenomenon can be effectively demonstrated 
by observed the change in relative abundance of a single peptide of interest from the 
ubiquitinated substrate as an increasing number of ubiquitins are attached (Figure 
25). 
 
Figure 25. A series of MALDI spectra excised from gel bands correlating to mono- 
through penta-ubiquitinated UbcH5b.  The relative abundance of a single peptide 




A small increase is easily overcome, but the problem is also dependent on the number 
of ubiquitin moieties present in the complex mixture, and the relative number of 
linkages associated with each one. 
   A mixture of wild type ubiquitin oligomers was digested and subsequently 
injected for LC-MS/MS analysis. Higher order oligomeric state mixtures of wild type 
polyubiquitin species were used to further demonstrate the viability of the above 
outlined immunoprecipitation method.  Size exclusion chromatographic fractions 
containing  mixtures of engineered Lys63-only  linkage containing polyubiquitin 
were digested and subsequently immunoprecipitated with the Lys63 linkage specific 
antibody.  Higher order ubiquitin oligomers were fractionated using RP-LC prior to 
high resolution precursor and fragment ion detection.  All isopeptides eluted with 
similar retention times, as confirmed by viewing the extracted ion chromatograms of 
diagnostic b ions.  Deconvolution of the averaged spectra over the elution profile of 
all isopeptide bond containing peptides revealed several high molecular weight 






Figure 26.  Deconvoluted spectra averaged over the course of the elution profile of all 
isopeptides.  Labeled peaks demonstrate assignment of Lys63 containing isopeptides. 
Peaks separated by arrows in spectrum are ~629Da apart, showing the single missed 
cleavage mass shift associated with the Lys63 containing peptide is observed 
frequently in higher order oligomers.  Primary sequence structure with isopeptide 
bonds of the highest molecular weight species is shown on the right. 
 
The high molecular weight species depicted in Figure 26 show characteristic mass 
shifts associated with the Lys63 containing peptide.  The 629Da mass shift indicative 
of a change in the number of missed cleavages observed from in gel digestion is 




the Lys63 linked part of the polyubiquitin chain.  In Figure 26, a quartet of peaks are 
separated by 629Da each, indicative of a missed cleavage on three Lys63 branches.  
The triplet of peaks displays the same phenomenon, showing there are at least two 
Lys63 branches.  Larger branched peptides are observed with several charge states 
and require higher sensitivity for unambiguous identification.  Microwave-supported 
acid hydrolysis has kinetic selectivity for either side of Asp residues,43 often 
producing peptides that differ only by the presence or absence of an Asp residue at 
either terminus. While this is not a major concern for typical proteomics experiments 
examining unbranched peptides,22, 30, 35 the problem of having multiple ions per 
cleavage site is compounded by the increased number of cleavage sites per 
isopeptide.  Additionally, the signal for each distinct mass is spread out over multiple 
charge states, thereby decreasing the sensitivity of the analysis.  Matrix assisted laser 
desorption ionization MS circumvents this problem by producing predominantly 
singly charged ions.  Analysis was performed on a mixture of di- through hexa-
ubiquitin using MALDI-TOF and sequential singly charged 629Da doublets are 





Figure 27. MALDI spectra demonstrating a stepwise increase in C terminal ubiquitin 
peptides from di- through penta-ubiquitin.  Red double-headed arrows highlight 
characteristic 629Da doublets.  In the bottom right inset is a gel providing an 
equivalently informative ubiquitin ladder. 
 
 Identification of Ubiquitination Sites on UbcH5b.  The E2 ligase, UbcH5b, 
is implicated directly in the ubiquitination of the p53 tumor suppressor.94 To test the 
hypothesis that one could attribute a specific linkage combination to a known 
substrate protein based on precursor mass alone, a mixture of different oligomeric 
states of Lys63 ubiquitin was attached to the E2 enzyme UbcH5b enzymatically.  
Initially, work was done using monoubiquitinated UbcH5b.  High resolution fragment 




b ions. Further analysis of the precursors that produced the diagnostic b ions 
demonstrated predicted masses of specific acid digestion isopeptides.  Two peptides 
containing three possible lysines on UbcH5b, on the N terminal peptide, 
ALKIRHKELN (following removal of the initiator methionine) (Figure 28) and on 
Lys128, from the peptide DPLVPEIARIYKT were assigned with precursor masses 
matching within 5ppm (Figure 29) (both sites were confirmed using tryptic digestion 
(Figure 30)). 
 
Figure 28.  Isotopic cluster comparison of the observed (top) and theoretical (bottom) 





Figure 29. Isotopic cluster comparison of the observed (top) and theoretical (bottom) 





Figure 30. Product ion spectra of tryptic peptides from UbcH5b displaying the 
characteristic di-glycine tag indicative of a ubiquitination site. 
A useful property of this method is the inherent high mass of peptides that contain 
Lys63 isopeptide bonds.  For example, Lys63 linked diubiquitin will produce a C 
terminal isopeptide approximately twice the length of the smallest C terminal acid 
cleavage product ((2096Da x 2)-18Da), with the substrate conjugated species being 
even larger.  The minimal mass of  >4kDa allows for fast and efficient mass biased 
partitioning to exclude peptides of little significance to the analysis using 
commercially available molecular weight cutoff filters.63 This technique is further 
validated by the fact that Asp specific hydrolysis produces peptides that are longer on 
average than those produced using the standard tryptic digestion method.  This 




the sample prior to immunoprecipitation of the Lys63 linkage containing peptides to 
reduce complexity and minimize nonspecific binding to the antibody.  After antibody 
elution and injection, the observed m/z ratios can be deconvoluted, corrected to attain 
the monoisotopic mass, and then all possible mass combinations of the 0 and 1 
missed cleavage peptides (the two most commonly produced) can be subtracted.  
Since UbcH5b is the substrate, an in silico digestion of the primary sequence 
provided candidate neutral masses to search the leftover mass against.   Performing 
this type of analysis on the conjugated UbcH5b sample resulted in observation of 
mono- and di-ubiquitin on the acid digestion peptide DDPLVPEIARIYKT.  The only 
lysine, Lys128 is ubiquitinated (Figure 31). 
 
Figure 31. MALDI spectrum of the acid hydrolysis products of mixture of UbcH5b 
conjugated to differing numbers of ubiquitins.  Peptides derived from UbcH5b are 
shown in red font, peptides from ubiquitin are shown in black font. 
 
In the above Figure, characteristic 629Da mass shifts were used to identify potential 




K0 ubiquitin allowed for a priori knowledge of the ubiquitinated peptides. Mono and 
di-ubiqutinated UbcH5b at Lys128 were both observed in the above spectrum.   
  
Conclusions.  Ubiquitin is vital protein modifier that participates in many cellular 
processes that are not yet fully understood.  As demonstrated with Lys48 linked 
ubiquitin and proteasomal degradation, the length as well as the linkage pattern of the 
modifying ubiquitin moiety play crucial roles in determining a substrate protein’s 
fate.95  Despite a significant contribution to the ubiquitin field thus far, current tryptic 
proteomic methods have been unable to discern anything more than the site of 
modification on a substrate protein.  Presented is an Asp specific hydrolysis method 
that can effectively measure the length of a Lys63 linked ubiquitin moiety, and 
identify the site of ubiquitination provided the substrate protein is known.  Although 
Asp specific hydrolysis is well suited for ubiquitinated single proteins and simple 
mixtures on its own, parallel digestion with trypsin for confirmation of the 
ubiquitination site simplifies manual assignment.  Manual assignment is further 
simplified by the presence of peaks correlating to 0 and 1 missed cleavages on each 
monomer unit of the ubiquitin chain. Here the two digestion methods were used in 
parallel to identify two ubiquitination sites following conjugation in vitro.  Using the 
above outlined method, there is the potential for analysis of polyubiquitin isolated 
directly from lysates after enzymatic removal from their substrates, which could 













 Extracellular vesicle (ECV) describes several types of extracellular organelle. 
Apoptotic blebs, exosomes, and shedding microvesicles are all included in this 
umbrella term.  Generally, the three different subtypes listed are defined by their size 
and morphology.96  In all cases, the biomolecules (whether protein, nucleic acid, 
carbohydrate, or lipid)97 contained in the ECVs are apportioned there by the parent 
cell, meaning that all molecules found inside an ECV are also found in parental cells.  
This complexity make extracellular vesicles an excellent model system for further 
evaluation of the optimized methods outlined in the previous chapters.  Previously 
outlined examples of model systems to evaluate our methods have done so on 
chemically unique samples (ribosomes or poly-ubiquitins) or without observing the 
combined effects of multiple methods (in gel acid hydrolysis or mass biased 
partitioning of a whole cell lysate).  The complexity and communal interest in 
extracellular vesicles make them an excellent model system for evaluating a 
microwave-supported acid hydrolysis driven analysis. Studies are underway around 
the world to ascertain how closely the proteins in exosomes and the other ECVs 




commonly excreted.  Presented here is a proteomic analysis of ECVs shed by myeloid 
derived suppressor cells using microwave-supported acid hydrolysis both in gel and 
in solution, according to the optimized methods outlined in Chapters 2 and 4.  
 
Materials and Methods 
 
 Extracellular Vesicle Protein Preparation.  Extracellular vesicles were 
provided by the laboratory of Dr. Suzanne Ostrand-Rosenberg (University of 
Maryland, Baltimore County). Myeloid derived suppressor cells (MDSC) were 
isolated from BALB/c mice 3-4 weeks post inoculation with 4T1 mammary 
carcinoma cells that were transfected to stably express Interleukin 1ß (IL-1ß).  
Following isolation, the MDSC were cultured overnight and intact cells were 
removed.  Extracellular vesicles (ECVs) were isolated from the supernatant using 
sucrose density gradient centrifugation.  Fractions correlating to densities between 1.1 
and 1.2g/mL were isolated and resuspended in phosphate buffered saline (PBS).  
After being transferred to our laboratory, the isolated ECVs were solubilized at 60°C 
in Laemmli buffer.  Proteins were precipitated using chloroform and methanol,58 and 
then resuspended in either gel loading buffer for in gel digestion or in 12.5% acetic 
acid for mass biased partitioning experiments. 
 
 In Gel Microwave-supported Acid Hydrolysis.  For in gel digestion, four 
aliquots, each containing 45µg of protein from ECVs were fractionated on an 8-16% 





Figure 32.  SDS-PAGE gel of fracationated ECVs. 
Following electrophoretic fractionation, eight bands per well were excised and 
destained according to the optimized methods outlined previously.59  Briefly, gel 
pieces were pooled and destained in 50/50 ACN/water for 30 minute intervals until 
the blue color of the coomassie stain was gone or significantly reduced.  The pooled 
gel pieces were then macerated and dehydrated in ACN, and subsequently rehydrated 
in 12.5% acetic acid.  Prior to digestion, additional solvent was added to ensure the 
gel pieces were covered during the digestion.  Gel pieces were digested for 30 
minutes at 140°C while using 300W of microwave energy to maintain temperature in 
a CEM Discover microwave.  Peptides were extracted using a 2:1 solution of ACN: 
5% formic acid while vortexing for 30 minutes.  The peptide containing extract was 
lyophilized to near dryness and resuspended in 0.1% formic acid prior to LC-MS/MS. 
 
 Mass Biased Partitioning and Lys63 Immunoprecipitation.  Extra cellular 
vesicles in PBS were precipitated as above and resuspended in the appropriate 




This ensured that all proteins were efficiently solubilized prior to digestion.  Protein 
was then digested as above.  Following digestion, Millipore 3kDa MWCO filters 
(Billerica, MA) were equilibrated in 12.5% acetic acid prior to use.  The digest was 
then fractionated by size using the 3kDa MWCO filters according to the 
manufacturer’s instructions.  The higher molecular weight retentate was first 
immunoprecipitated (IP) using a Lys63 ubiquitin specific antibody (Millipore) 
coupled to an agarose solid support (ThermoPierce, Rockford, IL) and recovered 
according to the manufacturer’s instructions. This specific antibody was selected, in 
part, because it was formulated against a short branched peptide immunogen rather 
than intact di-ubiquitin.  The smaller branched peptide ensures that epitope binding 
residues must be contained within the sequence present following Asp specific 
hydrolysis of a ubiquitinated substrate. The flow through of the IP reaction was 
analyzed directly by LC-MS/MS, and the lower mass MWCO filtrate was lyophilized 
to near dryness.  
  
 LC-MS/MS.  The peptides resulting from in gel digestion were injected into 
an LTQ-Orbitrap XL (ThermoFisher, San Jose, CA) via a Shimadzu Prominence 
(Columbia, MD) autosampler and LC.  Following injection, peptides were loaded and 
concentrated onto a C18 trap column and subsequently fractionated using a C18 
150mm x .150mm GraceVydac (Deerfield, IL) analytical column.  Peptides were 
fractionated using a linear gradient from 0-35% solvent B (97.5% ACN/2.5% 
water/0.1% formic acid) over the course of ~3 hours.  The low mass peptides 




triplicate in the same manner.  Higher mass and IP recovered peptides were analyzed 
with high resolution precursor and product ion detection on either the above 
mentioned C18 analytical column or a 100mm x .100mm C8 column.  Survey scans 
for the high mass flow through after the IP reaction were performed at 30,000 Rp and 
product ion scans at 7,500.  Data dependent parameters were adjusted such that only 
precursors with charge states of +4 or greater were selected for fragmentation.  
Immunoprecipitated Lys63 containing peptides were analyzed with identical data 
dependent parameters, but the precursor RP was set to 100,000.  
 
 Bioinformatics.  Low resolution fragment ion data resulting from both in gel 
acid hydrolysis and the low mass fraction after mass biased partitioning were 
searched using PepArML60 and the IPI Mouse database.  Results from six different 
search engines were combined and peptide specific estimated FDRs were generated.  
Dehydration of Asp, pyro-glutamate formation from Gln and Glu, and Met oxidation 
were chosen as variable modifications.  The high mass fraction after mass biased 
partitioning was searched against a database of reviewed mouse proteins from the 
UniProtKB using ProSightPC, (ThermoFisher).  A precursor mass tolerance of 250Da 
was set to accommodate dual terminal specificity of acid digestion.  A more stringent 
Evalue threshold of 1 x 10-8 was set based on previously calculated FDRs from the 
optimized workflow for the high mass peptides.  Later searches for specific PTMs 
were performed using Mascot, and Evalues better than 0.05 warranted manual 
inspection of the mass spectrum.  Peptide matches below this threshold were not 




ubiquitin modification.  Protein functional and gene ontology classification was 
performed using the Database for Annotation, Visualization, and Integrated 
Discovery (DAVID).98 
 
Results and Discussion 
 
 
 In Gel Microwave-supported Acid Hydrolysis.  Based on the gel shown in 
Figure 32, one would assume that the protein complement of ECVs from IL-1 beta 
expressing MDSCs is a relatively simple mixture.  Despite the amount of information 
that can be deduced from the Coomassie-stained gel image, in gel digestion coupled 
with mass spectrometry is more sensitive.  In gel digestion using microwave-
supported acid hydrolysis resulted in identification of 76 unique proteins from 96 
peptides that demonstrated the expected speficity.  Additional peptides were 
identified using search parameters that accommodated non-specific hydrolysis at 
either or both termini.  Consistent with the gel image, high sequence coverage was 
achieved for three histone proteins, H4, H3.2, and H3.3, whose molecular masses 
around 15kDa correlate to the darkest bands on the gel.   
 
 
 Mass Biased Partitioning and Ubiquitin.  Interrogation of the ECV sample 
using mass biased partitioning resulted in a more informative analysis.  The low mass 
fraction provided 202 total peptides, and an additional 20 peptides were identified in 




development of mass biased partitioning outlined in Chapter 2, there are distinct 
differences in the peptide mass distributions of each fraction (Figure 33). 
 
 
Figure 33.  Peptide mass distributions of low (blue) and high (red) mass fractions 
resulting from mass biased partitioning of ECVs after microwave-supported acid 
hydrolysis. 
The large peptides allowed unambiguous identification of two proteins with high 
sequence similarity.  Peptide [91-130] is specific to both mouse histones H2A type 1 
and H2 type 2-A, and differs in the two peptides only by a single Lys to Arg 
substitution at position 100 (Figure 34).  Analysis of the large ( >4kDa) peptides 
resulted in identification of both peptides.  Additional evidence for the presence of 
both proteins was found in the in gel analysis, based on peptide [44-72] with a 






Figure 34.  Sequence alignment of mouse histones H2A type 1 and H2A type 2. The 
four residue differences are indicated at their specific locations by two dots below the 
aligned sequences.  Peptides observed are indicated by shading.     
	  
Proteolytic methods alternative to trypsin are important in studies of histone sequence 
and modification.99  For one thing, many modifications occur on Lys and Arg, which 
would interfere with proteolysis. In addition, the frequency of Lys and Arg produces 
short peptides which contribute little to a given protein identification. In silico tryptic 
digestion of the two proteins assuming no missed cleavages results in a four-residue 
peptide containing the observed site of amino acid substitution (LLGK or LLGR).  
The two tryptic peptides have neutral masses of 429.30Da (for the Lys containing 
sequence) and 457.30Da.  In most ESI analyses, tryptic peptides will acquire two 
charges resulting in charge densities for the two tetrapeptides of 215.65 (for the Lys 
containing sequence) and 229.65.   In most cases, ESI analyses only detect ions in the 
range of m/z 400-2000 to avoid superfluous detection of uninformative peptide 





 Additional analysis of the low mass fraction was targeted to look for post-
translational modifications and revealed two separate monoacetylations  on both 
Lys27 and Lys29 of ubiquitin (Figure 35 and Figure 36). 
 






Figure 36. Product ion spectrum demonstrating the site of acetylation on Lys29 of 
ubiquitin. 
	  
Additionally, N terminal peptides from ferritin heavy chain, S100A9, and isocitrate 
dehydrogenase  were identified with post translationally acetylated N termini 
following removal of the initiator Met residue. An important factor that aids in 
assignment of these PTMs is the observation of several additional high confidence 
peptides from the same proteins. Proteins identified with only a single post 
translationally modified peptide were confirmed by manual inspection.  For ubiquitin, 
all peptides aside from the most C terminal peptide were observed.  This is consistent 
with the biochemistry associated with ubiquitin, in which the C terminal end is 




 Evidence from both in gel microwave-supported acid hydrolysis and mass 
biased partitioning indicates protein ubiquitination.  Ubiquitin peptides were observed 
in five of the eight excised gel bands, and in the low mass fraction recovered from 
digestion in solution the most abundant peptide (as determined by LC peak area 
integration of extracted ion chromatograms) was [40-51] assigned to ubiquitin 
(Figure 37).  
 
Figure 37. Base peak chromaogram (top) and extracted ion chromatograms (XIC) for 
peptide [40-51] of ubiquitin. 
Taken together, this evidence spurred further investigation. Ubiquitination has been 
proposed to sort proteins into both exosomes and the proteoasome.9   Manual 
inspection of the LC-MS/MS data file acquired from injection of the IP eluate was 
used to assign ubiquitination sites on substrate proteins. Similar to assignment of the 
two acetylated peptides on ubiquitin, a prerequisite was that the modified peptide was 




observed from the IP eluate revealed one peptide in common to both mouse histone 
H3.3 and H3.2.  A methylated peptide [107-136] was found to match within 2ppm to 
the predicted mass of the ubiquitinated sequence at Lys116 (Figure 38).   
 
Figure 38.  (A) Observed (top) and theoretical (bottom) isotope clusters of the 
ubiquitinated (at Lys123) and methylated (at Lys116) peptide [107-136] from histone 
H3. 
Histone H3 is known to be monoubiquitinated in order for somatic recombination to 
occur.100 Somatic recombination is a process in which variable, diverse, and joining 
(V(D)J) gene segments are rearranged and recombined to facilitate diverse 
immunoglobulin production.101  Grazini and co-workers hypothesize that 




ubiquitination at specific sites.100 Removal of this activity results in mice that are 
severe combined immunodeficient due to lack of fully mature B and T lympocytes.102 
Although it is not absolutely certain that Histone H3 carries only mono-ubiquitin at 
only one site, the absence of observed ubiquitinated peptides from ubiquitin, itself, 
strengthens the conclusion.  It is of interest that several enzymes that function directly 
in the protein ubiquitination cycle - E3 ubiquitin ligase DZIP3, ubiquitin conjugating 
enzyme E2N, ubiquitin like modifier activating enzyme 1 (UBA1), protein VBRBP103 
and four different sequences present in the 26S proteasome  were identified as well.  
Included also is a protein implicated directly in hydrolysis of Lys63 linked 
polyubiquitin chains, Josephin-2 (see Table 2).  The presence of these proteins in 
conjunction with the high abundance of peptides from ubiquitin, itself, all support the 
hypothesis that ubiquitination is an important step in assigning proteins for 
extracellular vesicle export.95 
 Both the in gel and mass biased partitioning experiments using microwave-
supported acid hydrolysis resulted in a total of 398 distinct peptides representing 240 
proteins (Appendix Table 6).  The higher mass peptides provide significantly 
increased sequence coverage.  The average sequence coverage achieved from the high 
mass fraction (~22.5%) is more than 6 fold greater than that achieved from the low 
mass fraction (~3.6%).  Combining the results from both the in gel and in solution 
experiments further illustrates this point.  Even higher average sequence coverage 
was achieved for proteins that were observed in the high mass portion in addition to 
either the in gel or low mass portion following mass biased partitioning (~34%).  All 




greater sequence coverage. For this sample the increase in sequence coverage allowed 
identification of two distinct isoforms of histone H2, and allowed probable 
identification of a specific ubiquitination site on histone H3, which is known to have 
significant biological implications. 
 Combining protein identifications from all peptides displaying the expected 
specificity provides a mixture with sufficient complexity for functional analysis.  
Using the DAVID gene ontology software, all genes represented by a single 
UniProtKB accession number (at one gene per accession number) are compared to a 
background gene list composed of the mouse genome.  When compared to the 
background, the gene list generated from all of the proteins identified in the 
extracellular vesicle experiments demonstrates significant enrichment in certain 
functional gene ontologies (GOs).  The GO categories are clustered to reduce 
redundancy.  Specifically, based on annotation in the SwissProt database, 71 of the 
240 interrogated genes were implicated in nucleotide binding demonstrating high 
enrichment with a P value of 9.0 x 10-20 (where a P value <0.01 is indicative of 
greater enrichment than would be observed by random chance alone).  Additional 
enrichment was observed for gene products involved in ubiquitin-like modification 
(23 gene products resulting in a P value of 1.8 x 10-6).  As a final test of the methods 
efficacy, the comprehensive acid hydrolysis workflow was compared to an in gel 
tryptic analysis (which has been shown to be the most effective method for 
comprehensive analysis).56  The results are summarized in Error! Reference source 
not found.. Importantly, it is shown that the although the total number of 




two-fold higher.  Taken together, these data suggest that the protein component of 
extracellular vesicles shed by MDSC from mammary carcinoma bearing mice is 
highly enriched in proteins involved in ubiquitination, and it is likely that many of 
which originate from the nucleus and are involved in DNA/RNA maintenance. 
 
Table 1.  Average sequence coverage and number of unique and shared proteins 
observed using the comprehensive microwave-supported acid hydrolysis workflow in 
comparison to in gel tryptic digestion of the same sample. 
 Acid Hydrolysis Trypsin 




Shared Proteins 125 
 
 
Table 2. Sequence coverage achieved using in gel microwave-supported acid 




1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2 0.87% 
14-3-3 protein epsilon 9.02% 




26S proteasome non-ATPase regulatory subunit 2 3.08% 
40S ribosomal protein S12 11.36% 
40S ribosomal protein S16 15.75% 
40S ribosomal protein S23 18.88% 
40S ribosomal protein SA 5.42% 
6-phosphofructokinase, muscle type 3.21% 
6-phosphogluconate dehydrogenase, decarboxylating 2.48% 
60 kDa heat shock protein, mitochondrial 6.28% 
60S acidic ribosomal protein P2 18.26% 
60S ribosomal protein L30 10.43% 
60S ribosomal protein L9 10.42% 
78 kDa glucose-regulated protein 3.82% 
A-kinase anchor protein 10, mitochondrial 1.21% 
Actin-related protein 2/3 complex subunit 1B 3.49% 
Actin-related protein 3B 2.39% 
Actin, aortic smooth muscle 19.36% 
Actin, cytoplasmic 1 31.47% 
Activator of 90 kDa heat shock protein ATPase homolog 1 2.66% 
Activin receptor type-2A 1.75% 
Adenine phosphoribosyltransferase 6.67% 
Adenylyl cyclase-associated protein 1 5.06% 
ADP-ribosylation factor 3 5.52% 




Alanyl-tRNA synthetase, cytoplasmic 1.55% 
Aldehyde dehydrogenase family 16 member A1 1.87% 
Aldehyde dehydrogenase, mitochondrial 2.31% 
Alpha-enolase 16.13% 
Annexin A11 2.78% 
Aspartate aminotransferase, mitochondrial 2.56% 
AT-rich interactive domain-containing protein 1A 1.05% 
Ataxin-10 3.16% 
ATP synthase subunit alpha, mitochondrial 2.17% 
ATP synthase subunit beta, mitochondrial 5.29% 
ATP-citrate synthase 2.47% 
ATP-dependent RNA helicase DDX39 3.75% 
Autophagy-related protein 2 homolog B 0.67% 
Barrier-to-autointegration factor 15.73% 
Calcium homeostasis endoplasmic reticulum protein 0.85% 
Calmodulin 10.07% 
Calreticulin 6.25% 
Cathelin-related antimicrobial peptide 4.05% 
CD9 antigen 11.06% 
Chloride intracellular channel protein 1 6.22% 
Chromodomain-helicase-DNA-binding protein 9 0.52% 





Coiled-coil domain-containing protein 151 3.04% 
Coronin-1A 13.23% 
Coronin-7 2.06% 
Creatine kinase M-type 3.15% 
Cytoplasmic dynein 1 heavy chain 1 0.52% 
Cytoplasmic tyrosine-protein kinase BMX 3.07% 
Cytosolic phospholipase A2 delta 4.12% 
DNA repair protein REV1 2.48% 
DNA replication licensing factor MCM6 3.05% 
DNA topoisomerase 1 1.04% 
Dynamin-2 2.41% 
Dynein heavy chain 12, axonemal 0.68% 
E3 ubiquitin-protein ligase DZIP3 1.00% 
Elongation factor 1-alpha 1 25.76% 
Elongation factor 1-gamma 2.97% 
Endoplasmin 1.50% 
Eukaryotic initiation factor 4A-II 4.42% 
Eukaryotic translation initiation factor 3 subunit E 2.92% 
Eukaryotic translation initiation factor 3 subunit G 4.06% 
Eukaryotic translation initiation factor 3 subunit L 2.30% 
Eukaryotic translation initiation factor 4H 6.85% 
Exportin-1 0.93% 




FH2 domain-containing protein 1 0.96% 
Fibrinogen beta chain 2.70% 




Forkhead box protein J2 4.60% 




Glucose-6-phosphate 1-dehydrogenase X 6.02% 
Glucose-6-phosphate isomerase 13.44% 
Glutamate dehydrogenase 1, mitochondrial 1.61% 
Glutamate--cysteine ligase regulatory subunit 2.92% 
Glyceraldehyde-3-phosphate dehydrogenase 30.63% 
Glycogen phosphorylase, liver form 2.00% 
GTP-binding nuclear protein Ran 12.50% 
GTP-binding protein 1 2.40% 
GTP-binding protein SAR1a 7.58% 
GTP-binding protein SAR1b 7.58% 
Guanine deaminase 4.63% 




Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 4.41% 
Guanylate cyclase soluble subunit beta-1 1.77% 
H-2 class I histocompatibility antigen, alpha chain (Fragment) 3.36% 
Heat shock 70 kDa protein 1-like 5.93% 
Heat shock cognate 71 kDa protein 10.84% 
Heterogeneous nuclear ribonucleoprotein A/B 3.86% 
Heterogeneous nuclear ribonucleoprotein A1 5.31% 
Heterogeneous nuclear ribonucleoprotein F 3.37% 
Heterogeneous nuclear ribonucleoprotein K 3.02% 
Heterogeneous nuclear ribonucleoprotein L 10.24% 
Heterogeneous nuclear ribonucleoproteins A2/B1 8.22% 
Hexokinase-3 1.08% 
Histone chaperone ASF1A 8.82% 
Histone H2A type 1 53.08% 
Histone H2A type 2-A 53.08% 
Histone H2A.Z 24.22% 
Histone H2B type 1-A 12.60% 
Histone H2B type 1-M 58.73% 
Histone H2B type 3-B 79.37% 
Histone H3.2 39.71% 
Histone H3.3 39.71% 





Importin subunit beta-1 2.40% 
Integrator complex subunit 3 1.83% 
Interleukin enhancer-binding factor 2 5.64% 
Josephin-2 7.98% 
Kelch domain-containing protein 2 3.45% 
Keratin, type I cytoskeletal 10 2.11% 
Keratin, type I cytoskeletal 24 1.56% 
Keratin, type II cytoskeletal 1 6.12% 
Keratin, type II cytoskeletal 6A 6.33% 
Kinesin-like protein KIF9 1.52% 
Lactotransferrin 3.96% 
Leukotriene-B(4) omega-hydroxylase 2 1.53% 
Lipoxygenase homology domain-containing protein 1 0.87% 
Lysozyme C-2 6.76% 
Macrophage mannose receptor 1 1.03% 
Macrophage migration inhibitory factor 19.13% 
Major vault protein 1.39% 
Metastasis-associated protein MTA3 2.71% 
Microtubule-associated protein 2 0.55% 
Microtubule-associated serine/threonine-protein kinase 2 1.33% 
MMS19 nucleotide excision repair protein homolog 3.30% 
Moesin 1.73% 





Myosin light polypeptide 6 20.53% 
Myosin regulatory light chain 12B 5.81% 
Myosin-9 1.28% 
Myosin-Ig 1.46% 
NAD-dependent malic enzyme, mitochondrial 3.06% 
NEDD4-binding protein 1 1.12% 
NEDD9-interacting protein with calponin homology and LIM domains 2.00% 
Neutral alpha-glucosidase AB 1.38% 
Neutrophil elastase 3.40% 
Neutrophil gelatinase-associated lipocalin 9.00% 
NHL repeat-containing protein 2 1.66% 
Nucleolin 3.11% 
Nucleoside diphosphate kinase B 26.97% 
Olfactomedin-4 2.18% 
One cut domain family member 3 4.69% 
Peptidyl-prolyl cis-trans isomerase B 6.94% 
Peptidyl-prolyl cis-trans isomerase G 1.20% 
Peroxiredoxin-2 14.14% 







Proteasome subunit alpha type-5 10.79% 
Proteasome subunit beta type-4 3.41% 
Proteasome subunit beta type-8 3.62% 
Protein CDV3 2.85% 
Protein diaphanous homolog 2 1.00% 
Protein disulfide-isomerase A3 3.17% 
Protein disulfide-isomerase A4 3.76% 
Protein Dok-7 2.98% 
Protein MEMO1 4.38% 
Protein phosphatase 1G 1.66% 
Protein S100-A6 7.87% 
Protein tyrosine phosphatase domain-containing protein 1 2.14% 
Protein VPRBP 1.26% 
Prothymosin alpha 24.32% 
Proto-oncogene vav 1.30% 
Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 1.38% 
Pyruvate kinase isozymes M1/M2 19.77% 
Rab GDP dissociation inhibitor beta 2.02% 
Ras GTPase-activating-like protein IQGAP1 0.72% 
Ras-related C3 botulinum toxin substrate 2 5.21% 
Ras-related protein Rab-7a 4.83% 
Ras-related protein Rap-1A 5.98% 




Receptor-type tyrosine-protein phosphatase U 1.66% 
Reticulon-4 receptor 2.96% 
Retinoic acid early-inducible protein 1-alpha 4.35% 
Rho-related GTP-binding protein RhoB 4.59% 
Rho-related GTP-binding protein RhoG 5.24% 
SAFB-like transcription modulator 0.87% 
Scavenger receptor cysteine-rich domain-containing protein LOC284297 
homolog 0.88% 
Selection and upkeep of intraepithelial T-cells protein 5 1.44% 
Serine/threonine-protein kinase 38-like 1.72% 
Serine/threonine-protein kinase D1 1.85% 
Seryl-tRNA synthetase, cytoplasmic 3.32% 
Sister chromatid cohesion protein PDS5 homolog B 1.87% 
Small nuclear ribonucleoprotein Sm D1 9.24% 
Small nuclear ribonucleoprotein Sm D2 11.86% 
Stefin-3 9.28% 
Stress-70 protein, mitochondrial 3.68% 
Stress-induced-phosphoprotein 1 2.21% 
Structural maintenance of chromosomes protein 3 1.07% 
Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial 4.85% 
Synaptojanin-2 1.67% 
T-complex protein 1 subunit alpha 1.44% 




T-complex protein 1 subunit gamma 1.65% 
T-complex protein 1 subunit theta 1.64% 
Talin-1 2.24% 
TAR DNA-binding protein 43 3.38% 
Thrombospondin-1 0.77% 
Tight junction protein ZO-2 1.46% 
Transitional endoplasmic reticulum ATPase 1.36% 
Transketolase 5.78% 
Translocon-associated protein subunit beta 10.93% 
Transportin-1 1.78% 
Triosephosphate isomerase 5.22% 
Tubulin alpha-1B chain 7.10% 
Tubulin beta-5 chain 11.04% 
Tumor suppressor p53-binding protein 1 0.56% 
Tyrosine-protein kinase Lyn 1.56% 
Tyrosine-protein phosphatase non-receptor type 6 3.70% 
Tyrosyl-tRNA synthetase, cytoplasmic 2.46% 
U6 snRNA-associated Sm-like protein LSm3 11.76% 
Ubiquitin-conjugating enzyme E2 N 13.16% 
Ubiquitin-like modifier-activating enzyme 1 3.69% 
Uncharacterized protein C15orf39 homolog 1.27% 
Uncharacterized protein C1orf190 homolog 3.77% 




Uncharacterized protein KIAA1671 2.92% 
UPF0704 protein C6orf165 homolog 1.45% 
Valyl-tRNA synthetase 0.79% 
Vinculin 0.75% 
WD repeat-containing protein 1 4.95% 
Zinc finger and BTB domain-containing protein 7C 2.26% 
Zinc finger protein 37 1.85% 
Zinc finger protein 638 1.02% 
 




























Chapter 6:  Conclusions and Prospectus 
 
 Microwave-supported acid hydrolysis has previously been shown to be a 
viable method for analysis of single proteins and samples of low complexity.35, 43  
Presented in this work, were several experiments that further developed this digestion 
method and the associated sample preparation, MS, and bioinformatic techniques 
required for successful analysis.  First, two modifications on sample preparation both 
before and after microwave-supported acid hydrolysis were implemented. 
Specifically, microwave-supported acid hydrolysis was extended for in gel digestion 
of a whole cell lysate, resulting in identification of over 600 proteins.  Although in gel 
digestion with acid hydrolysis is not new, it has previously only been used in well 
resolved gel bands and spots consisting of single or only a few proteins.  Next, mass 
biased partitioning was used to enhance analysis of peptides produced from acid 
digestion by fractionating them into two distinct populations based on their size.  The 
3kDa molecular weight cutoff filters conveniently bifurcate the sample into aliquots 
with specific MS analysis parameters. The high mass parameters used were then 




exhibit a high incidence of basic amino acids in their primary sequence in order to 
bind the nucleic acid phosphate backbone are poorly suited for tryptic digestion.  
Microwave-supported acid hydrolysis resulted in identifcation of 70 of the 79 
predicted ribosomal proteins (~89%).22 Average sequence coverage provided by 
peptides greater than (n = 161 peptides) and less than 3kDa (n = 221 peptides) was 
~36% and ~21%, respectively.  Next a novel application for ubiquitinated proteins 
and Lys63 polyubiquitin chains was demonstrated.  Examination of ubiquitin’s 
primary sequence demonstrates that Asp specific hydrolysis will reveal the site of 
substrate ubiquitination.  Additionally, for examination of polyubiquitins joined 
exclusively via Lys63 linkages, it will produce a single peptide composed of the C 
terminal peptides of all constituent monomers, the mass of which is directly 
indicative of polyubiquitin length.  Finally, extracellular vesicles isolated from 
mammary carcinoma bearing mice were examined utilizing all of the above outlined 
techniques.  Combining in gel digestion, mass biased partitioning, and potential 
ubiquitination analysis identified 389 peptides representing 240 proteins.  Far more 
important than a numerical total of proteins and peptides identified, the microwave-
supported acid hydrolysis workflows were able to provide information sufficient for 
drawing testable biological hypotheses – the main goal for discovery type high 
throughput proteomic experiments. 
 The work outlined in this dissertation has demonstrated that microwave-
supported acid hydrolysis is a viable workflow for rapid, high throughput analysis of 
complex proteomic samples both in gel and in solution.  It also has specific benefits 




polyubiquitinated proteins that cannot be achieved using standard tryptic methods.  
Currently, the proteomics community relies nearly exclusively on tryptic digestion.  
Thanks to bioinformatic and instrumental advancements in high resolution Orbitrap 
and TOF mass spectrometry the observable mass range is ever increasing.  
Microwave-supported acid hydrolysis has been shown to be an effective way of 
observing, in a high throughput manner, peptides that are longer on average, and 




















Appendix Table 1. Peptides identified with the expected cleavage specificity 
following in gel microwave-supported acid hydrolysis of multiple myeloma whole 
cell lysate.  In rare cases (denoted by an asterisk) the confidently identified peptide 
was not mapped to a parent protein in the database. 
	  








Q8WU90 LSLYIPR 860.51 860.51 0.00 0.040106306 
Q9BX68 GNEVAKAQQATPGGAAPTIFSRIL 2396.28 2396.27 -0.01 0.035242291 
Q9BX68 QQLLGHLLLVAKQTAKAEGLG 2170.25 2170.27 0.03 0.001593625 
O95833 TVCAHFRQAPIP 1338.69 1338.65 -0.03 0.022452989 
P62258 LVYQAKLAEQAERY 1680.88 1681.90 1.02 0.001593625 
P62258 EMVESMKKVAGM 1320.62 1320.62 0.00 0.002276608 
P62258 TLSEESYK 955.45 955.45 0.00 0.005398111 
P62258 STLIMQLLR 1073.63 1073.62 -0.01 0.001593625 
P26640 LAAVTALLLPFRYVL 1659.01 1660.01 1.00 0.002276608 
P26640 LSVFYPGTLLETGH 1532.79 1532.79 0.00 0.042135504 
P26640 EAKLQQTEAELRKV 1623.89 1623.89 0.00 0.039757576 
P26640 EAIALFQKML 1144.63 1144.63 0.00 0 
Q9Y4L1 LFERVPGPVQQALQSAEMSL 2199.14 2199.16 0.03 0.001593625 
Q9Y4L1 EAAAMGAVYQAAALSKAFKVKPFVVR 2704.49 2706.48 1.99 0.003157895 
P42765 LSEFAAKAALSAGKVSPETV 1975.06 1976.06 1.00 0.001593625 
P42765 EHARPQTTLEQLQKLPPVFKK 2469.39 2469.36 -0.02 0.012337217 




P42765 LVEVNEAFAPQYLAVERSL 2147.13 2148.11 0.98 0.001593625 
P42772 DVAGYLRTATG 1104.56 1104.52 -0.03 0.026450742 
Q14974 VVMASLLRMFQSTAGSGGVQE 2167.08 2168.09 1.02 0.001593625 
Q14974 EVMQLLLENLGNENVHRSVKPQILSVFG 3144.67 3145.66 0.99 0.012337217 
Q9UJW8 ACAGSTR 664.30 664.87 0.58 0.078844169 
Q9Y6B6 ETIANVPILILGNKI 1588.95 1589.97 1.02 0.002276608 
P52292 QIQQVVNHGLVPFLVSVLSKA 2258.28 2259.27 0.99 0.001593625 
P34897 PKTGREIPYTFE 1436.73 1437.72 0.99 0.090652699 
P34897 ALLERGYSLVSGGT 1421.75 1421.75 -0.01 0.026450742 
Q9Y6Q1 DGHKVIMSLQQK 1382.73 1382.78 0.05 0.063943162 
Q13541 EPPMEASQSHLRNSPE 1789.80 1790.81 1.01 0.001593625 
P34932 PFVEAEKSNLAY 1366.68 1366.67 0.00 0.002276608 
P34932 EAVTRGCALQCAILSPAFKVREFSIT 2791.45 2791.43 -0.02 0.063654574 
P34932 PAIAQFSVQKVTPQS 1599.86 1599.86 -0.01 0.001593625 
Q562R1 LYANTVLSGGSTMYPGIA 1829.89 1827.90 -1.99 0.021633931 
P11021 QGNRITPSYVAFTPEGERLIG 2287.16 2288.18 1.02 0.001593625 
P11021 AAKNQLTSNPENTVF 1632.81 1632.81 -0.01 0.001593625 
P11021 IKFLPFKVVEKKTKPYIQV 2304.40 2304.42 0.02 0.006197432 
P11021 AGTIAGLNVMRIINEPTAAAIAYGL 2499.35 2499.34 -0.01 0.001593625 
P11021 LFRSTMKPVQKVLE 1674.95 1674.94 -0.01 0.00757257 
P11021 EIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINP 3632.02 3632.03 0.01 0.022452989 
P11021 LTGIPPAPRGVPQIEVTFEI 2133.18 2134.19 1.01 0.002276608 
P11021 VNGILRVTAE 1070.61 1070.60 -0.01 0.001593625 
P11021 TRNELESYAYSLKNQIG 1984.99 1984.97 -0.02 0.001593625 
P11021 KETMEKAVEEKIEWLESHQ 2343.14 2344.15 1.00 0.012337217 
O43324 ILLYYGLHRFIV 1505.88 1505.88 0.00 0.022452989 
Q16706 EGSFPQGQLSMLQEK 1693.80 1695.91 2.11 0.092548077 
P52565 EHSVNYKPPAQKSIQEIQEL 2319.19 2320.19 1.00 0.001593625 
P52565 ESLRKYKEALLGRVAVSA 1971.13 1972.12 1.00 0.012337217 
P52566 ESLIKYKKTLLG 1373.83 1373.82 0.00 0.002276608 
P11142 AAKNQVAMNPTNTVF 1604.80 1604.80 0.00 0.002276608 
P11142 AGTIAGLNVLRIINEPTAAAIAYGL 2481.40 2481.40 0.00 0.001593625 
P11142 KKVGAERNVLIF 1372.82 1372.81 -0.01 0.002276608 
P11142 GIFEVKSTAG 1007.53 1007.52 0.00 0.001593625 
P11142 PVEKALR 811.49 811.49 0.00 0.003157895 
P11142 PVEKALRD 926.52 926.52 0.00 0.010505051 
P11142 IVLVGGSTRIPKIQKLLQ 1962.24 1962.22 -0.01 0.002276608 









3967.13 3968.11 0.97 0.005398111 
P11142 NQPGVLIQVYEGERAMTK 2032.04 2034.03 1.99 0.001593625 
P11142 IERMVQEAEKYKAE 1722.86 1722.88 0.02 0.007002188 
P11142 KVSSKNSLESYAFNMKATVE 2232.11 2232.09 -0.02 0.012337217 
P52597 PPLKFMSVQRPGPY 1615.85 1615.84 -0.01 0.001593625 
P36578 KAAAAAAALQAKS 1170.67 1171.67 0.99 0.001593625 
P28562 MVMEVGTL 894.42 894.53 0.11 0.079587629 
P61088 ESNARYFHVVIAGPQ 1668.84 1668.81 -0.03 0.024608501 
Q93009 PANYILHAVLVHSG 1489.80 1490.79 0.99 0.016024653 
Q93009 PELAASGATLPKF 1300.70 1301.71 1.01 0.003157895 
P01889 TELVETRPAG 1071.56 1071.55 0.00 0.028343211 
P54136 LENPPLLVTPSQQAKFG 1837.99 1839.97 1.98 0.015837821 
P38117 LVLLGKQAI 953.63 953.62 0.00 0.00757257 
P38117 GGLETLRLKLPAVVTA 1636.99 1636.98 0.00 0.031793343 
P38117 LVAKLKEIGRI 1238.81 1238.80 0.00 0.001593625 
Q08945 PVEAFAQNVLSKA 1372.74 1372.72 -0.01 0.002276608 
Q08945 EISFVNFARGTTTTRSF 1914.96 1914.95 -0.01 0.003775366 
P36776 FQVTEEVKALTAEIVKTIR 2174.23 2175.23 1.00 0.024896266 
O15160 EILAHRLGLIPIHA 1533.91 1533.90 -0.01 0.020577308 
Q12905 ETSFSEALLKRNQ 1503.77 1503.77 0.00 0.004582951 
Q12905 LAPNSAEQASILSLVTKINNVI 2294.28 2295.29 1.01 0.001593625 
P52815 LNELLKKTLKIQ 1439.91 1439.90 0.00 0.02661101 
Q86U42 ARSIYVGNV 977.53 977.52 -0.01 0.040106306 
Q9UHV9 EKPAAKENSEGAGAKASSAGVLVS 2239.14 2240.14 1.00 0.087783172 
Q9C0J9 DSRGGGSGGGPGGGAAAAAAALLGP 1950.95 1951.08 0.13 0.073445128 
P82970 MPKRKAAGQGD 1139.59 1137.65 -1.94 0.004582951 
O15355 AKLTTEEVIKELAQIAGRPTE 2296.26 2297.26 1.00 0.003157895 
O15355 FIQSKISQR 1105.62 1105.62 0.00 0.001593625 
O60641 AFAAPSPATTASPAKVD 1600.81 1600.83 0.02 0.006197432 
Q9Y3C6 PTGTGRGGASIYGKQFE 1724.85 1724.85 0.00 0.02661101 
P54577 VYRLSSVVTQH 1287.69 1287.69 0.00 0.010505051 
P54577 EKWGGNKTYTAYV 1497.72 1497.72 0.00 0.059104342 
P54577 LKNSVEVALNKLL 1439.87 1439.86 -0.01 0.012337217 
P54577 PPAGSAPGEHVFVKGYEKGQP 2151.07 2152.07 0.99 0.012337217 
Q9Y221 IPLGFGVAAKSTQ 1287.72 1287.72 0.00 0.002276608 
Q9Y221 PMAIVVFHQA 1127.58 1127.57 -0.01 0.012337217 
P60953 PSTIEKLAKNKQKPITPETAEKLAR 2790.60 2791.60 1.00 0.042949177 
Q9Y2H5 KVLIPERYIDLEPD 1698.92 1697.94 -0.98 0.078844169 
O43447 GTGVASIYRGPFA 1294.67 1294.66 -0.01 0.015837821 





P54652 GIFEVKSTAG 1007.53 1007.52 0.00 0.001593625 
P54652 PVEKALR 811.49 811.49 0.00 0.003157895 
P54652 PVEKALRD 926.52 926.52 0.00 0.010505051 
P54652 IVLVGGSTRIPKIQKLLQ 1962.24 1962.22 -0.01 0.002276608 
P54652 IVLVGGSTRIPKIQKLLQD 2077.26 2078.28 1.01 0.004582951 
P54652 FFNGKELNKSINP 1506.78 1506.78 0.00 0.016024653 
P54652 EAVAYGAAVQAAILIGD 1612.85 1613.77 0.92 0.016024653 
P68371 LQLERINVYYNEATGGKYVPRAVLV 2864.55 2865.56 1.00 0.012337217 
P68371 SVRSGPFGQIFRP 1446.77 1446.76 -0.01 0.003775366 
P68371 RIMNTFSVVPSPKVS 1660.90 1660.89 0.00 0.001593625 
P68371 TVVEPYNATLSVHQLVENT 2113.07 2115.05 1.98 0.001593625 
P38646 IKNVPFKIVRASNG 1541.90 1541.89 -0.01 0.001593625 
P38646 AGQISGLNVLRVINEPTAAALAYGL 2510.39 2510.38 0.00 0.001593625 
P38646 ISILEIQKGVFEVKSTNG 1961.08 1961.08 0.00 0.003775366 
P38646 QALLRHIVKEFKRETGV 2006.14 2006.14 0.00 0.003775366 
P38646 ANGIVHVSAK 994.56 994.55 0.00 0.001593625 
P38646 TETKMEEFK 1141.53 1141.53 0.00 0.054851348 
Q01469 EYMKELGVGIALRKMGAMAKP 2274.20 2274.20 -0.01 0.039757576 
P13284 ALQPPHEYVPWVTVNGKPLE 2273.18 2274.17 0.99 0.016024653 
P54709 IIGLKPEGVPRI 1290.80 1290.83 0.03 0.02661101 
Q01518 SLLAGPVAEYLKISKEIGG 1944.09 1945.06 0.96 0.012337217 
Q01518 VVGIVEIINSK 1169.70 1169.70 -0.01 0.001593625 
P46782 ELINAAKGSSNSYAIKKK 1903.05 1904.05 1.00 0.003157895 
P46782 ELERVAKSNR 1182.65 1183.65 1.00 0.029044586 
P11940 EAVAVLQAHQAKEAAQKAVNSATGVPTV 2769.48 2769.47 -0.01 0 
P05387 MRYVASYLLAALGGNSSPSAK 2171.10 2171.11 0.00 0 
P05387 YVASYLLAALGGNSSPSAK 1867.97 1867.97 0.00 0.074812968 
P05387 DRLNKVISELNGKNIE 1841.00 1843.00 2.00 0.020057307 





3667.99 3668.96 0.97 0.001593625 
Q07666 PAARMSRSSGRSGSM 1536.72 1536.72 0.00 0.070288918 
Q07666 PSFTHAMQLLTAEIEKIQKG 2241.18 2241.18 0.00 0.001593625 
Q07666 PKYAHLNM 988.48 988.48 0.00 0.062583818 
P62736 EAQSKRGILTLKYPIEHGIITNW 2648.44 2648.43 -0.01 0.01536 
P62736 EAQSKRGILTLKYPIEHGIITNWDD 2860.49 2861.49 1.00 0.074812968 
O76021 SASASLSSAAATGTSTSTPAAPTARKQL 2590.32 2591.32 1.00 0.001593625 





Q9NP55 ILKPGGGTSGGLLGGLLGKVTSVIPGLNNII 2914.72 2915.73 1.01 0.022133939 
Q01851 DHISSPSLALMAGAGGAGAAAGGGGAH 2242.05 2242.11 0.06 0.055479138 
P13645 LKNQILNLTT 1156.68 1156.68 -0.01 0.001593625 
P13645 LTQLLNNMRSQYEQLAEQNRK 2576.31 2576.31 0.00 0.002276608 
P13645 AEAWFNEKSKELTTEI 1894.93 1894.93 0.00 0.002276608 
P13647 EINKRTTAENEFVMLKK 2032.08 2032.08 0.00 0.012721794 
P13647 AAYMNKVELEAKV 1464.76 1464.76 0.00 0.012337217 
P13647 AELSQMQTHVS 1229.57 1230.58 1.00 0.001593625 
P13647 SIIAEVKAQYE 1249.66 1250.66 1.00 0.001593625 
P13647 YQELMNTKLAL 1322.69 1322.69 0.00 0.004582951 
O95467 DFETEPETAPTTEPETEPE 2129.88 2130.16 0.28 0.087783172 
P13667 PPIPVAKI 833.54 833.55 0.02 0.003157895 
P13667 PPIPVAKID 948.56 948.56 0.00 0.006197432 
P13667 ATSASVLASRF 1108.59 1108.58 0.00 0.003775366 
P13667 YEGSRTQEEIVAKVREVSQP 2304.17 2304.16 -0.01 0.026450742 
P13667 YNGPREKYGIV 1294.67 1294.66 -0.01 0.019836639 
P13667 YMIEQSGPPSKEILTLKQVQEFLK 2805.50 2805.50 0.00 0.001593625 
P13667 VIIIGVFKGES 1160.68 1160.68 0.00 0.001593625 
P13667 KKNPVKFEGG 1102.61 1102.60 -0.01 0.010505051 
P56537 VLKVEVFRQTVA 1387.82 1387.81 0.00 0.082482646 
P56537 TTSTELSVVESVFKLNEAQPSTIATSMR 3025.53 3025.53 0.00 0.002276608 
P31146 VRVSQTTW 975.51 975.51 0.00 0.060606061 
P31146 VGTGAAMLTLGPEVHP 1548.80 1548.79 -0.01 0.001593625 
P31146 PALTAEEWLGGR 1298.66 1298.67 0.00 0.001593625 
P31146 AGPLLISLK 910.59 910.58 0.00 0.001593625 
P31146 AVSRLEEEMRKLQATVQELQKRL 2754.52 2754.51 -0.01 0.012337217 
P62829 NTGAKNLYIISVKGIKGRLNRLPAAGVG 2879.68 2880.69 1.00 0.052436195 
P62829 LWPRIASNAGSIA 1354.74 1354.74 0.01 0.006197432 
P31153 ALKEKVIKAVVPAKYL 1769.12 1770.11 0.99 0.016423358 
P31153 TIYHLQPSGRFVIGGPQG 1926.01 1927.01 1.00 0.002276608 
P31153 AGLTGRKIIV 1026.65 1026.65 -0.01 0.029101856 
P31153 LRPGVIVR 908.59 908.59 0.00 0.001593625 
Q9NZD4 MALLKANK 903.52 905.50 1.98 0.084638861 
P83916 LIAEFLQSQKTAHET 1714.89 1715.90 1.01 0.003157895 
P83916 PERIIGATD 970.51 971.54 1.03 0.093906094 
Q9HCS4 MPQLGGGGGGGGGGSGGGGGSSAGAAGGG 2060.86 2060.19 -0.67 0.022452989 
Q9HCS4 MPQLGGGGGGGGGGSGGGGGSSAGAAGGGD 2175.88 2177.13 1.25 0.012337217 
O00178 AGKSTLLGVLTHGELD 1609.87 1609.89 0.03 0.073445128 
O00178 DEGGPSGGPAVGAPPPG 1417.65 1418.84 1.20 0.028593311 




P13796 EFIKIFHGLKST 1400.78 1400.77 -0.01 0.002276608 
P13796 SKAYYHLLEQVAPKG 1702.90 1702.90 0.00 0.001593625 
P13796 VVRGNPKLNLAFIANLFNRYPALHKPENQ 3332.83 3334.82 1.99 0.024896266 
P13796 PKISTSLPVL 1053.64 1053.64 0.00 0.003775366 
P48643 GYEQAARVAIEHL 1455.75 1455.74 -0.01 0.010505051 
P23246 EMEKQQREQVEKNMK 1915.92 1915.95 0.02 0.032956222 





2831.18 2829.69 -1.49 0.07975334 
P07237 LAQQYGVRGYPTIKFFRNG 2214.17 2214.17 0.00 0.012337217 
P07237 TASPKEYTAGREA 1379.67 1379.67 0.00 0.001593625 
P07237 IVNWLKKRTGPAATTLP 1865.09 1866.10 1.01 0.019836639 
P07237 GAAAESLVESSEVAVIGFFK 2010.03 2010.06 0.03 0.001593625 
P07237 SAKQFLQAAEAI 1275.68 1275.67 -0.01 0.001593625 
P07237 GVVLFKKF 936.58 936.57 -0.01 0.001593625 
P07237 GVVLFKKFD 1051.61 1051.60 0.00 0.019836639 
P07237 EGRNNFEGEVTKENLL 1829.89 1829.90 0.01 0.001593625 
P07237 KQPVKVLVGKNFE 1484.87 1484.86 -0.01 0.001593625 
P07237 HENIVIAKM 1069.56 1069.55 -0.01 0.002276608 
P07237 STANEVEAVKVHSFPTLKFFPASA 2576.33 2576.32 -0.01 0.001593625 
P07237 GFKKFLESGGQ 1196.62 1196.61 -0.01 0.001593625 
O00299 DEEIELAYEQVAKALK 1847.95 1848.97 1.01 0 
O00299 EEIELAYEQVAKALK 1714.91 1715.91 1.00 0 
P56730 MTLARFVLALMLGALPEVVGFD 2362.28 2361.27 -1.00 0.017501509 
P15374 AIRVTHETSAHEGQTEAPSI 2133.05 2133.90 0.86 0.052436195 
O14979 LTEYLSRFGEVV 1411.73 1411.73 0.00 0.009079653 
Q6P3S6 GSPILNGGSLSPGTAAVGGSSLD 1994.99 1994.11 -0.88 0.026450742 
O43242 GKTAAAAAEHSQREL 1538.78 1538.77 -0.01 0.020057307 
Q13158 FEAGAAAGAAPGEE 1246.55 1244.66 -1.89 0.068678915 
P23526 IGLAAWGRKAL 1154.69 1154.69 0.00 0.019836639 
P23528 KKNIILEEGKEILVG 1682.00 1682.00 0.00 0.001593625 
P23528 PYATFVKMLP 1181.62 1181.61 0.00 0.001593625 
P23528 PYATFVKMLPD 1280.65 1281.64 1.00 0 
P23528 LVFIFWAPESAPLKSKMIYASSK 2628.40 2628.40 0.00 0.01536 
P15531 SVESAEKEIGLWFHPEELV 2198.09 2199.09 1.00 0.001593625 
O43390 EAKIKALLERTGYTL 1686.97 1686.99 0.03 0.001593625 
O43390 VTTGQRKYGGPPP 1356.71 1357.70 0.99 0.008347245 
O43390 SVYSGVQPGIGTEVFVGKIPR 2189.18 2190.19 1.01 0.016423358 
O43390 ELVPLFEKAGPIW 1479.81 1479.81 -0.01 0.002276608 
P23588 TEQQSPTSGGGKVAPAQPSEEGPGRK 2579.26 2579.25 -0.01 0.073160357 




Q9H773 IRRLHAEFAAER 1467.81 1467.80 0.00 0.020057307 
Q13200 KAPVQPQQSPAAAPGGT 1603.83 1603.82 -0.01 0.001593625 





3492.54 3490.82 -1.72 0.047058824 
Q13310 ESLKELFSQFGKTLSVKVMR 2308.26 2310.25 1.99 0.049226442 
P62917 PGRGAPLAKVVFR 1366.82 1366.81 -0.01 0.002276608 
Q16630 YGSAIETLVTAISLIKQSKVSA 2278.28 2279.27 0.99 0.002276608 
P60228 LVKVIQQESYTYK 1597.87 1598.86 0.99 0.001593625 
Q16543 PLLEAVPKTG 1023.60 1023.59 -0.01 0.003775366 
Q13405 QELKAWLLEKGF 1443.78 1444.78 1.00 0.002276608 
P33240 QIAMLPPEQRQSILILKEQIQKSTGAP 2999.65 3000.65 1.01 0.016024653 
P62269 LTKRAGELTE 1116.61 1116.61 0.00 0.002276608 
P62269 GKYSQVLANGL 1148.62 1148.61 -0.01 0.002276608 
P07814 PPLGALLAVEHVK 1342.80 1342.79 0.00 0.002276608 
P33316 YTI PPMEKAVVKT 1475.81 1475.80 0.00 0.003775366 
Q13526 ASFALRTGEMSGPVFT 1669.81 1670.81 1.00 0.004582951 
O43707 PVTNLNNAFEVAEKYL 1820.93 1821.96 1.03 0.002276608 
P31943 PPRKLMAMQRPGPY 1640.86 1640.86 -0.01 0.001593625 
P31948 PTNMTYITNQAAVYFEKG 2046.97 2046.96 -0.01 0.001593625 
P31948 AIHFYNKSLAEHRTP 1782.92 1782.91 -0.01 0.073160357 
P31948 PAMRLILEQMQK 1456.79 1456.78 -0.01 0.001593625 
P31948 PQALSEHLKNPVIAQKIQKLM 2385.36 2385.35 -0.01 0.002276608 
P31949 GYNYTLSKTEFLSFMNTELAAFTKNQK 3145.54 3147.54 2.00 0.001593625 
P31949 SFLKAVPSQKRT 1360.78 1361.78 1.00 0.010505051 
P25398 VNTALQEVLKTALIH 1648.95 1648.96 0.01 0.001593625 
O96018 GETQPMTEVD 1087.45 1086.53 -0.92 0.04361223 
Q15046 PMRQRQLFEEQAKAKAAG 2058.08 2058.08 0.00 0.026450742 
P09417 QVTAEVGKLLGEEKV 1581.86 1581.86 0.00 0.001593625 
Q99471 VGTGYYVEKTAE 1315.63 1315.63 0.00 0.002276608 
Q05823 DGAGGASGLASPGC 1118.47 1117.60 -0.87 0.092548077 
O95137 VPIRTVSSAASQGLHMQND 2010.00 2011.18 1.19 0.010505051 
P09622 TKNILIATGSEVTPFPGITI 2071.16 2072.17 1.01 0.001593625 
P09622 VVAGPMLAHKAE 1221.65 1221.65 0.00 0.001593625 
P51149 VTAPNTFKTL 1090.60 1090.61 0.00 0.024896266 
P51149 PENFPFVVLGNKI 1472.80 1473.80 1.00 0.001593625 
Q15365 AYSIQGQHTISPL 1413.73 1413.72 -0.01 0.005398111 
Q9NSE4 KVASVASTLETTFETISTLSGV 2240.18 2241.18 1.00 0.001593625 
P43243 GSASAAAKKKLKKV 1385.87 1385.87 0.00 0.028343211 




Q15427 EKVSEPLLWELFLQAGPVVNTHMPK 2843.50 2844.52 1.02 0.001593625 
P35244 LGLYNEAVKIIH 1368.78 1368.77 0.00 0.007002188 
P35269 TGPQSLSGKSTPQPPSGKTTPNSG 2310.15 2310.18 0.04 0.001593625 
Q15459 EPTSKKLKTE 1141.63 1141.63 0.00 0.020057307 
P17844 VKFVINY 881.50 881.50 0.00 0.028593311 
Q99714 PAEYAHLVQAIIENPFLNGEVIRL 2705.45 2706.45 1.00 0.001593625 
P62316 RYISKMFLRG 1269.70 1269.70 0.00 0.021633931 
P62316 SVIVVLRNPLIAGK 1477.93 1477.93 -0.01 0 
O60506 GALAVLQQFK 1073.62 1073.62 -0.01 0.001593625 
O60506 EAKIKALLERTGYTL 1686.97 1686.99 0.03 0.001593625 
O60506 VTTGQRKYGGPPP 1356.71 1357.70 0.99 0.008347245 
O60506 ELVPLFEKAGPIW 1479.81 1479.81 -0.01 0.002276608 
P00505 PILGVTEAFKR 1229.71 1229.71 0.00 0.001593625 
P00505 AGMQLQGYRYY 1364.62 1364.61 0.00 0.002276608 
P00505 GRISVAGVTSSNVGYLAHAIHQVTK 2564.38 2565.39 1.00 0 
P33991 LGSAQKGLQV 999.57 999.56 -0.01 0.022133939 
P33991 IKKGILLQLFGGTRK 1671.06 1671.09 0.03 0.003775366 
P33991 PETRQLVLQTGALVLS 1723.98 1724.03 0.04 0.012337217 
P33991 FLTVTGKTVRLL 1346.83 1346.82 -0.01 0 
P33992 FMPTILSRF 1110.59 1110.58 -0.01 0.007002188 
Q99832 GATILKLL 827.55 827.54 -0.01 0.00757257 
Q99832 VVHPAAKTLV 1033.63 1033.62 -0.01 0.003775366 
Q99832 LLQLKMIGIKKVQGGALE 1938.17 1940.17 2.00 0.028343211 
Q99832 SVVAGGGAIEMELSKYLR 1878.99 1879.00 0.01 0.001593625 
Q99865 EWRGMVLAQAPIMKAWFYITYEKD 2927.45 2926.42 -1.03 0.035242291 
P43490 LRHLIVSRSTQAPLIIRP 2069.26 2071.25 1.99 0.070288918 
Q96QK1 EQSLVGRFIHLLRSE 1764.96 1764.96 0.00 0.003157895 
P78330 AFIGFGGNVIRQQVK 1632.91 1633.92 1.01 0.054851348 
P35527 GGILTANEKSTMQELNSRLASYL 2495.27 2495.26 -0.01 0.001593625 
P35527 KKGPAAIQKNYSPYYNTI 2055.08 2056.06 0.98 0.001593625 
P35527 KKGPAAIQKNYSPYYNTIDD 2267.12 2269.12 2.00 0.078844169 
P35527 LTVGNNKTLL 1071.63 1071.63 0.00 0.001593625 
P35527 FRIKFEMEQNLRQGV 1893.99 1894.99 1.00 0.012337217 
P35527 INGLRQVL 911.56 911.55 0.00 0.012721794 
P35527 VNVEINVAPGK 1138.63 1138.63 0.00 0.001593625 
P35527 VNVEINVAPGKD 1253.66 1254.64 0.98 0.001593625 
P35527 MRQEYEQLIAKNRK 1805.96 1805.95 0.00 0.012337217 
P35527 MRQEYEQLIAKNRKD 1920.98 1920.97 -0.01 0.001593625 
P51571 ISIIPPLFTVSV 1284.77 1284.77 0.00 0.039757576 
Q9NV70 GGTLSRQHNCGTPLPVSSEKD 2182.04 2180.58 -1.46 0.00757257 




P78417 PTVSALLTSEK 1144.63 1144.63 0.00 0.016423358 
Q9NR48 DAVIATASAPPSSSPGRSHSK 2022.01 2023.15 1.13 0.035242291 
P27797 FGKFVLSSGKFYG 1435.75 1435.74 -0.01 0.001593625 
P27797 DEFTHLYTLIVRP 1602.84 1603.86 1.01 0.001593625 
P27797 EFTHLYTLIVRP 1469.80 1469.80 0.00 0.001593625 
P27797 EFTHLYTLIVRPD 1584.83 1584.84 0.01 0 
P27797 NTYEVKI 865.45 865.45 0.00 0.005398111 
P27797 FLPPKKIK 969.64 969.63 0.00 0.04361223 
P27797 DYKGTWIHPEI 1357.67 1358.65 0.99 0.016024653 
P27797 YKGTWIHPEI 1242.64 1242.63 -0.01 0.003775366 
P27797 LWQVKSGTIF 1177.65 1177.64 -0.01 0.001593625 
P27797 EAYAEEFGNETWGVTKAAEKQMK 2598.21 2598.19 -0.02 0.002276608 
Q9NY33 VQLLEYEASAAGLIRSFSERFPE 2611.33 2612.33 1.00 0.055479138 
P51858 EMPEAAVKSTANKYQVFFFGTHETAFLGPK 3326.64 3326.64 0.00 0.017501509 
P51858 EPAKEKNEKGALKRRAG 1863.04 1865.04 1.99 0.01536 
P53396 LYFTYLEINPLVVTK 1812.01 1813.05 1.05 0.001593625 
P53396 EVAPAKKAKPAMPQ 1446.80 1446.81 0.00 0.002276608 
P53396 VLINFASLRSAY 1352.75 1352.73 -0.02 0.001593625 
P53396 AAAKMFSKAF 1070.56 1070.56 0.00 0.004582951 
P35908 PEIQNVKAQEREQIKTLNNKFASFI 2944.58 2946.58 2.00 0.002276608 
P35908 GLTAERTSQNSELNNMQ 1891.87 1892.88 1.01 0.001593625 
P35908 LLNQEIEFLKVLY 1620.91 1620.91 0.00 0.001593625 
P35908 AEISQIHQSVT 1211.61 1211.61 0.00 0.001593625 
P35908 SIIAEVKAQYE 1249.66 1250.66 1.00 0.001593625 
P35908 LEEALQQAKE 1157.59 1157.59 0.00 0.001593625 
P35908 YQELMNVKLAL 1320.71 1320.71 0.00 0.00757257 
P60709 EAQSKRGILTLKYPIEHGIVTNW 2634.43 2634.42 -0.01 0.043333333 
P60709 DGVTHTVPIYEGYALPHAILRL 2434.30 2434.28 -0.02 0.001593625 
P60709 GVTHTVPIYEGYALPHAILRL 2319.27 2319.27 0.00 0.001593625 
P60709 GVTHTVPIYEGYALPHAILRLD 2434.30 2435.27 0.97 0.001593625 
P60709 YLMKILTERGYSFTTTAEREIVR 2776.46 2776.45 -0.01 0.032956222 
P60709 FEQEMATAASSSSLEKSYELP 2304.05 2305.03 0.99 0.017501509 
P60709 LYANTVLSGGTTMYPGIA 1827.91 1828.91 1.00 0.001593625 
O60869 LATKINEKPQVIA 1423.84 1424.85 1.01 0.040106306 
P12004 TLALVFEAPNQEKVS 1644.87 1644.88 0.00 0.001593625 
P10606 EEQATGLEREIMLAAKKGL 2068.10 2068.11 0.01 0.001593625 
P10606 PYNVLAPKGASGTRE 1558.81 1558.81 0.00 0.002276608 




Q9Y6E2 LEAVAKFL 889.53 889.52 0.00 0.006197432 
Q9Y6E2 ILVAGSMLAPGGTRI 1454.83 1454.83 0.00 0.003775366 
P29597 NKCLELSLPSRAAALSFVSLVD 2314.24 2314.19 -0.04 0.026450742 
P02786 QTKFPIVNAELSFFGHAHLGTG 2353.19 2353.18 0.00 0.042135504 
P55060 ANLQTLTEYLKKTL 1634.92 1634.93 0.01 0.010505051 
P55072 LEQVANETHGHVGA 1460.70 1460.70 0.00 0.003775366 
P55072 SIAKARGGNIG 1042.59 1042.59 0.00 0.003775366 
P55072 RVINQILTEM 1215.66 1216.67 1.00 0.052802223 
P55072 PVPEIRR 865.51 865.51 0.00 0.022133939 










3064.30 3065.62 1.32 0.096697175 
O14602 EARSLKAYGELPEHAKINET 2237.14 2237.13 -0.01 0.024896266 
P29692 IARARENIQKSLAGSSGPGASSGTSG 2458.25 2459.26 1.00 0.002276608 
P29692 LLEEEITKFEEHVQSV 1928.97 1930.97 2.00 0.001593625 
O43542 DALLRGGLPL 1023.61 1023.66 0.05 0.069489685 
Q13765 TYIVFGEAKIE 1268.67 1268.66 -0.01 0.01536 
P55209 PKGIPEFWLTVFKNV 1773.98 1773.98 -0.01 0.026450742 
P55209 EPILKHLK 958.60 958.55 -0.04 0.021118721 
Q00610 TIRRFQSVPAQPGQTSPLLQYFGILL 2929.62 2931.60 1.98 0.062583818 
Q00610 AILGNQMFTHY 1293.62 1294.62 1.01 0.043333333 
Q00610 VNTSAVQVLIEHIGNL 1705.94 1705.92 -0.01 0.001593625 
O14818 IVVLGVEKKSVAKLQ 1610.01 1610.00 -0.01 0.003775366 
Q92903 FANTIPGHGGIMD 1328.62 1327.73 -0.88 0.062583818 
P98153 DPAQSGSTPAAEALPGGGRHSRSSLNTVV 2818.40 2820.36 1.96 0.096697175 
Q92953 SSQEGCKMENHLFAPEIHSNPGD 2524.07 2522.62 -1.45 0.092548077 
Q92973 QFPLPLKERLAAFYGV 1831.00 1832.01 1.01 0 
Q9NYU2 EVQGFLFGKLR 1274.71 1275.70 0.99 0.001593625 
Q00765 AITKEAKKATVNLLGEEKKST 2258.28 2259.27 0.98 0 
Q9Y2C2 ILSEKHGFNLVTSDIHNK 2033.07 2037.75 4.68 0.082482646 
P30040 TVTFYKVIPKSKFVLVKF 2143.28 2143.28 0.00 0.00757257 
P30040 EFKRLAENSASS 1319.65 1319.64 0.00 0.039757576 
P30040 KESYPVFYLFR 1447.75 1447.75 0.00 0.002276608 
P30040 ALAGEFIRASGVEARQALLKQGQ 2412.32 2412.32 0.00 0.003157895 
P30042 AAIFPGGFGAAKNLSTFAV 1837.97 1837.96 -0.01 0.002276608 
P30044 AFVTGEWGRAHKAEGKVRLLA 2295.26 2295.27 0.01 0.001593625 




P30049 LGAAKANLEKAQAELVGTA 1854.02 1855.02 1.00 0.001593625 
P30049 EATRAEIQIRIEANEALVKALE 2448.33 2449.34 1.01 0.002276608 
P20618 TRLSEGFSIHTR 1402.73 1402.73 0.00 0.002276608 
P22087 QIHIKPGAKVLYLGAASGTTVSHVS 2516.37 2517.38 1.01 0.001593625 
P30101 SFSEAHSEFLKAASNLR 1892.94 1892.92 -0.01 0.001593625 
P30101 AGHKLNFAVASRKTFSHELS 2199.15 2200.16 1.00 0.066064743 
P30101 GKALERFLQ 1060.60 1060.60 0.00 0.019836639 
P30101 PNIVIAKM 900.51 900.50 -0.01 0.001593625 
P30101 FISYLQREATNPPVIQEEKPKKKKKAQE 3326.84 3327.85 1.02 0.082482646 
O75363 SSLGSVKLD 886.48 886.45 -0.02 0.021633931 
P60842 LKATQALVLAPTRELAQQIQKVVMALG 2889.68 2890.67 0.98 0.012721794 
P60842 EMLSRGFK 948.48 948.48 0.00 0.007002188 
P60842 VLEVTKKFMR 1249.72 1249.71 -0.01 0.001593625 
P60842 FTVSAMHG 848.39 848.38 0.00 0.010505051 
P04792 GVVEITGKHEERQ 1480.76 1480.77 0.00 0.048379521 
Q13148 AGWGNLVYVVNYPK 1578.82 1578.80 -0.02 0.001593625 
Q13148 ASSAVKVKRAVQKTS 1558.92 1558.92 0.00 0.002276608 
P39687 YRENVFKLLPQLTYL 1896.05 1896.06 0.01 0.002276608 
O75531 FVAEPMGEKPVGSLAGIGEVLGKKLEERGF 3143.67 3143.66 0.00 0.015837821 
O75531 KAYVVLGQFLVLKK 1605.00 1605.00 0.00 0.001593625 
P14317 AAKGFGGKYGVER 1338.70 1338.71 0.00 0.01536 
P22392 SVKSAEKEISLWFKPEELV 2218.19 2218.18 -0.01 0.002276608 
P04908 VGAGAPVYLAAVLEYLTAEILELAGNAAR 2914.58 2916.58 2.00 0.074812968 
O95881 GGYIPRILFL 1147.68 1147.67 0.00 0.004582951 
Q9H6Z4 VLAPSGATAAGAGD 1138.56 1138.63 0.07 0.018474374 
P55809 ESFAMIRGGHV 1184.58 1184.57 0.00 0.001593625 
P49257 IKEHLHIVKR 1271.78 1271.78 0.00 0.022133939 
P55851 LPCHFTSAFGAGFCTTVIASPVD 2340.09 2338.68 -1.42 0.082482646 
Q15370 AKESSTVFELKRIVEGILKRPP 2496.44 2496.44 0.00 0.003775366 
P49327 PGSAELQKVLQG 1225.67 1225.66 0.00 0.001593625 
P49327 LVEAVAHILGIR 1289.78 1290.78 1.00 0.055479138 
O75747 QEIRKVAVQQLD 1425.79 1425.81 0.01 0.078844169 
Q16378 QGPQRPPPEGLLPRPPG 1774.95 1774.96 0.01 0.001593625 
P49411 YVKNMITGTAPL 1306.70 1307.69 0.99 0.005398111 
P49411 PELGLKSVQKLL 1323.81 1323.81 -0.01 0.003775366 
P49411 TYIPVPAR 915.52 915.51 -0.01 0.004582951 
P14625 KIRLISLT 942.62 942.63 0.01 0.02661101 
P14625 KEKNLLHVT 1080.63 1080.63 0.00 0.027496757 
P14625 EYKAFYKSFSKES 1594.77 1594.76 -0.01 0.012337217 
P14625 MMPKYLNFVKGVV 1524.82 1524.82 0.00 0.026450742 




P14625 GKRFQNVAKEGVKF 1606.89 1606.92 0.02 0.048379521 
P61254 MKFNPFVTS 1069.53 1069.52 0.00 0.002276608 
P32119 EGIAYRGLFII 1232.69 1233.69 1.00 0.070288918 
P32119 EALRLVQAFQYT 1419.75 1419.75 0.00 0.07211848 
P49588 PTLLFANAGMNQFKPIFLNTI 2349.26 2350.27 1.01 0.00757257 
P49588 TGMGLERLVSVLQNKMSNY 2139.08 2140.08 1.00 0.012337217 
P49588 LTGLIAEEKGLVV 1340.79 1340.82 0.03 0.01536 
P49588 PVRVVSIGVPVSELL 1562.94 1562.93 0.00 0.001593625 
P06744 YSKNLVTE 952.49 952.48 0.00 0.012337217 
P06744 LGPLMVTEALKPYSSGGPRVWYVSNI 2833.48 2834.48 1.00 0.002276608 
P06744 PSAVAKHFVALSTNTTKVKEFGI 2444.34 2444.33 -0.01 0.001593625 
P06744 QYLHRFAAYFQQG 1610.76 1610.76 0.00 0.060906835 
P06744 QWGVELGKQLAKKIEPEL 2048.13 2048.12 -0.01 0.003775366 
P40227 VLRTNLGPKGTMKMLVSGAG 2029.12 2030.11 0.99 0.020057307 
P40227 GTTSNVLIIGELLKQA 1655.95 1655.95 0.00 0.004582951 
P40227 SILAIKKQ 899.58 899.58 0.00 0.008347245 
P40227 KGFVVINQKGI 1201.72 1201.72 0.00 0.043333333 
P40227 ALLIIPKVLAQNSGF 1582.94 1583.95 1.01 0.002276608 
P40227 EIMRAGMSSLKG 1260.63 1260.63 0.00 0.004582951 
Q9BQ67 QRPFVGHTRSVE 1394.71 1394.70 -0.01 0.02661101 
P14866 DQHGGGGGGGGGAGAAGGGGGGENY 1911.75 1913.21 1.46 0.032956222 
P14866 QHGGGGGGGGGAGAAGGGGGGENY 1814.73 1814.51 -0.22 0.047058824 
P14866 QHGGGGGGGGGAGAAGGGGGGENYD 1894.72 1894.60 -0.12 0.074812968 
P14866 PHKTPASPVVHIRGLI 1721.01 1721.00 -0.01 0.001593625 
P14866 NQIYIAGHPAFVNYSTSQKISRPG 2647.35 2647.35 0.00 0.001593625 
P14866 SRSVNSVLLFTILNPIYSITT 2337.29 2337.30 0.01 0.001593625 
P14866 SVQSAQRAKASLNGA 1486.79 1486.80 0.02 0.001593625 
P14866 PGSNPNKRQRQPPLLG 1757.96 1757.96 -0.01 0.063654574 
P57737 AAKQQPLTELAAHG 1433.76 1433.76 0.00 0.020057307 
P57737 PHRLAVAGE 948.51 948.52 0.00 0.002276608 
P49720 AVSGMGVIVHIIEK 1451.82 1451.81 0.00 0.001593625 
P61158 ITYFIQQLLR 1293.74 1293.73 -0.01 0.002276608 





2863.38 2862.49 -0.89 0.052802223 
Q14103 QKEHKLNGKVI 1275.73 1275.72 0.00 0.003775366 
P49915 QEKLMQITSLHSLNAFLLPIKTVGVQG 2947.62 2948.63 1.01 0.024896266 
P49915 VTPTFLTTGVLSTLRQA 1804.01 1804.01 0.00 0.001593625 
Q04837 PVLRQVEGKNPVTIFSLATNEMWRSG 2944.52 2945.52 1.00 0.001593625 





Q12874 TSLFAKNPKSKGTKR 1661.96 1661.95 -0.01 0.002276608 
O95336 EAAARLLTVPFEKHSTL 1864.02 1864.01 -0.01 0.022133939 
P34130 DNAEEGGPGAGGGGCRGV 1540.63 1538.78 -1.86 0.038527188 
O60568 EQPSLRPHH 1081.54 1081.54 0.00 0.012721794 
Q12931 TGIGMTQEELVSNLGTIARSGSKAFL 2679.39 2679.39 0.00 0.001593625 
Q12931 ELTLLHLREF 1251.70 1251.69 -0.01 0.001593625 
Q12931 PRAMVGRLNELLVKALERH 2201.26 2201.24 -0.02 0.012337217 
P24752 VMVAGGMESMSNVPYVMNRGSTPYGGVKLE 3159.49 3160.44 0.95 0.001593625 
P24752 AAKRLNVTPLARIVAFA 1810.09 1810.08 -0.01 0.002276608 
P24752 FPIAPVYAASMVLK 1505.83 1505.83 0.00 0.099189883 
Q9BT73 EPLIHVFAKNLVAFVSQEAGNRAVLLAVAVK 3284.88 3285.85 0.97 0.012721794 
Q14566 LAAAAEPGAGSQHLEVR 1675.86 1675.87 0.00 0.024608501 
P26368 VPPPGFEHITPMQYKAMQAAGQIPATALLPTMTP 3603.83 3605.82 1.99 0.012337217 
P26368 DQVKELLTSFGPLKAFNLVK 2246.27 2248.26 1.99 0.003775366 
P26368 QVKELLTSFGPLKAFNLVK 2114.21 2114.21 0.00 0.001593625 
O75223 EVWGVVWKMNKSNLNSL 1985.02 1985.01 -0.01 0.002276608 
P32969 IELVSNSAALIQQATTVKNK 2127.19 2127.19 0.00 0.001593625 
P32969 GIYVSEKGTVQQA 1378.71 1378.70 -0.01 0.001593625 
Q9BVC6 FAPPGQQKREAPV 1423.76 1423.75 0.00 0.003157895 
P16930 ALMPFAVPNPKQ 1311.70 1311.69 -0.01 0.012337217 
Q13387 PEAAAGPGGVELV 1165.60 1164.72 -0.88 0.05671164 
P16989 PAPKSPVGSGAPQAAAPAPAAHVAGNPGG 2501.28 2502.29 1.01 0.001593625 
P67809 TKPGTTGSGAGSGGPGGLTSAAPAGG 2070.00 2069.98 -0.02 0.001593625 
P67809 VVEGEKGAEAANVTGPGGVPVQGSKYAA 2641.33 2642.34 1.00 0.001593625 
Q9Y285 ALFQPQQHPAR 1291.68 1291.67 -0.01 0.002276608 
Q9C0K7 IYSVGITACELASGQVPFQD 2079.00 2077.12 -1.88 0.0466541 
P26447 VMVSTFHKYSGKEG 1568.77 1568.77 0.00 0.001593625 
P26447 EAAFQKLMSNL 1232.62 1232.62 0.00 0.003775366 
Q14657 QLSLVVRTMQRFGPPVSR 2053.13 2053.12 0.00 0.001593625 
P50502 VAQNPANMSKYQSNPKVMNLISKLSAKFGGQA 3420.76 3421.78 1.01 0.015837821 
Q9Y3B8 LNILAEGPNLIIKQP 1631.96 1631.97 0.01 0.00757257 
O95725 DITLFHYI 1002.52 1002.55 0.03 0.001593625 
P61923 VPLTEQTVSQVLQSAKEQIKWSLLR 2880.61 2880.60 -0.01 0.024896266 
Q9UBQ5 QAHQEERPIRQILYLG 1933.02 1933.02 0.00 0.012337217 
Q9NVP2 SVLVGPVPAGRHMFVFQA 1911.02 1912.00 0.98 0.001593625 









2978.45 2977.51 -0.94 0.034355828 
Q9UHX1 TIRQAFAPFGPIKSI 1644.94 1645.93 0.99 0.052436195 
P62158 GQVNYEEFVQMMTAK 1773.81 1773.81 0.00 0 
* EMVESMKKVAGM 1320.62 1320.62 0.00 0.002276608 
* TLSEESYK 955.45 955.45 0.00 0.005398111 
* CKLIMQLLR 1116.65 1115.63 -1.02 0.017501509 
Q96I99 QITKLYNLFLKI 1475.87 1475.87 0.00 0.003157895 
Q96I99 IIFLNGGKPANFL 1402.80 1402.80 0.01 0.002276608 
Q86VP6 PFYKITSEALLVTQQLVKVIRPL 2655.57 2656.57 1.00 0.001593625 
Q9UNZ2 IVTISQATPSSVSRGTAPS 1857.98 1857.97 -0.01 0.001593625 
Q9UNZ2 ESQTLKEANLLNAVIVQRLT 2221.24 2222.24 1.00 0 
Q96HN2 GCCAALK 664.30 664.84 0.54 0.090652699 
Q96JI7 EALQKLIDDQDISISLLSLR 2233.23 2237.27 4.04 0.096863835 
Q8IYB5 KNAIAITNISSSD 1332.69 1332.91 0.22 0.073445128 
Q96L73 PLQTSGKAAAPSE 1255.64 1255.62 -0.02 0.005398111 
Q8WU39 DRAPLTATAPQL 1252.68 1252.68 0.00 0.001593625 
Q8WU39 RAPLTATAPQL 1137.65 1137.65 0.00 0.001593625 















3425.61 3423.78 -1.83 0.031793343 
O00231 ILHSIVKR 964.62 964.61 -0.01 0.052802223 
O00231 PIISTHLAKLY 1254.73 1254.73 0.00 0.010505051 
Q5VSY0 MASAVLSSVPTTASRFALLQV 2164.16 2164.07 -0.09 0.060606061 
Q7KZF4 SHHQKPVNAIIEHVR 1763.95 1763.95 0.00 0.012721794 
Q96Q04 DAGAAGGEAGGAGAPGPAEE 1592.67 1591.97 -0.70 0.070288918 
Q9NR45 EMAVEFLHELNVPFFKVGSG 2231.11 2231.08 -0.03 0.001593625 





5357.79 5359.43 1.64 0.066064743 
Q8TDN2 QQAGEVTTAKPEGPS 1481.70 1480.70 -0.99 0.026450742 
Q7LBR1 ELSQRLARLR 1222.73 1222.73 0.00 0.06291834 
Q8IXH7 PPPVELIRVPAFL 1446.86 1446.84 -0.02 0.029101856 
Q96EP5 EIGKLFVGGLD 1146.63 1148.62 1.99 0.027496757 
Q96EP5 QAVNMHFH 965.42 965.41 0.00 0.001593625 




Q8N7A4 DPCHGSGPALM 1081.43 1081.58 0.15 0.004582951 
Q8N7I6 MWICPGGGGGGGGGGGGGGG 1519.59 1519.88 0.29 0.062583818 
P20591 PAAASHPLLLNG 1159.63 1159.63 0.00 0.001593625 
P20591 SLRALGVEQ 971.54 971.55 0.01 0.02661101 
P20591 IATTEALSMAQEV 1362.67 1362.66 -0.01 0.012337217 
P20591 QLSLSEALQREKIFFENHPYFR 2734.39 2734.38 -0.01 0.019836639 





3945.80 3945.28 -0.52 0.066725198 
Q8NFL0 TFFNLTLKEIHFLKWL 2049.15 2048.19 -0.96 0.028343211 
P00558 NGAKSVVLMSHLGRP 1564.85 1565.83 0.98 0.012721794 
P00558 KYSLEPVAVELKSLLGK 1873.09 1873.08 -0.01 0.001593625 
P00558 KIQLINNML 1101.62 1101.62 0.00 0.003775366 
P00558 EEGAKIVK 854.49 854.48 0.00 0.003775366 
P00558 LMSKAEKNGVKITLPV 1727.00 1728.00 1.00 0.042949177 
P00558 ENAKTGQATVASGIPAGWMGL 2040.01 2040.01 0.00 0.001593625 
P00558 KVSHVSTGGGASLELLEGKVLPGV 2333.30 2333.29 0.00 0.010505051 
Q53EQ6 RAPAPPPPAEGGYGD 1450.68 1449.77 -0.92 0.066064743 
Q8NBS9 PHSKHLYTA 1052.54 1052.54 0.00 0.001593625 
Q8NBS9 AKVYVAKV 876.54 876.54 0.00 0.020577308 
Q8NBS9 AKVYVAKVD 991.57 991.57 0.00 0.003775366 
Q8NBS9 KGTVLALTENNF 1305.69 1305.69 -0.01 0.001593625 
Q8NBS9 SLHRFVLSQAK 1284.73 1284.72 -0.01 0.003157895 
Q8NBT0 DFSINTKQLASGSM 1497.71 1496.82 -0.90 0.031793343 
Q8NEY1 GIKVHGQKAAWED 1437.74 1437.75 0.01 0.047058824 
O94776 QFLVVARAVGTFARAL 1700.97 1700.97 0.00 0.001593625 
P52272 FFPPERPQQLPHGLGGIGMGLGPGGQPI 2853.47 2854.49 1.01 0.004582951 
Q96KP4 GSEIPLPPILLGRLGS 1617.95 1617.93 -0.02 0.001593625 
Q96KP4 ELIFARK 857.51 857.51 0.00 0.00757257 
Q96KP4 VGAQILLHSHKK 1329.79 1329.78 -0.01 0.02661101 
Q96KP4 LTREGGSIPVTLTFQEATGKNVMLLPVGSA 3085.65 3086.63 0.98 0.003157895 
Q8TBM8 NCKELERLTSLYKGG 1709.88 1710.87 1.00 0.060606061 
P62979 TIENVKAKIQ 1142.67 1142.67 0.00 0.001593625 
P62979 QQRLIFAGKQLE 1412.78 1412.78 0.00 0.001593625 
O95876 DRSLVGKLIS 1068.63 1068.66 0.03 0.062583818 
P49321 SEAKKLLGLGQKHLVMG 1808.03 1808.03 -0.01 0.04361223 
P26599 PVSAQHAKLSL 1149.65 1149.65 0.00 0.001593625 
Q9Y2K3 LGKVRSAAARLD 1255.74 1255.62 -0.12 0.063943162 
Q71U36 DSFNTFFSETGAGKHVPRAVFV 2412.19 2413.18 1.00 0.040106306 
Q71U36 SFNTFFSETGAGKHVPRAVFV 2297.16 2297.17 0.01 0.001593625 




Q71U36 AANNYARGHYTIGKEII 1889.97 1889.97 -0.01 0.015837821 
Q71U36 VNAAIATIKTKRTIQFV 1873.11 1873.11 0.00 0.0466541 
Q14011 EGKLFVGGLSF 1134.61 1134.60 -0.01 0.002276608 
Q14011 TNEQSLEQVFSKYGQISEVVVVK 2610.35 2610.34 -0.01 0.012337217 
P49736 QQIGEKIFASIAPSIYGHE 2070.04 2070.05 0.00 0.001593625 
P49736 LTEPIISRF 1074.61 1075.60 0.99 0.010505051 
O00232 ESEAFLSNLVVNKTIFAKV 2090.14 2090.13 -0.01 0.001593625 
P13639 ITKGVQYLNEIK 1404.80 1404.79 -0.01 0.001593625 
P39019 TVKLAKHKELAPY 1496.87 1497.87 1.00 0.002276608 
P39019 LDRIAGQVAAANKKH 1572.88 1572.88 0.00 0.078844169 
P63173 KEKAEKLKQSLPPGLAVKELK 2333.40 2334.40 0.99 0.003775366 
O76094 PEKAKALSKHLPSS 1491.84 1492.84 1.00 0.00757257 
P61204 AVLLVFANKQ 1101.65 1101.65 0.00 0.001593625 
P18085 AVLLLFANKQ 1115.67 1115.67 0.00 0.001593625 








GGSGGGGGGGSS 1691.65 1692.89 1.24 0.049226442 
P61978 SSGPERILSISA 1215.65 1215.64 -0.01 0.082482646 
P61978 IETIGEILKKIIPTLEEGLQLPSPTATSQLPLES 3658.03 3660.02 1.99 0.001593625 
P61978 LISESPIKGRAQPY 1557.85 1557.84 -0.01 0.001593625 
P61978 YSYAGGRGSYG 1136.49 1136.48 -0.01 0.001593625 
P61978 LGGPIITTQVTIPK 1436.86 1436.85 -0.01 0.001593625 
P61978 LGGPIITTQVTIPKD 1551.89 1552.88 0.99 0.017501509 
P61978 LAGSIIGKGGQRIKQIRHESGASIKI 2716.58 2717.59 1.01 0.028343211 
P61978 RIITITGTQ 1001.59 1001.58 -0.01 0.002276608 
P61978 QIQNAQYLLQNSVKQYSGKFF 2486.26 2487.25 0.99 0 
P09104 LYTAKGLFRAAVPSGASTGIYEALELR 2853.54 2854.54 1.00 0.00757257 
P10599 VKQIESKTAFQEAL 1590.86 1590.86 0.00 0.074812968 
P31946 KSELVQKAKLAEQAERY 1990.08 1990.08 0.00 0.001593625 
P31946 TLNEESYK 982.46 982.46 0.00 0.010505051 
P31946 STLIMQLLR 1073.63 1073.62 -0.01 0.001593625 
P83876 EVLYSIAEKVKNFAVIYLV 2179.23 2180.23 1.00 0.002276608 
P07737 LRTKSTGGAPTFNVTVTKT 1978.08 1978.06 -0.02 0.001593625 
P07737 LRTKSTGGAPTFNVTVTKTD 2093.11 2094.12 1.01 0 
Q0VF49 DPWLSPKY 1004.50 1002.55 -1.95 0.069489685 
P29728 ETIRNILLHQLQSARPVIL 2195.29 2196.32 1.03 0.029101856 
P22234 VTTKEIVLA 972.59 972.58 0.00 0.052802223 




P08779 KVRALEEANA 1099.60 1099.60 0.00 0.043333333 
P08779 YSPYFKTIE 1146.56 1146.56 0.00 0.005398111 
P08779 LSRILNEMR 1130.62 1131.62 1.00 0.002276608 
P08779 QYEQMAEKNRR 1434.67 1434.66 -0.01 0.029101856 
P00338 LVKVTLTSEEEARLKKSA 2001.15 2001.14 -0.01 0.002276608 
P20700 QLLLNYAKKES 1288.70 1289.70 1.00 0.020057307 
P20700 QIAQLEASLAAAKKQLA 1735.98 1735.96 -0.02 0.001593625 
P20700 QPMGGWEMIRKIG 1484.73 1484.72 -0.01 0.012337217 
Q9Y6N9 DLVVAVCPPKEY 1313.67 1312.68 -0.99 0.066725198 
P51572 VGNAEVKLEEENRSLKA 1884.99 1885.99 1.00 0.073744437 
P11586 PETITWQRVL 1241.68 1241.68 0.01 0.001593625 
P62266 EVLVAGFGRKGHAVG 1477.81 1477.82 0.00 0.001593625 
P07741 PASFRAAIGLLARHLKATHGGRI 2412.40 2412.40 0.00 0.002276608 
P07741 ALEPGQRVVVV 1165.68 1165.68 0.00 0.005398111 
P54819 VVFASILAAFSKATS 1510.84 1510.84 0.00 0.06495802 





3702.90 3704.90 2.00 0.003157895 
P04406 NFGIVEGLMTTVHAITATQKTV 2330.23 2331.25 1.02 0.001593625 
P04406 GPSGKLWR 899.50 899.50 0.00 0.012337217 
P04406 NEFGYSNRVV 1183.56 1183.56 -0.01 0.019836639 
P04406 LMAHMASKE 1016.48 1016.48 0.00 0 
P35754 LVSLQQSGELLTRLKQIGALQ 2294.33 2295.34 1.01 0.008347245 
P17174 SAYQGFASGNLER 1398.65 1399.64 0.99 0.002276608 
P62888 IIRSMPEQTGE 1259.62 1259.62 0.00 0 
P62888 IIRSMPEQTGEK 1387.71 1388.71 1.00 0 
P09382 AKSFVLNLGK 1075.64 1076.64 1.01 0.034355828 
P62310 GVVLVAPPLRVG 1175.74 1175.74 0.00 0 
P61326 VMIRKEAYVHKSVMEELKRII 2571.44 2572.44 1.00 0.016024653 
P61326 EHISFTTSKIGSLI 1513.81 1513.82 0.00 0.001593625 
P34949 EAATHLKQTMSH 1334.64 1334.63 -0.01 0.002276608 
P26038 AELEFAIQPNTTGKQLF 1905.98 1906.97 0.98 0.002276608 
P26038 AVLEYLKIAQ 1146.66 1146.66 -0.01 0.004582951 
O43678 QVTRALENVLSGKA 1467.80 1467.80 0.00 0.001593625 
P30086 LSKWSGPLSLQEV 1442.78 1442.78 0.00 0.001593625 
P30086 EQPQHPLHVTYAGAAV 1698.85 1698.85 0.00 0.001593625 
P30086 ELGKVLTPTQVKNRPTSISW 2235.24 2235.26 0.02 0.001593625 
P30086 SGKLYTLVLT 1093.64 1094.64 1.00 0.012721794 
P30086 YVGSGPPKGTGLHRYVWLVYEQ 2505.28 2506.27 0.99 0.020057307 
P30086 DYVPKLYEQLSGK 1538.80 1538.80 0.00 0 
P30086 YVPKLYEQLSGK 1423.77 1423.77 0.00 0 




P52209 EGAGHFVKMVHNGIEYG 1825.86 1826.87 1.01 0.002276608 
P07205 NGAKAVVLMSHLGRP 1548.86 1547.81 -1.05 0.042135504 
P07205 EEGAKIVK 854.49 854.48 0.00 0.003775366 
Q13867 FLKKMVAASIKD 1331.76 1331.65 -0.11 0.001593625 
P25787 ERSVHKVEPITKHIGLVYSGMGP 2531.33 2531.32 -0.01 0.001593625 
P30085 QTMAANAQKNKFLI 1559.81 1559.82 0.01 0.007002188 
Q8NFF5 EVATIAAEVTSFSNRFTHVLTAGGIGPTH 2964.51 2964.49 -0.02 0.001593625 
P30041 SWGILFSHPR 1198.62 1198.62 0.00 0.001593625 
P30041 EKGMPVTARVVFVFGP 1730.92 1731.91 1.00 0.012721794 
P30041 KKLKLSILYPATTGRNF 1949.15 1950.14 0.99 0.003775366 
P30041 EILRVVISLQLTAEKRVATPV 2316.39 2317.39 1.00 0.001593625 
P04264 PEIQKVKSREREQIKSLNNQFASFI 2988.61 2989.63 1.02 0.002276608 
P04264 PEIQKVKSREREQIKSLNNQFASFID 3103.64 3105.63 1.99 0.001593625 
P04264 KVRFLEQQNQVLQTKWELLQQV 2754.52 2754.52 0.00 0.001593625 
P04264 KVRFLEQQNQVLQTKWELLQQVD 2869.55 2871.54 1.99 0.001593625 
P04264 FLEQQNQVLQTKWELLQQVDTSTR 2931.51 2933.50 1.99 0.074812968 
P04264 TSTRTHNLEPYFESFINNLRRRVD 2964.50 2965.51 1.02 0.022452989 
P04264 EINKRTNAENEFVTIKK 2015.08 2015.09 0.01 0.001593625 
P04264 EINKRTNAENEFVTIKKD 2130.11 2130.10 -0.01 0.001593625 
P04264 SIIAEVKAQYE 1249.66 1250.66 1.00 0.001593625 
P04264 IAQKSKAEAESLYQSKYEELQITAGRHG 3134.60 3135.61 1.01 0.001593625 
P04264 IAQKSKAEAESLYQSKYEELQITAGRHGD 3249.63 3250.62 1.00 0 
P04264 NVKKQISNLQQSIS 1585.88 1585.88 0.00 0.012337217 
P04264 NVKKQISNLQQSISD 1700.91 1701.89 0.99 0.001593625 
P04264 YQELMNTKLAL 1322.69 1322.69 0.00 0.004582951 
P63162 GRIFIGTFKAF 1255.71 1256.71 1.01 0.020057307 
P61604 KVLLPEYGGTKVVL 1514.91 1514.91 0.00 0.001593625 
P61604 KVLLPEYGGTKVVLDD 1726.95 1726.97 0.02 0.092548077 
Q96EZ8 SGPDSQGLLDSSLMASGTASR 1999.93 2001.12 1.20 0.078844169 
P61981 REQLVQKARLAEQAERY 2087.12 2087.11 -0.01 0.062583818 
P61981 STLIMQLLR 1073.63 1073.62 -0.01 0.001593625 
P13010 IESKIQPGSQQA 1284.67 1284.67 0.00 0.001593625 
P13010 EAAAVALSSLIHAL 1346.76 1346.75 -0.01 0.001593625 
P13010 GITLITKEEASGSSVTAEEAKKFLAPK 2804.52 2804.53 0.02 0.01536 
P62277 VKEQIYKLAKKGLTPSQIGVILR 2581.57 2581.55 -0.02 0.001593625 
Q9C0A1 MATLNSASTTGTTPSPGHNAPSLPS 2412.12 2413.31 1.19 0.099189883 




P08708 FGSLSNLQVTQPTVGMNFKTPRGPV 2690.39 2691.39 1.01 0 
Q9H1R3 DGILFMHKMRVLHL 1690.92 1690.96 0.04 0.026450742 
P49773 EIAKAQVARPGG 1177.66 1177.66 0.00 0.001593625 
P49773 EIAKAQVARPGGD 1292.68 1292.69 0.01 0 
P49773 TIFGKIIRKEIPAKIIFE 2115.28 2115.27 -0.01 0.010505051 
P49773 ISPQAPTHFLVIPKKHISQISVAE 2639.48 2639.48 0.00 0.004582951 
P49773 LGLNKGYRMVVNEGS 1635.84 1635.84 0.00 0.001593625 
P98196 EETGEGPLVNTSD 1328.57 1329.82 1.25 0.059104342 
P35637 DQSSMSGSGGGGGGGGGGGSGGGGGYGNQ 2240.84 2241.13 0.30 0.048379521 
P35637 QSSMSGSGGGGGGGGGGGSGGGGGYGNQ 2126.79 2128.16 1.37 0.099189883 
P35637 QSSMSGSGGGGGGGGGGGSGGGGGYGNQD 2223.81 2225.11 1.30 0.012337217 
P31939 KTGLVEFARNLTALGLNLVASGGTAKALR 2940.69 2941.68 0.99 0.029101856 
P31939 VPTAKIISREVS 1298.76 1299.77 1.01 0.003775366 
P10323 IGSNALRMIQSATPPPPTTR 2107.12 2108.24 1.12 0.096863835 
P08621 ERPGPSPLPHR 1223.65 1223.65 0.00 0.003775366 
O75821 LQELFRPFGSISRIYLAK 2137.20 2137.20 -0.01 0.02661101 
O75821 AARAIAGVSGFGY 1238.64 1239.63 0.99 0.001593625 
P17987 GATILKLL 827.55 827.54 -0.01 0.00757257 
P17987 AVLAIKYT 877.53 877.52 0.00 0.004582951 
P17987 ITKERIQKILATGANVILTTGGI 2409.43 2409.43 0.00 0.028593311 
Q96T23 ECRADPK 817.38 818.73 1.36 0.090652699 
P40926 IVRANTFVAELKGL 1529.89 1530.89 1.00 0.052436195 
Q8WV74 PQKATVVPVLAGVGPL 1544.93 1545.93 1.00 0.003157895 
P31483 EMPKTLYVGNLSR 1488.78 1488.77 0.00 0.029101856 
P28066 PGAMSRPFGVALLFGGV 1674.89 1674.89 0.00 0.001593625 
P28066 EKGPQLFHM 1067.52 1067.52 0.00 0.001593625 
Q14978 LYPLVLGFLR 1189.72 1189.72 0.00 0.001593625 
Q99470 VRYGSGSGQQSVTGVTSV 1767.88 1768.89 1.02 0.012337217 
P14174 PMFIVNTNVPRASVP 1656.87 1656.85 -0.01 0.074812968 
P14174 PMFIVNTNVPRASVPD 1755.90 1755.90 0.00 0.031793343 
P14174 GFLSELTQQLAQATGKPPQYIAVHVVP 2891.55 2892.57 1.01 0.002276608 
P14174 GFLSELTQQLAQATGKPPQYIAVHVVPD 3006.58 3007.57 0.99 0.026450742 
P14174 RVYINYY 989.50 989.49 0.00 0.003775366 
Q99541 DSVASTITGVM 1095.51 1094.48 -1.03 0.069489685 
Q92499 VLMAAETGSGKTGAFSIPVIQIVYETLK 2922.58 2924.58 2.00 0.002276608 
Q92804 TGKPKGEATVSF 1220.64 1220.66 0.02 0.00757257 
Q9Y3C8 EATRRVVSEIPVLKTNAGPR 2174.23 2174.23 0.00 0.029101856 
Q9Y4K0 DLVLNAEMVQQTTYLE 1865.91 1866.10 0.19 0.078844169 




















3703.76 3704.91 1.14 0.031793343 
Q02818 EQELEALFTKELEKVY 1950.00 1949.99 -0.01 0.003775366 
P07858 IMAEIYKNGPVEGAFSVYS 2074.01 2073.98 -0.03 0.001593625 
P07954 PKIANAIMKAA 1126.65 1126.65 -0.01 0.001593625 
P07954 AKSKEFAQIIKIGRTHTQ 2055.16 2055.14 -0.02 0.022452989 
P29374 SGAVWKQIYMD 1296.62 1295.83 -0.79 0.068935428 
P78527 EFVKSVLKIVEKL 1512.93 1512.91 -0.01 0.005398111 
Q8N1G1 AGYQPTPLAAPAEPGSKYSLASLD 2385.18 2383.22 -1.96 0.063943162 
P78371 LVKSTLGPKGM 1145.65 1145.65 0.00 0.003775366 
P78371 KILLSSGR 872.54 872.54 0.00 0.008347245 
P78371 LVAQLRAAHSEGNTTAGL 1807.95 1808.95 1.00 0.002276608 
Q13224 LQKEEAALAPRSVSLKD 1836.01 1835.95 -0.06 0.042135504 
P41091 LQYAAPGGLIGVGTKI 1556.89 1556.88 -0.02 0.002276608 





4007.28 4008.29 1.01 0.012337217 
Q12906 ITQSAQHALRLAAFGQLHKVLGM 2489.37 2490.35 0.98 0.003775366 
O14980 QGEVVREFMK 1204.59 1204.58 -0.01 0.029101856 
Q9Y490 PETQVVLINAVK 1309.76 1309.76 0.00 0.004582951 
Q9UQ80 LVVTKYKMGG 1110.61 1110.60 -0.01 0.001593625 
Q9UQ80 VAQGTQVTGRKA 1214.67 1214.66 -0.01 0.002276608 
Q9UQ80 GEKTIIQNPT 1099.59 1101.58 2.00 0.022452989 
Q9UQ80 AMPFTLRAFE 1181.59 1181.58 -0.01 0.007002188 
O43497 MHTLLLSALESNMQPHPTELPGPD 2659.26 2658.38 -0.88 0.015837821 
Q5TAT6 DPGMTGPTGAAGLPGLHGPPG 1837.88 1836.93 -0.94 0.060606061 
Q99460 VMAKFGAILAQGIL 1430.83 1432.80 1.97 0.003157895 
P33993 PGVAKSQLLSYI 1274.72 1274.72 0.00 0.002276608 
P33993 RLAPRSQYTTGRGSSGVGLTAAVLR 2573.42 2573.40 -0.01 0.074812968 
P33993 QPMVPESLADYITAAYVEMR 2299.09 2304.39 5.30 0.096863835 
P43004 MASTEGANNMPKQVEVRMH 2160.97 2159.36 -1.61 0.018962963 
Q01118 GGSKEKIKQSSSSECSTVD 1937.90 1939.11 1.21 0.064587481 
Q6ZN04 DLERNGSGGGGGGSSGGGETL 1801.78 1802.98 1.19 0.068301226 




Q9UHP3 DTQILQQALK 1156.65 1156.58 -0.06 0.020057307 
P42126 VQNFVSFISK 1167.63 1167.63 0.00 0.012337217 
Q15424 SGAAGAAALSSASSETGTRRLS 2007.00 2006.99 -0.01 0.016024653 
P02538 EINKRTAAENEFVTLKK 1972.07 1972.07 0.00 0.028343211 
P02538 EINKRTAAENEFVTLKKD 2087.10 2088.11 1.01 0.02661101 
P02538 AAYMNKVELQAKA 1435.75 1435.74 -0.01 0.001593625 
P02538 EINFLRALY 1119.61 1119.60 0.00 0.031793343 
P02538 AELSQMQTHIS 1243.59 1243.58 0.00 0.001593625 
P02538 SIIAEVKAQYE 1249.66 1250.66 1.00 0.001593625 
P02538 AKNKLEGLE 1000.56 1000.55 0.00 0.070288918 
P02538 YQELMNVKLAL 1320.71 1320.71 0.00 0.00757257 
Q9NRR4 STVVGTSRLR 1074.61 1074.61 -0.01 0.035242291 
Q01105 ETSEKEQQEAIEHI 1651.77 1651.76 -0.01 0.001593625 
Q01105 EEALHYLTRVEVTEFE 1945.94 1945.94 0.00 0.001593625 
Q01105 ENPYFENKVLSKEFHLNESG 2362.12 2363.11 0.99 0.001593625 
P63208 VEIAKQSVTIKTMLE 1688.94 1689.92 0.99 0.010505051 
P62995 LREVFSKYGPIA 1378.76 1378.76 0.00 0.003775366 
Q9H6D7 LLQNPYFSKLLLNLSQHVD 2223.20 2223.19 -0.01 0.042135504 
P13637 IAARLNIPVSQVNPR 1646.96 1647.94 0.98 0.024896266 
P50991 PENVAPRSGATAGAAGGRGKGAYQ 2242.12 2242.11 -0.01 0.074812968 
P50991 AIRTSLGPKGM 1145.62 1145.62 -0.01 0.003157895 
P20929 MLQVTQAKKSQAIASD 1717.90 1717.98 0.08 0.074812968 
P06576 GTEGLVRGQKVL 1255.72 1255.72 -0.01 0.018962963 
P06576 NIFRFTQAGSEVSALLGRIPSAVGYQPTLAT 3263.73 3265.72 1.99 0.012337217 
P06576 PAPATTFAHL 1024.53 1024.53 0.00 0.00757257 
P06576 ATTVLSRAIAELGIYPAV 1844.04 1844.03 -0.01 0.001593625 
P06576 PNIVGSEHY 1014.48 1014.47 -0.01 0.003775366 
P06576 VARGVQKILQ 1110.69 1110.68 -0.01 0.02661101 
P06681 TICGVGNMSANASD 1336.54 1336.78 0.24 0.069489685 
Q9BPZ3 PSRSSTSPSIINE 1373.68 1373.67 0.00 0.057481752 
Q9BPZ3 LVVKSNLNPNAKEFVPGVKYGNI 2499.38 2500.39 1.01 0.003775366 
P40429 KYTEVLKTHGLLV 1499.87 1499.87 0.00 0.003775366 
Q96QP1 GAGPTFK 676.35 676.47 0.12 0.092548077 
Q2M3C7 DYYAGKNASSILNSAMQQACRKS 2487.16 2487.82 0.66 0.061925062 
P08107 AAKNQVALNPQNTVF 1613.85 1613.84 -0.01 0.002276608 
P08107 AGVIAGLNVLRIINEPTAAAIAYGL 2479.42 2479.39 -0.02 0.001593625 
P08107 PVEKALR 811.49 811.49 0.00 0.003157895 
P08107 PVEKALRD 926.52 926.52 0.00 0.010505051 
P08107 LVLVGGSTRIPKVQKLLQ 1948.22 1948.21 -0.01 0.004582951 
P08107 NQPGVLIQVYEGERAMTK 2032.04 2034.03 1.99 0.001593625 




P08107 EVQRERVSAKNALESYAFNMKSAVE 2837.41 2838.40 0.99 0.028593311 
O43592 QQKANVEAIMLAVMKKLTY 2161.16 2163.15 1.98 0.001593625 
Q08J23 PLFPPIEKFYAL 1433.80 1434.82 1.02 0.002276608 
O15014 RGGCGVVGGGGSCSSVGGASGGERSV 2194.98 2196.21 1.23 0.062583818 
O15014 RGGCGVVGGGGSCSSVGGASGGERSVD 2310.01 2310.94 0.93 0.00757257 
A4D1E1 HQLQSDR 864.42 865.01 0.59 0.084638861 
Q09028 LVMTHALEWPSLTAQWLP 2092.08 2093.10 1.02 0.0466541 
Q09028 FSIHRLVLGTHTS 1466.80 1467.80 1.00 0.059104342 
Q09028 AKTIFTGHTAVVE 1372.74 1372.73 -0.01 0.003157895 
Q96KC9 DAEISITSEVSGTLK 1548.79 1547.96 -0.83 0.068301226 
Q9Y4E6 DKQGSEEGLAMTTSISLQEAF 2223.04 2221.23 -1.81 0.031793343 
Q99729 AGKMFVGGLSW 1151.58 1151.57 -0.01 0.001593625 
Q99729 AASVEKVL 815.48 815.47 0.00 0.004582951 





3908.11 3909.07 0.96 0.029101856 
P62837 ALKRIHKELNDLARD 1791.01 1792.00 0.99 0.074812968 
P62837 PLVPEIARIYKT 1398.82 1398.82 0.00 0.001593625 
Q7Z6J2 DSEVAPAAPVPTPGPPAAAATPGPPA 2305.16 2305.09 -0.07 0.074812968 
Q9BX82 MNVEVVKVMPQ 1304.65 1305.66 1.02 0.099189883 
P61758 EAQALLEKNLSTATKNL 1824.99 1824.99 0.00 0.001593625 
Q9UJZ1 PEYAVTQLAQTTMRSELGKLSL 2435.27 2436.28 1.01 0.02661101 
P60660 VMRALGQNPTNAEVLKVLGNPKS 2435.33 2435.33 0.00 0.001593625 
P60660 FEHFLPMLQTVAKNK 1801.95 1801.95 -0.01 0.001593625 
P60660 YVEGLRVF 981.53 981.53 0.00 0.002276608 
P17066 PVEKALR 811.49 811.49 0.00 0.003157895 
P17066 PVEKALRD 926.52 926.52 0.00 0.010505051 





3909.06 3910.12 1.07 0.012721794 
Q16777 VGAGAPVYMAAVLEYLTAEILELAGNAAR 2948.53 2950.53 2.00 0.074812968 
Q7Z5K2 DVKLEFFGFE 1211.59 1211.69 0.10 0.020057307 
Q96AE4 YGYGGQKRPLE 1266.64 1266.63 0.00 0.002276608 
P05161 RVPLASQGLGPGSTVLLVV 1862.10 1863.10 1.00 0.01536 
P62913 TGNFGFGIQEHI 1318.63 1318.63 -0.01 0.001593625 
P62913 FYVVLGRPGFSIA 1424.78 1424.78 0.00 0.001593625 
Q14697 PPIARLSVSGR 1151.68 1151.70 0.02 0.00757257 
Q14697 EPGAWEETFKTHS 1499.67 1499.66 -0.01 0.00757257 
Q14697 SKPYGPMSVGL 1134.57 1134.58 0.01 0.001593625 




Q14697 ISSNTAGKTLFGKMM 1584.80 1584.81 0.01 0.005398111 
Q14697 VRWMSETGII 1190.61 1190.64 0.02 0.008347245 
Q14697 SGYRVHEELRNLGLYVKTR 2289.23 2289.26 0.02 0.020057307 
Q14697 MNEPSVFNGPEVTMLK 1791.85 1791.85 -0.01 0.001593625 
Q14697 AQHYGGWEHR 1239.55 1239.55 0.00 0.001593625 
Q14697 ALLVHPVS 834.50 834.50 0.00 0.003775366 
Q14697 SGAHGVQVYLPGQGEVWY 1945.93 1946.93 1.00 0.001593625 
Q14697 PETSVLVLRKPGINVAS 1779.03 1779.02 -0.01 0.001593625 
Q86UH8 LLLGHPTAVGCAKGTD 1551.81 1551.96 0.16 0.001593625 
Q9ULD6 GLNSGDHSDSAKSVSSLNPVK 2080.02 2085.10 5.08 0.074812968 
P06889 YYCQAWNSSSVLFGGGTKLTVLG 2450.19 2450.21 0.01 0.026450742 
Q16576 TRSNTTSKPSHLV 1426.75 1426.75 0.00 0.090652699 
P22626 AAMAARPHSI 1023.53 1023.52 0.00 0.002276608 
P22626 YFEEYGKI 1047.49 1047.49 0.00 0.001593625 
P22626 SRGGGGNFGPGPGSNFRGGS 1820.83 1820.83 0.00 0.001593625 
P68104 FIKNMITGTSQA 1309.67 1309.66 -0.01 0.001593625 
P68104 KPLRLPLQ 963.62 963.62 0.00 0.003157895 
P68104 NVGFNVKNVSVK 1303.72 1303.71 -0.01 0.001593625 
P68104 GPKFLKSG 832.48 832.48 0.00 0.003157895 
P68104 GPKFLKSGD 947.51 947.51 0.00 0.003157895 
P68104 MRQTVAVGVIKAV 1370.81 1370.83 0.02 0.001593625 
P68104 KKAAGAGKVTKSAQKAQKAK 1998.21 1998.22 0.01 0 
Q7Z7F0 DERNGSGTLTGSH 1329.59 1328.73 -0.86 0.099189883 
Q9UHD9 QLVLIFAGKILK 1324.85 1324.85 0.00 0.001593625 
Q9UHD9 INAAIERLLGSQPS 1467.80 1468.81 1.01 0.004582951 
Q86WA8 LSFVTASCLD 1036.49 1036.49 0.00 0.006197432 
A6NIZ1 TAGTEQFTAMR 1211.56 1211.56 0.00 0.001593625 
Q96K17 SLTSLRKLAEQFPRQVL 1985.14 1985.14 -0.01 0.012337217 
P55957 LATALEQLLQAYPR 1585.88 1585.89 0.01 0.012721794 
Q9NP62 FNSYVQSPAYHSPQED 1867.80 1866.04 -1.77 0.070288918 
P08238 SGKELKID 888.49 888.51 0.01 0.006197432 
P08238 IIPNPQERTLTLV 1492.86 1492.86 0.00 0.003775366 
P08238 TGIGMTKAD 892.43 892.43 0.00 0 
P08238 LINNLGTIAKSGTKAFMEALQAGA 2418.29 2419.31 1.01 0.001593625 
P08238 KKKKTKKIKEKYI 1662.09 1663.09 1.00 0.039757576 
P08238 QEELNKTKPIWTRNP 1835.95 1835.94 -0.01 0.001593625 
P08238 QEELNKTKPIWTRNPD 1950.98 1950.97 -0.01 0.001593625 
P08238 QEELNKTKPIWTRNPDD 2048.00 2047.99 -0.01 0.074812968 
P08238 KENYKKFYEAFSKNLKLGIHE 2585.36 2585.35 -0.02 0.016024653 
P08238 ASRMEEV 820.37 820.39 0.01 0.061725614 
Q92882 IVQLLLAKGART 1281.81 1283.74 1.93 0.073160357 









2945.36 2943.73 -1.63 0.017501509 
P25788 IVKEVAKIIYIVH 1523.94 1523.94 0.00 0.002276608 
Q6IC83 MGSKLTCCLGPSGGLNC 1655.71 1654.92 -0.79 0.072407883 
P51991 GRVVEPKRAVSRE 1481.84 1481.84 0.00 0.02661101 
P51991 SVKPGAHLTVKKIFVGGIKE 2107.25 2108.25 1.00 0.003775366 
P62937 GEPLGRVSFELFA 1420.74 1420.73 0.00 0.001593625 
P62937 FTRHNGTGGKSIYGEKFE 2026.99 2026.98 -0.01 0.001593625 
Q6NVY1 FHEGVRAVLIDKD 1497.79 1497.91 0.11 0.092548077 
O60814 TGISSKAMGIMNSFVN 1655.80 1657.78 1.98 0.043333333 
O60814 TGISSKAMGIMNSFVND 1770.83 1770.85 0.02 0.017501509 
P47914 QTKAQAAAPASVPAQAPKRTQAPTKASE 2786.47 2786.46 0.00 0 
P62495 QRLQSKVLKLV 1293.81 1293.81 -0.01 0.042135504 
Q6UXW
0 DLVLGAEEAHGSRL 1465.75 1466.83 1.07 0.005398111 
O43895 DVRIWIGTSYTMYGIYEMIPKEKLVT 3103.58 3103.17 -0.41 0.074812968 
P25705 VPVGEELLGRVV 1265.73 1265.73 -0.01 0.001593625 
P25705 AKLKEIVTNFLAGFEA 1749.97 1750.96 0.99 0.001593625 
P23508 MMAAAAAAAAGSSSSGGGGGGSGSSSSSS 2277.91 2277.17 -0.74 0.055479138 
Q6ZS46 DVLLSGRGGGGGGGGGARTGGGEGE 2085.98 2084.17 -1.81 0.047058824 
P62805 GVLKVFLENVIR 1385.84 1385.84 0.00 0.096697175 
P62805 AVTYTEHAKRKTVTAM 1821.94 1822.93 0.99 0.004582951 
P62805 VVYALKRQGRTLYGFGG 1884.04 1884.03 0.00 0.001593625 
Q6XQN6 PAFFEHLRAL 1199.65 1199.64 0.00 0.039757576 
Q96FL8 AVTLAIAVINVTGVSVGFGLSSAC 2248.21 2248.13 -0.09 0.090652699 
P06733 LFTSKGLFRAAVPSGASTGIYEALELR 2853.54 2854.55 1.01 0.001593625 
P06733 EGGFAPNILENKEGLELLKTAIGKAGYT 2914.54 2914.53 -0.01 0.001593625 
P06733 EGGFAPNILENKEGLELLKTAIGKAGYTD 3029.57 3030.56 0.99 0.001593625 
P06733 VAASEFFRSGKY 1360.68 1360.67 -0.01 0.001593625 
P06733 VAASEFFRSGKYD 1475.70 1476.69 0.99 0.001593625 
P06733 PSRYISPD 933.46 933.45 0.00 0.026450742 
P06733 LYKSFIK 897.53 897.53 0.00 0.006197432 
P99999 LIAYLKKATNE 1262.72 1262.72 -0.01 0.001593625 
P04075 PYQYPALTPEQKKELS 1890.97 1890.96 -0.01 0.084638861 
P04075 IAHRIVAPGKGILAA 1485.91 1485.91 -0.01 0.001593625 
P04075 IAHRIVAPGKGILAAD 1600.94 1600.93 -0.01 0.001593625 
P04075 DGRPFPQVIKSKGGVVGIKV 2080.22 2081.21 0.99 0.031793343 




P04075 GRPFPQVIKSKGGVVGIKVD 2080.22 2080.21 -0.01 0 
P04075 KGVVPLAGTNGETTTQGL 1741.92 1742.92 1.00 0.001593625 
P60981 PFKHFVGMLPEK 1428.76 1428.76 0.00 0.052436195 
P07910 PRSMNSRVFIGNLNTLVVKKS 2359.32 2360.29 0.97 0.026450742 
P61586 EHTRRELAKMKQEPVKPEEGR 2529.32 2530.32 1.00 0.005398111 
Q8N6N2 SLTGTPSGGGGMGHEGRGQSGELGD 2297.99 2298.89 0.90 0.032956222 
P14618 PILYRPVAVAL 1210.74 1210.74 0.00 0.001593625 
P14618 PILYRPVAVALD 1325.77 1325.76 -0.01 0.010505051 
P14618 TKGPEIRTGLIKGSGTAEVELKKGATLKITL 3208.88 3209.89 1.02 0.001593625 
P14618 DGLISLQVKQKGA 1355.78 1355.77 0.00 0.002276608 
P14618 GLISLQVKQKGA 1240.75 1240.74 -0.01 0.001593625 
P14618 FLVTEVENGGSLGSKKGVNLPGAAV 2442.31 2443.34 1.03 0.001593625 
P14618 FLVTEVENGGSLGSKKGVNLPGAAVD 2557.34 2557.35 0.01 0 
P14618 MVFASFIRKAS 1255.67 1255.67 -0.01 0.001593625 
P14618 MVFASFIRKASD 1370.70 1370.69 -0.01 0.003157895 
P14618 LRVNFAMNVGKARGFFKKGD 2236.20 2237.20 0.99 0.07211848 
P14618 VVIVLTGWRPGSGFTNTMRVVPVP 2581.42 2581.41 -0.01 0 
Q92945 RGGGGPGGGGPGGGSAGGPSQPPGGGGPGIRK 2553.25 2553.25 -0.01 0.001593625 
Q92945 QPESKKLASQG 1154.59 1154.59 0.00 0.002276608 
Q9HCE6 AHQPGAERNLLYED 1593.75 1592.92 -0.83 0.026450742 
Q14031 GPSGLPGPPGALGD 1190.59 1190.98 0.39 0.02661101 





3193.45 3194.64 1.19 0.084638861 
P06748 ENEHQLSLRTVSLGAGAK 1890.99 1890.99 0.00 0.001593625 
P06748 ENEHQLSLRTVSLGAGAKD 2006.02 2006.01 -0.01 0.001593625 
P06748 VKLLSISGKRSAPGGGSKVPQKKVKLAA 2803.71 2804.73 1.01 0.002276608 
P06748 EEAEEKAPVKKSIR 1594.87 1595.86 0.99 0.001593625 
P06748 QEAIQDLWQWRKSL 1764.89 1764.89 0.00 0.078844169 
Q9BV86 EIYHVYSFALR 1378.70 1378.70 0.00 0 
P39023 PSKPVHLTAFLGYKAGMTHIVREV 2650.44 2650.42 -0.03 0.063654574 
P37802 VGRPQPGRENFQNWLK 1925.00 1925.00 -0.01 0.049226442 
P37802 PNWFPKKSKENPRNFS 1975.01 1976.00 0.99 0.015837821 
Q9Y266 PEINTKKINPENSKLS 1810.98 1810.97 -0.01 0.020057307 
Q9Y266 EQKKQEILKKFM 1530.86 1530.85 -0.01 0.00757257 
P13693 GVTPYMIFFK 1201.62 1201.61 -0.01 0.02661101 
Q96AB3 SGLLGLFQGQNSLLH 1582.85 1583.84 0.99 0 
P08865 VLKFLAAGTHLGGTNL 1610.91 1610.91 0.00 0.001593625 





O60888 SEVLMMIKTQSSLVPALT 1963.04 1963.03 0.00 0.015837821 
Q9BZZ5 SAEFNLVNNALLSIFKM 1910.00 1911.00 1.00 0.001593625 
Q9BZZ5 EVLTKEVEELILTESKKVLE 2310.29 2311.29 0.99 0.002276608 
P28070 FQYLKQVLGQMVI 1565.86 1565.87 0.01 0.063943162 
O60422 GGGGGGGGGAGGAGGAGSAGGGAD 1526.61 1524.87 -1.74 0.001593625 
Q14549 MQRAGGGSAPGGNGGGGGGGPGTAFSID 2346.04 2347.22 1.18 0.031793343 
P19338 VKLAKAGKNQG 1112.67 1112.66 0.00 0.07975334 
P19338 EIEPAAMKAAAAAPASE 1608.78 1610.76 1.98 0.002276608 
P19338 SEEEAMETTPAKGKKAAKVVPVKAKNVAE 3039.63 3040.63 1.00 0.003775366 
P19338 ARTLLAKNLPYKVTQ 1715.01 1715.02 0.01 0.012337217 
P19338 AAEIRLVSK 985.59 985.59 0.00 0.001593625 
P19338 GKSKGIAYIEFKTEA 1640.88 1640.86 -0.01 0.016024653 
P19338 AEKTFEEKQGTEI 1508.74 1509.75 1.01 0.003157895 
P19338 GRSISLYYTGEKGQNQ 1799.88 1799.87 -0.01 0.002276608 
P19338 TTEETLKESF 1183.56 1183.56 -0.01 0.001593625 





3774.01 3775.02 1.02 0.012337217 
O75061 LFGGGGAAGPTQAGQSGVED 1756.80 1755.88 -0.92 0.04361223 
B4DJU8 KIQLHLT 851.52 851.52 -0.01 0.072407883 
Q5SXX8 DTGPRAMGSLSRPSFS 1662.78 1662.91 0.13 0.026450742 
Q8IWT0 EFFIPREVKVLSI 1557.89 1559.88 1.99 0.002276608 
Q5HYB6 EKKMELQEIQLKEAKHIAEEA 2494.31 2494.21 -0.10 0.019836639 
Q53G59 GVWYSVAPMNVRRGLAGATTLGD 2406.21 2405.70 -0.51 0.093906094 
P62826 RKVKAKSIVFHRKKNLQYY 2405.42 2406.41 1.00 0.026450742 
P62826 PNLEFVAMPALAPPEVVM 1923.98 1923.98 0.00 0.002276608 
P62826 PALAAQYEH 998.48 998.48 0.00 0.001593625 
P62826 PALAAQYEHD 1113.51 1113.51 0.00 0.001593625 
Q5ST30 DAEVVVGTTRPETLPG 1639.84 1640.81 0.97 0.032956222 
Q9Y5Y2 FIQEFPGSPAFAALTSIAQKIL 2348.28 2349.29 1.01 0.001593625 
P0C7M2 ESLRSHFEQWGTLT 1671.80 1671.80 0.00 0.052436195 
P0C7M2 GRVVEPKRAVSRE 1481.84 1481.84 0.00 0.02661101 
P0C7M2 SQRPGAHLTVKKIFVGGIKE 2164.25 2164.14 -0.11 0.096863835 
Q15084 VIELTPSNFNREVIQS 1844.96 1844.96 0.00 0.003775366 
Q15084 AALSALRQLVK 1168.73 1168.72 -0.01 0.002276608 
Q15084 RLGGRSGGYSSGKQGRS 1708.87 1708.87 0.00 0.070288918 
P22314 SNGEQPLSAMVSMVTK 1677.81 1677.84 0.03 0.001593625 




P22314 TAAAAVRQMNPHIRVTSHQNRVGP 2610.37 2610.38 0.01 0.068678915 
P22314 VNNPLHL 805.44 805.44 0.00 0.070288918 
P22314 FIVAASNLRAENY 1466.75 1467.75 1.00 0.002276608 
P23284 EKKKGPKVTVKVYF 1631.98 1631.97 0.00 0.001593625 
P23284 VGRVIFGLFGKTVPKTV 1817.09 1817.09 0.00 0.001593625 
P23284 GTGGKSIYGERFP 1367.68 1367.68 -0.01 0.001593625 
P23284 ENFKLKHYGPGWVSMANAGK 2215.10 2215.09 -0.01 0.001593625 
P23284 TNGSQFFITTVKTAWL 1812.94 1812.94 0.00 0.001593625 
Q8IVT5 AAAMGEK 676.32 676.47 0.15 0.078844169 
P62854 KAIKKFVIRNIVEAAAVR 2025.26 2025.25 -0.01 0.012337217 
P62854 RTPPPRFRPAGAAPRPPPKPM 2293.27 2294.28 1.01 0.00757257 
A6NKD9 EERAALAATGAASGGGGGGGGAGSRSSI 2313.11 2314.27 1.16 0.069489685 
A6NKD9 EERAALAATGAASGGGGGGGGAGSRSSID 2410.12 2408.16 -1.96 0.066725198 
Q9BYG9 ENEHQLSLRTVSLGAGAK 1890.99 1890.99 0.00 0.001593625 
Q9BYG9 ENEHQLSLRTVSLGAGAKD 2006.02 2006.01 -0.01 0.001593625 
Q9BYG9 VKLLSISGKRSAPGGGSKVPQKKVKLAA 2803.71 2804.73 1.01 0.002276608 
Q9BYG9 EEAEEKAPVKKSIR 1594.87 1595.86 0.99 0.001593625 
Q9BYG9 IKAKMQASIEKAH 1453.81 1453.80 0.00 0 
P52739 HLVIHTGD 890.46 890.50 0.04 0.02661101 
Q6PIQ7 RFSGSKSGNTASLTISGLQAE 2110.07 2110.06 0.00 0.001593625 
Q6PIQ7 FYPGAVTVAWKA 1308.69 1308.68 0.00 0.001593625 
Q8TAF3 SIYSLAMNQLGTIIVSGSTEKVLRVWD 2995.57 2993.98 -1.59 0.042135504 
P62857 VLTLLESEREARRLR 1840.06 1840.06 -0.01 0.008347245 
A5A3E0 ESGPSIVHRKCL 1306.68 1306.67 -0.01 0.012337217 
Q9Y262 QKVYELQASRVSS 1476.76 1477.75 0.99 0.012337217 
P02768 ETYVPKEFNAETFTFHA 2011.93 2012.93 1.00 0.001593625 
O75083 EGKLLEAKGPVT 1222.69 1223.68 0.99 0.082482646 
 DGKGSASGQGSC 1052.42 1050.57 -1.85 0.042135504 
Q9H299 EMRALAGNPKATPPQIVNG 1945.02 1946.04 1.02 0.001593625 
P49459 ILQNRWSPTY 1276.66 1277.66 1.00 0.017996401 
B4E2M5 MTKLHQAVAAG 1141.59 1142.64 1.04 0.01536 
P17542 PVVGAGGGGGGGGGGAPP 1276.62 1275.78 -0.83 0.087221095 




GGGYRRY 1886.80 1884.95 -1.85 0.07975334 
Q92614 LESLEAANQSLQAD 1469.70 1469.76 0.06 0.02661101 
P41250 TVNKTPHTATLR 1337.74 1337.74 0.00 0.028343211 
O75179 DNSGGGGGGGGGGGGGGGTSSNNSEEEE 2295.83 2294.27 -1.57 0.078844169 





P50990 TGANVVVTGGKVA 1171.66 1171.65 0.00 0.001593625 
P50990 GVNTFKVLTR 1133.66 1133.65 -0.01 0.001593625 
P50990 QIIMAKPAGGPKPPSGKK 1787.01 1787.01 0.00 0.004582951 
P10809 ARALMLQGV 957.54 957.54 0.00 0.003157895 
P10809 AVAVTMGPKGRTVIIEQSWGSPKVTK 2739.51 2740.52 1.01 0.001593625 
P10809 GVTVAKSID 888.49 888.49 0.00 0.003157895 





3870.15 3871.13 0.98 0.012337217 
P10809 AVIAELKKQSKPVTTPEEIAQVATISANG 2992.64 2992.64 -0.01 0.001593625 
P10809 KEIGNIIS 872.50 872.49 0.00 0.003775366 
P10809 AMKKVGRKGVITVK 1513.95 1513.94 -0.01 0.001593625 
P10809 AYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAE 3813.21 3814.23 1.02 0.003775366 
P10809 GEALSTLVLNRLKVGLQVVAVKAPGFG 2735.61 2736.61 1.00 0.001593625 
P10809 GEALSTLVLNRLKVGLQVVAVKAPGFGD 2850.63 2852.62 1.99 0.003157895 
P10809 LGKVGEVIVTK 1141.71 1141.70 0.00 0.001593625 
P10809 LGKVGEVIVTKD 1256.73 1256.73 0.00 0 
P10809 LGKVGEVIVTKDD 1353.75 1352.72 -1.03 0.074812968 
P10809 AMLLKGKG 816.49 816.49 0.00 0.00757257 
P10809 KAQIEKRIQEIIEQL 1838.06 1838.05 -0.01 0.001593625 
P10809 VTTSEYEKEKLNERLAKLS 2237.19 2237.18 -0.01 0.002276608 
P10809 GVAVLKVGGTS 986.58 986.57 0.00 0.001593625 
P10809 GVAVLKVGGTSD 1101.60 1101.60 -0.01 0.002276608 
P10809 FVNMVEKGII 1148.63 1148.62 0.00 0.003157895 
P10809 PTKVVRTALL 1096.70 1096.69 -0.01 0.003775366 
P10809 PTKVVRTALLD 1211.72 1211.72 0.00 0 
P10809 AAGVASLLTTAEVVVTEIPKEEK 2354.29 2354.26 -0.04 0.001593625 
P10809 DPGMGAMGGMGGGMGGGMF 1705.60 1707.43 1.82 0.038527188 
P10809 PGMGAMGGMGGGMGGGMF 1606.57 1605.93 -0.64 0.096697175 
P07900 SGKELHINLIPNKQ 1589.89 1589.89 0.00 0.001593625 
P07900 TGIGMTKAD 892.43 892.43 0.00 0 
P07900 LINNLGTIAKSGTKAFMEALQAGA 2418.29 2419.31 1.01 0.001593625 
P07900 TGEPMGRGTKVILHLKE 1865.02 1865.01 -0.01 0.029101856 
P07900 QEELNKTKPIWTRNP 1835.95 1835.94 -0.01 0.001593625 
P07900 QEELNKTKPIWTRNPD 1950.98 1950.97 -0.01 0.001593625 
P07900 QEELNKTKPIWTRNPDD 2048.00 2047.99 -0.01 0.074812968 
Q08828 MAGAPRGGGGGGGGAGEPGGAER 1897.85 1892.99 -4.86 0.092548077 
Q2M3C6 GAVIILSLAPMVASTVANGPRSPWD 2503.33 2504.73 1.41 0.082482646 




 TLVKNQRGPK 1139.68 1141.64 1.97 0.003775366 
Q8NAP3 DNIQTGVENVVL 1299.67 1297.70 -1.97 0.029101856 
P19838 DSFGGGSGAGAGGGGMFGSGGGGGGTGSTGP 2371.94 2370.31 -1.63 0.047058824 
P60174 EREAGITEKVVFEQTKVIA 2128.15 2129.17 1.02 0.001593625 
P60174 EREAGITEKVVFEQTKVIAD 2243.18 2243.18 0.00 0.005398111 
P60174 GFLVGGASLKPEFV 1419.78 1421.76 1.99 0.001593625 
P60174 GFLVGGASLKPEFVD 1534.80 1535.81 1.00 0 
Q8N2G4 MQAPRAAPAAPLSYD 1557.76 1556.90 -0.86 0.017996401 
P06454 LKEKKEVVEEAENGR 1756.93 1756.93 0.00 0.001593625 
P06454 EEAESATGKRAAE 1329.62 1330.61 0.99 0.001593625 
Q63HN8 AAPLEAASVPSAD 1179.58 1179.63 0.05 0.028593311 
A2J423 IWGQGTMVTVSSGGGGTGGGGSGGGGS 2239.98 2241.16 1.19 0.090652699 
A6NL28 EEKMELQEIQLKEAKHIAEEA 2477.25 2478.25 1.00 0.001593625 
Q13813 QLIAAGHYAKG 1110.58 1110.57 -0.01 0.001593625 
Q08211 FVNYLVRINEIKSEEVPAFGVASPPPLT 3085.65 3086.60 0.95 0.001593625 
Q08211 AVIEAEHTLREL 1379.74 1380.74 1.00 0.003157895 
Q8N554 SALAVKWPRD 1123.61 1123.49 -0.12 0.062583818 
O15050 WSTQEIEACLQ 1306.59 1306.65 0.07 0.020577308 
Q13838 FLLKPELLRAIV 1410.90 1410.89 -0.01 0.007002188 
Q13838 ISSYIEQTR 1095.56 1095.55 -0.01 0 
P23468 SSIPNNKEIPSHHPTDPVELR 2366.20 2366.12 -0.07 0.082482646 
Q9P1F3 GKLSVKFGVLFRD 1446.83 1446.77 -0.07 0.070288918 
Q6IS14 IFTGKKYE 984.53 984.52 -0.01 0.004582951 
Q6IS14 LGKEIEQKY 1106.60 1106.59 0.00 0.001593625 
P32004 QNNVTIMANLKVKD 1568.83 1568.82 -0.01 0.039757576 




CPGTYR 2326.12 2321.21 -4.91 0.096863835 
Q6IMJ6 AFIHVHTHTHTCTHRGAD 2039.95 2041.05 1.10 0.093906094 
P62942 YAYGATGHPGIIPPHATLVF 2081.07 2082.08 1.01 0.002276608 
P62942 VELLKLE 842.51 842.51 0.00 0.001593625 
P59510 ICVQGQCMAAGCD 1297.49 1298.72 1.22 0.004582951 
P59510 CELRGMLLAKKSECSSQCGQGYRTLD 2875.34 2875.43 0.09 0.082482646 
Q8NER1 MLLVEPLNRLLQD 1552.86 1552.93 0.06 0.024608501 
Q99757 RVVNSETPVVV 1197.67 1197.67 0.00 0.028593311 
Q99757 LAIEYEVSAVPTVLAMKNG 2004.06 2004.07 0.01 0.001593625 
Q99757 QLEAFLKKLIG 1241.74 1241.73 0.00 0 
Q5UCC4 DTGGQGGGGGGGGGGGSGLCCVPPSL 2041.86 2041.03 -0.83 0.04361223 















3032.56 3031.57 -0.99 0.057481752 
 MGAGVGSSVAW 1036.46 1036.52 0.06 0.02661101 
Q3SY00 CGSHQEPAAGLGAAAAGGAAAGRAAAGPD 2432.13 2431.33 -0.80 0.099189883 
A2AB27 MGERVLWPLRAGQHWRHRPLPAGLQD 3057.61 3057.30 -0.31 0.024896266 
Q9BY44 LAPTPAPQSTPRNTVSQSISG 2108.09 2109.07 0.98 0.001593625 
B4DWP8 MLLSGAPPAAPPAPPP 1498.79 1500.77 1.99 0.068301226 
B4DX20 VLRTNLGPKGTMKMLVSGAG 2029.12 2030.11 0.99 0.020057307 
B4DX20 GTTSNVLIIGELLKQA 1655.95 1655.95 0.00 0.004582951 
B4DX20 VLTEVVVDSVLAVRRPGYPID 2260.26 2261.14 0.88 0.087221095 
B4DX20 KGFVVINQKGI 1201.72 1201.72 0.00 0.043333333 
B4DNX1 AAKNQVALNPQNTVF 1613.85 1613.84 -0.01 0.002276608 
B4DNX1 LVLVGGSTRIPKVQKLLQ 1948.22 1948.21 -0.01 0.004582951 
B4DNX1 NQPGVLIQVYEGERAMTK 2032.04 2034.03 1.99 0.001593625 
B4DNX1 IERMVQEAEKYKAE 1722.86 1722.88 0.02 0.007002188 
B4DNX1 EVQRERVSAKNALESYAFNMKSAVE 2837.41 2838.40 0.99 0.028593311 
B4DNX1 SRRGPGPGGFGAQGPKGGSGSGPTIEEV 2595.28 2594.16 -1.12 0.090652699 
Q96GF2 PGSGGGGGGGGGGGSSSGSSSSD 1649.61 1647.90 -1.72 0.092548077 
Q96GF2 AGKSTIGGQIMYLTGMV 1725.88 1725.91 0.03 0.012337217 
Q96GF2 EGKTIAIGKVLKLVPEK 1804.12 1804.13 0.01 0.002276608 
P07437 RISVYYNEATGGKYVPRAILV 2368.29 2368.28 -0.01 0.001593625 
P07437 SVRSGPFGQIFRP 1446.77 1446.76 -0.01 0.003775366 
P07437 RIMNTFSVVPSPKVS 1660.90 1660.89 0.00 0.001593625 
P07437 TVVEPYNATLSVHQLVENT 2113.07 2115.05 1.98 0.001593625 
B4DUA0 IIVNWVNETLREAKKSSSISSFK 2635.43 2637.37 1.94 0.016024653 
B4DUA0 PKISTSLPVL 1053.64 1053.64 0.00 0.003775366 
Q14934 LGGPGGGAGGAGGGRVLECPSIR 1994.01 1995.02 1.01 0.074812968 
Q6UB99 DSQHSTPVPTAPTSACSPSFF 2144.95 2145.50 0.56 0.078844169 
P40925 LTAKELTEEKESAFEFLSSA 2229.11 2230.09 0.99 0 
P20839 PVVLSPSHTVG 1091.60 1091.59 -0.01 0.002276608 
Q9BTE6 PGSQVLVRV 953.57 954.56 1.00 0.012337217 
 DEVPVQLFTGAQMESRGGCKSHRQ 2657.24 2658.82 1.58 0.061925062 
B7Z620 GGGHDPR 676.30 676.72 0.42 0.096697175 





P47897 ETKGFHQVPFAPIVFIERT 2197.17 2198.16 0.99 0.012337217 
P68363 DSFNTFFSETGAGKHVPRAVFV 2412.19 2413.18 1.00 0.040106306 
P68363 SFNTFFSETGAGKHVPRAVFV 2297.16 2297.17 0.01 0.001593625 
P68363 EVRTGTYRQLFHPEQLITGKE 2483.29 2483.28 -0.01 0.073160357 
P68363 AANNYARGHYTIGKEII 1889.97 1889.97 -0.01 0.015837821 
P68363 VNAAIATIKTKRSIQFV 1859.10 1859.10 0.01 0.001593625 
P26641 AYLKTRTFLVGERVTLA 1937.11 1937.10 -0.01 0.003157895 
P26641 PFAHLPKSTFVL 1355.76 1355.75 -0.01 0.012337217 
P26641 TLSVALPYFWEHF 1608.80 1608.79 0.00 0.001593625 
P26641 YESYTWRKL 1244.62 1244.61 -0.01 0.002276608 
Q6ZTA4 AAAGPACGGAGGSAAGGLGGGAGGGG 1784.79 1784.81 0.02 0.07975334 
P50395 PRTFEGI 818.43 818.43 0.00 0.070288918 
P50395 FTGHALALYRT 1248.66 1248.66 0.00 0.016024653 
P50395 LGTESQIFISRTY 1513.78 1513.77 -0.01 0.001593625 
Q6NUN9 GSGPGTGGGGSGSGGGGGGSGGGSARD 1962.80 1963.21 0.41 0.032956222 
O00148 FLLKPELLRAIV 1410.90 1410.89 -0.01 0.007002188 
O00148 ISTYIEQSR 1095.56 1095.55 -0.01 0.022133939 
P25205 LTTLVAFPSSSVYPTK 1709.92 1709.93 0.00 0.001593625 
P25205 QLAKSLAPSIHGH 1340.72 1340.72 0.00 0.00757257 
P25205 LENGSHIRG 981.50 982.51 1.01 0.001593625 
Q15717 ELRSLFSSIGEVESAKLIR 2115.17 2116.16 0.99 0.001593625 
Q15717 QTTGLSRGVAFIRF 1534.83 1535.83 1.00 0.002276608 
O00303 LQQVGGASARIQ 1226.67 1226.66 -0.01 0.001593625 
P62491 EARAFAEKNGLSFIETSAL 2035.04 2036.03 0.99 0.001593625 
P27824 TTAPPSSPKVTYKAPVPTGEVYFA 2507.29 2507.32 0.03 0.003775366 
O43852 AFLGAEEAKTF 1182.59 1182.58 -0.01 0.002276608 
O43852 FGEALVRH 927.49 927.49 -0.01 0.001593625 
P29401 QQKLQALK 938.55 938.56 0.01 0.002276608 
P29401 GHPVPKQAFT 1080.57 1080.57 0.00 0.069489685 
P29401 PAPLQHQM 920.45 920.45 0.00 0.006197432 
P29401 KIATRKAYGQALAKLGHAS 1983.14 1983.11 -0.02 0.002276608 
P29401 LAMFRSVPTSTVFYPS 1817.90 1817.90 0.00 0.003157895 
P29401 FQVGQAKVVLKSK 1430.86 1430.86 0.00 0.003157895 
P29401 QVTVIGAGVTLHEALAAAELLKKEKINIRVL 3279.93 3280.94 1.01 0.012337217 
P29401 PFTIKPL 814.50 814.49 0.00 0.029101856 
P29401 AIAQAVRGLITKA 1310.80 1310.80 -0.01 0 
P14314 RVWAAIR 870.52 870.52 0.00 0.0466541 
P14314 AAQEARNKFEEAERSLK 1976.01 1976.00 -0.01 0.01536 
P31350 PQQLQLSPLKGLSLV 1619.96 1620.95 0.99 0.028343211 






Appendix Table 2. Table of peptides identified without designating enzymatic 
specificity after in gel microwave-supported acid hydrolysis. 











GSHAG N 2148.09 2148.10 -0.01 0.019 
P09104 A 
GNSDLILPVPAFNVING
GSHAG N 2148.09 2148.10 -0.01 0.014 
P23528 C 
TLAEKLGGSAVISLEG
KPL - 1882.08 1882.08 0.00 0.000034 
P02538 D SIIAEVKAQYE E 1249.65 1249.66 0.00 0.038 
P10809 D 
AAGVASLLTTAEVVVT
EIPKE E 2098.15 2097.16 0.99 0.026 
P35908 D SIIAEVKAQYE E 1249.65 1249.66 0.00 0.038 
P23284 D NFVALATGEKGFGYK N 1600.82 1600.82 -0.01 0.0013 
P32969 D 
IELVSNSAALIQQATTV
K N 1886.05 1885.05 1.00 0.00017 
P35527 D 
LEMQYETLQEELMAL
KK N 2097.05 2096.05 0.99 0.0052 
P05386 D KINALIKAAGVNVE P 1438.85 1438.85 0.00 0.0076 
P11021 D AGTIAGLNVMRIINE P 1570.85 1570.85 0.00 0.0047 
P04264 D LEIATYRTLLEGEE S 1635.83 1635.84 0.00 0.047 
P30046 E SWQIGKIGTVMTFL - 1580.85 1579.84 1.01 0.019 
O60361 E 
GLNVVKTGRVMLGET
NPA D 1856.00 1855.00 1.00 0.005 
P00558 E PVAVELKSLLGK D 1252.77 1252.78 -0.01 0.00073 
P00558 E PAKIEAFRASLSKLG D 1586.91 1586.91 -0.01 0.00045 
P06733 E LLKTAIGKAGYT D 1234.72 1234.73 -0.01 0.03 
P09651 E PEQLRKLFIGGLSFETT D 1936.04 1935.05 0.99 0.035 
P14625 E RIMKAQAYQTGK D 1393.75 1393.75 0.00 0.029 
P19338 E PAAMKAAAAAPASE D 1255.62 1255.62 0.00 0.0032 
P28065 E 
PPLVLAAANVVRNISY
KYRE D 2273.27 2272.27 1.00 0.041 
P28838 E PPLVFVGKGITF D 1273.74 1273.74 0.00 0.01 
P55884 E PPVPAQGEAPGEQAR D 1503.75 1502.75 1.01 0.0053 
P60709 E GYALPHAILRL D 1222.71 1222.72 -0.01 0.046 
P62249 E 
PRTLQYKLLEPVLLLG
KERFAGV D 2639.56 2639.55 0.01 0.0098 
P68363 E PYNSILTTHTTLEHS D 1712.83 1712.84 -0.01 0.0022 
Q14566 E PGAGSQHLEVR D 1149.59 1149.59 0.00 0.026 
Q14697 E PSVFNGPEVTMLK D 1418.73 1417.73 1.01 0.0045 
Q15056 E 
PPYTAYVGNLPFNTVQ
G D 1836.90 1836.90 0.00 0.0031 
P62314 E PVQLETLSIRG N 1211.69 1211.69 0.00 0.019 
Q07021 E PELTSTPNFVVEVIK N 1671.90 1671.91 0.00 0.028 
P04406 F 
GIVEGLMTTVHAITAT
QKTV D 2069.12 2069.12 0.00 0.00063 
P30049 G 
AAKANLEKAQAELVG
TA D 1683.92 1683.92 0.00 0.00088 






HAILRL D 2434.29 2434.30 -0.01 0.021 
P60709 H TVPIYEGYALPHAILRL D 1925.07 1925.08 -0.01 0.00022 
P68104 K 
AAGAGKVTKSAQKAQ
KAK - 1742.01 1742.02 0.00 0.0095 
P27037 L AFAVFLISC S 969.51 969.50 0.01 0.047 
P14174 M PMFIVNTNVPRASVP D 1640.87 1640.87 0.00 0.009 
P14174 M PMFIVNTNVPRA S 1357.72 1357.72 0.00 0.0097 
P00558 N GAKSVVLMSHLGRP D 1450.81 1450.81 0.00 0.04 
P04264 N VKKQISNLQQSIS D 1471.84 1471.84 0.00 0.014 
P25398 N TALQEVLKTALIH D 1435.84 1435.84 0.00 0.04 
P35527 N HKEEMSQLTGQNSG D 1544.69 1544.69 0.00 0.031 
P60174 N 
GRKQSLGELIGTLNAA
KVPA D 2022.16 2022.16 0.00 0.0025 
P60174 N GAFTGEISPGMIK D 1306.66 1306.66 0.00 0.044 
P68104 N 
GQTREHALLAYTLGV
KQLIVGVNKM D 2738.52 2738.53 -0.01 0.0000051 
P62266 P 
GVRFKVVKVANVSLL
ALYKGKKERPRS - 3041.83 3041.83 -0.01 0.0029 
P06732 P VSPLLLASGMAR D 1213.68 1213.69 -0.01 0.031 
P07737 P 
SVWAAVPGKTFVNITP
AEVGVLVGK D 2538.42 2538.42 -0.01 0.0012 
P28838 P SVVLVGLGKKAAGI D 1310.82 1310.83 -0.01 0.047 
P35527 P AAIQKNYSPYYNTI D 1644.81 1644.81 0.00 0.026 
P43308 P 
VVIGSTSAPGQGGILAQ
REF D 1986.04 1986.05 -0.01 0.0044 
P61088 P 
ALQIRTVLLSIQALLSA
PNP D 2118.26 2117.26 1.01 0.00095 
P04908 R 
VGAGAPVYLAAVLEY





SAK D 1867.97 1867.97 0.00 0.00073 
P22626 R 
GGGGNFGPGPGSNFRG
GS D 1577.69 1577.70 -0.01 0.017 
P62805 R GVLKVFLENVIR D 1385.84 1385.84 0.00 0.015 
Q16777 R 
VGAGAPVYMAAVLEY
LTAEILELAGNAAR D 2932.53 2932.54 -0.01 0.0018 
P13645 R ALEESNYELEGK I 1380.64 1380.64 0.00 0.000018 
P04264 R 
FLEQQNQVLQTKWEL
LQQVDTSTR T 2932.50 2931.51 0.99 0.01 
P07737 W 
AAVPGKTFVNITPAEV
GVLVGK D 2166.24 2166.24 0.00 0.00021 
A0M8
Q6 Y PGAVTVAWKA D 998.55 998.55 0.00 0.0084 
P00558 Y SLEPVAVELKSLLGK D 2148.09 2148.10 -0.01 0.0039 
 
Appendix Table 3. All peptides identified in the high mass fraction following mass 
biased partitioning.  Commonly observed mass differences from the theoretically 
observed mass can be explained by loss of a terminal Asp (~115Da), loss of a 
terminal Asp and formation of the cyclic intermediate in acid hydrolysis (~133Da), 
acetylation following loss of the initiator Met (~89Da), acetylation (~42Da), and loss 








Diff  E Value 
Q07666 
DPSFTHAMQLLTAEIE
KIQKG 2356.21 2241.18 -115.03 5.21E-40 
P06733 
DPSRYISPDQLADLYK




RLAPITS 4462.36 4347.34 -115.02 1.03E-32 
P48735 
DEMTRIIWQFIKEKLI




EG 3492.87 3403.84 -89.03 1.39E-28 
P42765 
MALLRGVFVVAAKR




GVMLAV 3985.18 3870.16 -115.02 3.28E-26 
P04406 
DNEFGYSNRVVDLM









R 3732.91 3617.89 -115.02 5.84E-22 
P63261 
DYLMKILTERGYSFTT




GVPLYRHIA 3883.08 3768.05 -115.03 8.33E-20 
Q14568 
DLINNLGTIAKSGTKA
FMEALQAGA 2533.32 2418.3 -115.02 5.79E-19 
P60709 
DGVTHTVPIYEGYAL
PHAILRL 2434.3 2319.28 -115.02 1.32E-17 
P04406 
DSTHGKFHGTVKAEN




KSTMGKPQRLY 4874.68 4741.65 -133.03 4.35E-16 
P63261 
DLTDYLMKILTERGY




TVRTIAM 4154.22 4021.19 -133.03 2.79E-15 
P31949 
MAKISSPTETERCIESL












LYGFGG 3902.03 3787 -115.03 8.53E-14 
P10809 
DAVAVTMGPKGRTVI
IEQSWGSPKVTK 2854.54 2739.51 -115.03 7.04E-13 
















GSPESRLSFQH 4595.43 4480.39 -115.04 8.66E-11 
P60174 
DEREAGITEKVVFEQT
KVIA 2261.19 2128.15 -133.04 1.34E-10 
P60709 
DGVTHTVPIYEGYAL
PHAILRLDLAGR 2946.57 2849.48 -97.09 1.72E-10 
P10809 
DAAGVASLLTTAEVV
VTEIPKEEK 2469.32 2354.3 -115.02 2.23E-10 
P26640 
DPEAEAALELALSITR
AVRSLRA 2451.34 2336.31 -115.03 4.21E-10 
P06733 MSILKIHAREIF 1456.82 1367.79 -89.03 4.21E-10 
P27348 
MEKTELIQKAKLAEQ








HLQGGAKRVIISAPSA 4729.42 4596.39 -133.03 1.94E-09 
Q6PEY2 
DSFNTFFSETGAGKH













GKIFK 4029.96 3914.95 -115.01 1.12E-08 
O94964 
DSYASEIKELQLVLAE




IL 3901.71 3767.68 -134.03 0.000000129 
P60174 
DELIGQKVAHALAEG




L 3411.98 3279.93 -132.05 6.86E-08 
P51665 
DQMVVVYLASLIRSV
VALHNLINNKIANR 3262.83 3130.79 -132.04 0.0000125 
P04406 
MGKVKVGVNGFGRI
GRLVTRAAFNSGKV 2917.65 2786.62 -131.03 0.00000225 
P21284 
DVSTQTSTISKKLRLK
EMITQTEGMSFD 3173.59 3050.54 -123.05 0.000000258 
P14618 
DLRVNFAMNVGKAR
GFFKKG 2254.22 2139.19 -115.03 0.000000356 
P23528 
DLVFIFWAPESAPLKS
KMIYASSK 2727.43 2612.4 -115.03 0.000000756 
P14625 
DPRGNTLGRGTTITLV








GGYGGRSRY 5198.22 5083.2 -115.02 6.66E-08 
P07237 
DGKLSNFKTAAESFK








FIA 3802.89 3703.91 -98.98 0.0000177 
P22234 
MATAEVLNIGKKLYE
GKTKEVYELL 2839.54 2750.52 -89.02 0.0000204 
	  
 
Appendix Table 4. All peptides in the low mass fraction following mass biased 
partitioning.   







P46777 IICQIAYARIEG 1348.72 1348.72 0.00 0.00804829 
P46777 YMRYLMEE 1133.49 1133.49 0.00 0.015540016 
Q16222 ENGVHELVKNGI 1289.67 1289.70 0.02 0.048727666 
P62258 LVYQAKLAEQAERY 1680.88 1680.88 0.00 0.021094265 
P62258 EMVESMKKVAGM 1320.62 1320.62 0.00 0.00804829 
P62258 STLIMQLLR 1089.62 1089.62 0.00 0.013125513 
P62258 STLIMQLLRD 1188.65 1188.65 0.00 0.062854199 
Q9Y4L1 FNFHINYG 1010.46 1010.46 0.00 0.070858283 
Q9Y4L1 RVESVFETLVE 1306.68 1306.67 0.00 0.021094265 
Q9Y4L1 
AEPISEPEKVETGSEP
G 1754.82 1754.82 0.00 0.00804829 
P34897 PEMWELLQREK 1457.73 1459.63 1.90 0.081632653 
P34897 ALLERGYSLVSGGT 1421.75 1421.75 -0.01 0.00804829 
P34932 PAIAQFSVQKVTPQS 1599.86 1599.87 0.01 0.00804829 
P11021 
QGNRITPSYVAFTPEG
ERLIG 2287.16 2288.18 1.02 0.00804829 
P11021 AAKNQLTSNPENTVF 1632.81 1632.81 0.00 0.00804829 
P11021 
AAKNQLTSNPENTVF
D 1747.84 1747.84 0.00 0 
P11021 NGVFEVVATNG 1105.54 1105.54 0.00 0.021094265 
P11021 FSETLTRAKFEELNM 1814.89 1814.88 0.00 0.070351759 
P11021 LFRSTMKPVQKVLE 1674.95 1675.95 1.00 0.020319303 
P11021 VNGILRVTAE 1070.61 1070.61 0.00 0.055818852 
P11021 VNGILRVTAED 1185.64 1185.63 0.00 0 
P11021 QNRLTPEEIERMVN 1710.84 1711.82 0.99 0.070858283 
Q15029 VSISKFF 826.46 826.46 0.00 0.04972973 
Q15029 PMLLELAKQ 1041.59 1041.59 0.00 0.00804829 
O96019 IGSYTVRAGYAGE 1342.65 1342.64 -0.01 0.00804829 






F 1604.80 1604.80 0.00 0.00804829 
P11142 
AAKNQVAMNPTNTV
FD 1719.83 1720.85 1.02 0 
P11142 KKVGAERNVLIF 1372.82 1372.82 0.00 0.00804829 
P11142 FFNGKELNKSINP 1506.78 1506.78 0.00 0.035756853 
P11142 FFNGKELNKSINPD 1621.81 1621.81 0.00 0.011100833 
P11142 IERMVQEAEKYKAE 1722.86 1722.87 0.01 0.016768293 
P11142 KCNEIINWL 1131.57 1131.57 0.00 0.017830609 
P52597 PPLKFMSVQRPGPY 1615.85 1615.85 0.00 0.00804829 
Q93009 VMLFLKMY 1043.55 1043.55 -0.01 0.057621792 
Q93009 PMLLQFFKSQGYR 1613.84 1613.62 -0.22 0.086289549 
P38117 LTSKLSVISVE 1174.68 1174.68 0.00 0.058001036 
Q08945 PVEAFAQNVLSKA 1372.74 1372.73 0.00 0.00804829 
P36776 MGAALTGAESHELQ 1413.66 1413.66 0.00 0.041498559 
O15143 AAAGMLSFGGRL 1149.60 1149.59 0.00 0.00804829 
Q12905 ETSFSEALLKRNQ 1503.77 1503.77 0.00 0.00804829 
Q01130 VEGMTSLKV 962.51 962.50 -0.01 0.072420635 
Q9H175 
DEEPSPTASCSLTGAQ
GSETQ 2093.87 2094.15 0.28 0.025157233 
O15488 DEVIEVNLI 1042.55 1041.66 -0.90 0.083855422 
P54577 VYRLSSVVTQH 1287.69 1287.70 0.00 0.086289549 
P54577 EKWGGNKTYTAYV 1497.72 1497.73 0.01 0.053219798 
P54577 
PPAGSAPGEHVFVKG
YEKGQP 2151.07 2151.07 -0.01 0.016768293 
Q9Y221 IPLGFGVAAKSTQ 1287.72 1289.70 1.98 0.017830609 
Q9Y221 PMAIVVFHQA 1111.58 1111.58 0.00 0.00804829 
O95373 PNTIIEALRGTM 1314.70 1314.70 0.01 0.00804829 
P38646 IKNVPFKIVRASNG 1541.90 1541.90 0.00 0.00804829 
P38646 IENMVKNAEKYAEE 1666.79 1666.79 0.00 0.02318094 
Q6P2Q9 PLEVHLL 819.49 819.49 0.00 0.013125513 
Q01518 SPSKAGAAPYVQAF 1392.70 1392.70 0.00 0.045733408 
Q01518 DVVGIVEIINSK 1284.73 1285.78 1.05 0.044742729 
Q01518 VVGIVEIINSK 1169.70 1169.70 0.00 0.011100833 
P46782 IKLFGKWST 1078.62 1078.62 0.00 0.016768293 
P46782 
ELINAAKGSSNSYAIK
KK 1903.05 1903.06 0.01 0.043206367 
P54840 FHVELTSPPTTEGFK 1688.84 1695.92 7.08 0.098585121 
P05455 VKNRSVYIKGFPT 1507.85 1507.84 -0.01 0.052462527 
Q9Y230 AFLFNELKGETM 1398.69 1398.70 0.01 0.021094265 
P46926 TILANARFF 1051.58 1051.58 0.00 0.042261565 
P13645 LKNQILNLTT 1156.68 1156.68 0.00 0.06676783 
P13667 PPIPVAKI 833.54 833.54 0.01 0.013125513 
P13667 PPIPVAKID 948.56 948.56 0.00 0.00804829 
P13667 ATSASVLASRF 1108.59 1108.59 0.00 0.012173913 
P13667 VIIIGVFKGES 1160.68 1160.68 0.00 0.00804829 
P13667 ESGKKFAMEPEEF 1509.68 1509.69 0.01 0.011100833 
P31146 
VGTGAAMLTLGPEV




P31146 PALTAEEWLGGR 1298.66 1298.66 0.00 0.00804829 
P31146 AGPLLISLK 910.59 910.58 0.00 0.021094265 
P15153 SKPVNLGLW 1012.57 1013.57 1.00 0.016768293 
Q9BYT8 FARFSGTNVET 1227.59 1227.59 0.00 0.038596491 
P13796 EEMMELREAFAKV 1563.74 1564.75 1.01 0.016768293 
P13796 SKAYYHLLEQVAPKG 1702.90 1703.89 0.98 0.026022305 
P13796 PKISTSLPVL 1053.64 1053.64 0.00 0.01458671 
P13796 PKISTSLPVLD 1168.67 1168.67 0.00 0.065106816 
P07237 
GAAAESLVESSEVAV
IGFFK 2010.03 2010.05 0.02 0.00804829 
P07237 SAKQFLQAAEAI 1275.68 1275.68 0.00 0.00804829 
P07237 SAKQFLQAAEAID 1390.71 1391.70 1.00 0 
P07237 GVVLFKKF 936.58 936.58 0.00 0.00804829 
P07237 GVVLFKKFD 1051.61 1051.61 0.00 0.00804829 
P07237 
EGRNNFEGEVTKENL
L 1829.89 1829.90 0.01 0.00804829 
P07237 KQPVKVLVGKNFE 1484.87 1484.87 0.00 0.02318094 
P07237 KQPVKVLVGKNFED 1599.90 1599.90 0.00 0 
P13804 QLHAAVGASRAAV 1232.66 1232.66 0.00 0.00804829 
P48735 RAGTFKMVFTPK 1381.75 1381.76 0.00 0.024065864 
Q6P3S6 
GSPILNGGSLSPGTAA
VGGSSL 1897.97 1898.02 0.04 0.048087432 
Q13011 AFFQVKEV 966.52 966.52 0.00 0.048087432 
P23526 IGLAAWGRKAL 1154.69 1154.69 0.00 0.024065864 
P23526 AIVCNIGHF 972.49 972.49 0.00 0.042261565 
P23528 KKNIILEEGKEILVG 1682.00 1682.00 0.00 0.011100833 
P23528 PYATFVKMLP 1165.62 1165.63 0.01 0.070858283 
P23528 PYATFVKMLPD 1280.65 1280.65 0.00 0 
P15531 FCIQVGRNIIHGS 1442.75 1442.74 0.00 0.015540016 
P23588 
GGTGGGSTYVSKPVS
WA 1609.77 1609.77 0.00 0.00804829 
Q9H773 LPLAVLSKM 970.59 970.59 0.00 0.00804829 
Q13200 ELEMLVERLGEK 1426.75 1426.76 0.02 0.043206367 
Q13247 LKNGYGFVEFE 1301.63 1301.62 -0.01 0.013125513 
Q13247 FMRQAGEVTYA 1271.60 1271.60 0.00 0.057621792 
P25054 
NGNETESEQPKESNE
NQEKEAEKTI 2861.28 2860.25 -1.03 0.048727666 
Q9BZ68 
KVQEVSSDGGCEAAL
GTHYR 2105.98 2105.09 -0.89 0.099316629 
P62917 PGRGAPLAKVVFR 1366.82 1366.82 0.00 0.020319303 
Q16630 VGEEFNQEAEYGGH 1564.64 1564.66 0.01 0.00804829 
P60228 LVKVIQQESYTYK 1597.87 1597.86 -0.01 0.041498559 
P62269 GKYSQVLANGL 1148.62 1148.62 0.00 0.00804829 
P62081 
MFSSSAKIVKPNGEK
P 1718.90 1718.90 0.00 0.04972973 
P07814 PPLGALLAVEHVK 1342.80 1342.80 0.00 0.012173913 
P15880 FFLGASLK 881.50 881.50 0.00 0.013125513 
O43719 PLVLNEIRE 1081.61 1081.62 0.00 0.013125513 
P31943 PPRKLMAMQRPGPY 1640.86 1640.87 0.00 0.00804829 





P31948 AIHFYNKSLAEHRTP 1782.92 1782.92 0.00 0.094348435 
P31948 
AIHFYNKSLAEHRTP
D 1897.94 1897.95 0.00 0.036556604 
P31948 PAMRLILEQMQK 1456.79 1456.80 0.01 0.021094265 
Q15911 
DPCSPSPGASGSAGKS




V 3661.74 3661.98 0.24 0.086289549 
Q15181 WKVIAINV 941.57 941.57 0.00 0.013125513 
Q15185 RFSEMMNNMGG 1272.50 1272.51 0.00 0.048727666 
Q9NX94 
RAATKAPGMEPSGSV
AGLGEL 1998.02 1996.66 -1.36 0.07925636 
O94903 QVELSMGMSA 1083.46 1083.48 0.02 0.075098814 
Q15365 SSSPEVKGYWASL 1409.68 1409.69 0.01 0.012173913 
P25786 LTTKNVSIGIVGK 1328.80 1328.80 0.00 0.036556604 
Q99613 FESHITSYKQNPEQSA 1864.86 1864.86 0.00 0.094348435 
Q9NWN
3 DEGKTKKGVLEAP 1370.74 1371.79 1.05 0.06676783 
P17844 VKFVINY 881.50 881.50 0.00 0.00804829 
P62316 SVIVVLRNPLIAGK 1477.93 1477.94 0.01 0 
O60506 ERAIEALKEFNE 1429.72 1429.72 0.00 0.00804829 
O60506 GALAVLQQFK 1073.62 1073.62 -0.01 0.00804829 
P00505 PILGVTEAFKR 1229.71 1229.71 0.00 0.00804829 
P00505 PILGVTEAFKRD 1344.74 1344.74 0.00 0.032667877 
P00505 AGMQLQGYRYY 1348.62 1348.63 0.01 0.021094265 
P33991 PLAKEEENVGI 1197.62 1197.63 0.00 0.024065864 
P33992 FMPTILSRF 1110.59 1110.59 0.00 0.083855422 
Q99829 PFLEFFRQG 1139.58 1139.58 0.01 0.026022305 
P35527 LTVGNNKTLL 1071.63 1071.63 0.00 0.058001036 
P35527 VNVEINVAPGK 1138.63 1138.64 0.01 0.00804829 
P78417 PTVSALLTSEK 1144.63 1144.63 0.00 0.00804829 
Q8N0Y2 
SGMIPLAGTAPGAEG
PAPG 1665.80 1666.93 1.12 0.078392945 
P35659 FIKTTVKELIS 1277.76 1277.76 0.00 0.026022305 
P35749 LGEELEALKTELE 1472.76 1473.78 1.02 0.039650146 
P27797 FGKFVLSSGKFYG 1435.75 1435.75 0.00 0.00804829 
P27797 FGKFVLSSGKFYGD 1550.78 1550.78 0.00 0.013125513 
P27797 EFTHLYTLIVRP 1469.80 1470.81 1.01 0.00804829 
P27797 EFTHLYTLIVRPD 1584.83 1584.84 0.01 0 
P27797 DYKGTWIHPEI 1357.67 1357.67 0.00 0.011100833 
P27797 YKGTWIHPEI 1242.64 1242.64 0.00 0.011100833 
P27797 LWQVKSGTIF 1177.65 1177.65 0.00 0.094348435 
P27797 LWQVKSGTIFD 1292.68 1292.68 0.00 0.017830609 
P27797 
EAYAEEFGNETWGV
TKAAEKQMK 2598.21 2599.22 1.02 0.020319303 
P02461 
DAIKVFCNMETGETC
ISANPLNVPRKHWWT 3459.65 3460.37 0.72 0.054881266 




P53396 ISYVLPEHMSM 1305.61 1305.62 0.01 0 
P10515 IEAFKNYTL 1097.58 1097.58 0.01 0.038596491 
P60709 IKEKLCYVAL 1178.67 1178.68 0.00 0.01458671 
P60709 
FEQEMATAASSSSLE
KSYELP 2304.05 2304.05 0.01 0.07925636 
P60709 
LYANTVLSGGTTMYP
GIA 1827.91 1827.91 0.00 0.043206367 
P60709 ESGPSIVHRKCF 1340.67 1340.67 0.00 0.05075594 
P12004 TLALVFEAPNQEKVS 1644.87 1644.88 0.01 0.00804829 
P12004 VPLVVEYKIA 1129.67 1129.67 0.00 0.00804829 
O14561 MPPLTLEGIQ 1097.58 1097.58 0.01 0.094348435 
O14561 PEKLSVNSHFMK 1415.72 1415.72 0.00 0.090995261 
P55060 LLTEMVNRFQSG 1393.70 1393.70 0.00 0.08 
P55072 NSVVSLSQPKM 1188.62 1188.62 0.00 0.020319303 
P55072 RVINQILTEM 1215.66 1216.67 1.00 0.058001036 
P55072 LEFLAKMTNGFSGA 1484.73 1486.73 1.99 0.043206367 
P53675 AILGNKMFTHY 1293.65 1293.61 -0.04 0.00804829 
P04350 SVRSGPFGQIFRP 1446.77 1446.77 0.00 0.013125513 
P04350 SVRSGPFGQIFRPD 1561.80 1561.80 0.00 0 
P04350 RIMNTFSVVPSPKVS 1660.90 1660.90 0.01 0.015540016 
P04350 
TVVEPYNATLSVHQL
VENT 2113.07 2114.05 0.98 0.00804829 
P04350 LVSEYQQYQ 1156.54 1157.52 0.98 0.054082715 
Q13765 TYIVFGEAKIE 1268.67 1269.69 1.02 0.072420635 
Q00610 FPVAMQISEKH 1285.65 1285.65 0.00 0.047330765 
Q00610 AILGNQMFTHY 1293.62 1293.62 0.01 0.011100833 
Q00610 NAIITMMNHPT 1241.59 1241.59 0.00 0.013125513 
Q9NYU
2 EVQGFLFGKLR 1274.71 1275.72 1.01 0.00804829 
Q9NYU
2 SALFINGLHM 1101.56 1101.56 0.00 0.013125513 
P45974 PSLAEHLSHFGI 1306.67 1306.66 0.00 0.024065864 
P45974 SISESVPVGPKVR 1353.76 1353.76 0.00 0.086289549 
O00487 KMTPEQLAIKNVGKQ 1683.93 1683.94 0.00 0.021094265 
P30040 KESYPVFYLFR 1447.75 1447.75 0.00 0.012173913 
P20618 TRLSEGFSIHTR 1402.73 1402.73 0.00 0.021094265 
P30101 
SFSEAHSEFLKAASNL
R 1892.94 1893.94 1.00 0.021094265 
P30101 GPVKVVVAENF 1157.64 1157.65 0.00 0.048087432 
P30101 PNIVIAKM 884.52 884.52 0.00 0.00804829 
P22102 LAGFAVGAMER 1120.57 1120.56 -0.01 0.064516129 
P60842 VLEVTKKFMR 1249.72 1249.72 0.00 0.00804829 
P57059 DLMPCSLGTFVLVQ 1537.75 1539.62 1.87 0.065106816 
P47756 SYRSPWSNKY 1286.60 1286.61 0.00 0.01458671 
Q02543 LTTAGAVTQCYR 1282.63 1282.64 0.01 0.00804829 
P55786 VFSPIGERLGW 1259.67 1259.66 -0.01 0.021094265 
O95881 GGYIPRILFL 1147.68 1147.67 0.00 0.017830609 




P55809 ESFAMIRGGHV 1184.58 1184.58 0.00 0.021094265 
P49327 GFKEQGVTFPSG 1252.61 1252.61 0.00 0.044742729 
P49327 PGSAELQKVLQG 1225.67 1225.67 0.00 0.00804829 
P49327 SLLGMEFSGR 1095.54 1095.54 0.00 0.00804829 
P49327 LVEAVAHILGIR 1289.78 1289.79 0.00 0.048727666 
P49411 YVKNMITGTAPL 1306.70 1306.69 0.00 0.094348435 
P49411 PELGLKSVQKLL 1323.81 1323.81 0.00 0.032667877 
P14625 KIRLISLT 942.62 942.62 0.00 0.071713147 
P14625 EYKAFYKSFSKES 1594.77 1594.77 0.00 0.025157233 
P14625 
EEEETAKESTAEKDE
L 1818.80 1818.81 0.00 0.098585121 
P61254 MKFNPFVTS 1069.53 1069.53 0.00 0.00804829 
P08134 GKQVELALW 1042.58 1043.58 1.00 0.015540016 
P08134 GKQVELALWD 1157.61 1156.61 -1.00 0.041498559 
P49588 LTGLIAEEKGLVV 1340.79 1340.78 -0.01 0.026022305 
P06744 PQNMFEFW 1097.46 1097.47 0.00 0.042261565 
P40227 KGFVVINQKGI 1201.72 1201.71 0.00 0.069556452 
P40227 EIMRAGMSSLKG 1260.63 1260.63 0.00 0 
P57737 LPVEVLQFHPTS 1365.73 1365.73 0.00 0.011100833 
P49720 FQKIFPMG 966.50 966.50 0.00 0.090995261 
P49915 LTSKPPGTTEWE 1344.66 1343.66 -1.00 0.013125513 
P84090 LSCLVYRA 923.49 923.49 0.00 0.00804829 
P24752 FPIAPVYAASMVLK 1505.83 1505.84 0.01 0.011100833 
Q14562 
ASLITVMQIHLTEPPG
D 1820.93 1822.70 1.77 0.058001036 
Q14566 
LAAAAEPGAGSQHLE
VR 1675.86 1675.87 0.00 0.00804829 
Q14566 
VSKLSTPGARAETNS
RVSGV 2015.08 2016.08 1.00 0.09762901 
P32969 MKTILSNQTV 1133.61 1133.61 0.00 0.00804829 
P32969 GIYVSEKGTVQQA 1378.71 1378.71 0.00 0.00804829 
P16989 
PAPKSPVGSGAPQAA
APAPAAHVAGNPGG 2501.28 2502.28 1.00 0.053219798 
P67809 
TKPGTTGSGAGSGGP
GGLTSAAPAGG 2070.00 2070.01 0.02 0.021094265 
Q9NZR2 DYVNRRLYWA 1354.68 1353.63 -1.05 0.020319303 
P01031 
AYSPGQTVSLNMATG
M 1642.73 1641.76 -0.97 0.045733408 
P26447 EAAFQKLMSNL 1250.63 1250.63 -0.01 0.057621792 
O14950 YLRELLTTMG 1195.63 1195.62 0.00 0.017830609 
Q9H1A4 DLKLGPYV 903.51 904.09 0.58 0.064516129 
Q969H8 
VRPGGVVHSFSHNVG
PG 1701.87 1701.87 0.00 0.044742729 
Q969H8 
VRPGGVVHSFSHNVG
PGD 1816.90 1817.90 1.00 0.00804829 
Q96GV9 KMIKEPAD 946.48 947.56 1.09 0.090995261 
Q7LG56 WALRWIAD 1029.54 1029.48 -0.06 0.047330765 
Q9P227 
RSVCSGASGRRAGAG
D 1505.71 1503.77 -1.94 0.011100833 
Q8WU3





9 RAPLTATAPQL 1137.65 1137.65 0.00 0.015540016 
Q8WU3
9 RAPLTATAPQLD 1252.68 1252.68 0.00 0 
Q8WW
H4 DEFTKNGITSK 1238.61 1238.63 0.01 0.086289549 
Q9ULL4 HVTVPLALMFE 1255.66 1255.61 -0.05 0.021094265 
O60281 
CTELVLKQLQEMKPT
VSLKKLEVHSN 2994.62 2993.58 -1.05 0.083855422 
Q6N069 LSLLQIQMR 1100.64 1100.64 0.00 0.013125513 
Q8N7Z3 
APVMTMTASLLPLVP
D 1670.86 1671.90 1.04 0.08 
P20591 IATTEALSMAQEV 1362.67 1362.67 0.00 0.012173913 




RLQ 3478.73 3480.67 1.94 0.09823911 
Q8NHS2 MPTLSVFMD 1071.46 1071.63 0.17 0.070858283 
P00558 
NGAKSVVLMSHLGR
P 1564.85 1564.85 0.00 0.00804829 
P00558 
NGAKSVVLMSHLGR
PD 1679.88 1679.88 0.00 0.00804829 
P00558 KIQLINNML 1085.63 1085.63 0.00 0.015540016 
Q8NBS9 KGTVLALTENNF 1305.69 1305.69 0.00 0.00804829 
Q8NBS9 KGTVLALTENNFD 1420.72 1420.72 0.00 0 
Q8NBS9 SLHRFVLSQAKDEL 1641.88 1641.88 -0.01 0.098585121 
Q9BU89 PEVLEILKQYSS 1404.75 1404.75 0.00 0.021094265 
Q96KP4 VKQLGGSVELV 1127.66 1127.66 0.00 0.013125513 
P24534 KSYIEGYVPSQA 1340.66 1340.65 -0.01 0.00804829 
P24534 VAVFEAVSSPPPA 1269.66 1270.66 1.00 0.090995261 
P24534 MLEEQITAFE 1209.56 1209.56 0.00 0.072420635 
P24534 YVQSMDVAAFNKI 1484.73 1485.74 1.00 0.098585121 
P62979 QQRLIFAGKQLE 1412.78 1412.78 0.00 0.012173913 
P62979 QQRLIFAGKQLED 1527.80 1527.81 0.00 0.015540016 
Q8N163 PELLLLR 852.54 852.55 0.00 0.015540016 
P49736 LTEPIISRF 1074.61 1074.61 0.00 0.00804829 
P13639 PIFKVFD 864.47 864.47 0.00 0.015540016 
P13639 ITKGVQYLNEIK 1404.80 1404.80 0.00 0.00804829 
Q8N5D0 DGLIRQY 863.45 863.48 0.03 0.072420635 
P61204 AVLLVFANKQ 1101.65 1101.65 0.00 0.00804829 
P18085 AVLLLFANKQ 1115.67 1116.67 1.00 0.046718576 
P09651 ESLRSHFEQWGTLT 1671.80 1671.80 0.00 0.054881266 
P09651 
SQRPGAHLTVKKIFV
GGIKE 2164.25 2164.25 0.00 0.016768293 
P21926 EVIKEVQEFYK 1392.73 1392.74 0.01 0.00804829 
P61978 SSGPERILSISA 1215.65 1216.64 1.00 0.038596491 
P61978 LISESPIKGRAQPY 1557.85 1557.85 0.00 0.00804829 
P61978 LGGPIITTQVTIPK 1436.86 1436.85 -0.01 0.00804829 
P09104 
LYTAKGLFRAAVPSG




P10599 VKQIESKTAFQEAL 1590.86 1590.86 0.00 0.098585121 
P31946 YFRYLSEVASG 1290.62 1290.63 0.01 0.044742729 
P07737 
LRTKSTGGAPTFNVT
VTKT 1978.08 1978.09 0.01 0.00804829 
P22234 MKIEFGV 822.43 822.43 0.00 0.036556604 
O75347 LEEAEEYKEARLVL 1690.88 1690.87 0.00 0.00804829 
Q8IWA6 KPMKSIKYMD 1255.63 1254.72 -0.91 0.058001036 
Q9H2U1 DPFVIPLGWEEAR 1527.77 1528.26 0.49 0.098585121 
P00338 TLWGIQKELQF 1361.73 1361.74 0.00 0 
P20700 QLLLNYAKKES 1288.70 1288.70 0.00 0.012173913 
P20700 QPMGGWEMIRKIG 1484.73 1484.73 0.00 0.053219798 
P20700 LIWKNQNSWGTGE 1531.74 1531.75 0.01 0.00804829 
Q8IZI9 
ESPGCLEASVTFNLFR
LLTR 2234.15 2237.19 3.04 0.098585121 
P62266 
EVLVAGFGRKGHAV
G 1477.81 1477.81 0.00 0.036556604 
P07741 FPTPGVVFR 1018.56 1018.57 0.01 0.090995261 
P07741 ALEPGQRVVVV 1165.68 1165.68 0.00 0.00804829 
P07741 ALEPGQRVVVVD 1280.71 1280.71 0.00 0.00804829 
P43320 SLSSLRPIKVD 1213.70 1215.64 1.94 0.077832512 
P15170 GPIRLPIV 863.56 863.56 0.00 0.041498559 




VIISAPSA 3702.90 3703.91 1.01 0.057621792 
P04406 APMFVMGVNHEKY 1537.71 1538.72 1.01 0.013125513 
P04406 APMFVMGVNHEKYD 1636.74 1636.74 0.00 0.011100833 
P04406 
NFGIVEGLMTTVHAI
TATQKTV 2330.23 2331.24 1.01 0.00804829 
P04406 HFVKLISWY 1191.64 1191.64 0.00 0.041498559 
P04406 NEFGYSNRVV 1183.56 1183.56 0.00 0.00804829 
P04406 NEFGYSNRVVD 1298.59 1298.59 0.00 0 
P07195 LQHGSLFLQTPKIVA 1650.95 1651.96 1.01 0.00804829 
P30086 LSKWSGPLSLQEV 1442.78 1443.78 1.00 0.013125513 
P30086 LSKWSGPLSLQEVD 1557.80 1557.81 0.00 0.021094265 
P30086 
EQPQHPLHVTYAGAA
V 1698.85 1698.85 0.00 0.00804829 
P30086 SGKLYTLVLT 1093.64 1093.64 0.00 0.078392945 
P30086 DYVPKLYEQLSGK 1538.80 1538.79 -0.01 0 
P30086 YVPKLYEQLSGK 1423.77 1424.77 1.00 0 
P06746 IRLIPKD 853.54 853.50 -0.04 0.065106816 
P07205 
NGAKAVVLMSHLGR
P 1548.86 1548.83 -0.03 0.021094265 
P54578 VKFPLML 846.50 846.51 0.00 0.075098814 
P35606 FQPSRSTAQQEL 1390.68 1390.69 0.00 0.02318094 
P30041 SWGILFSHPR 1198.62 1198.62 0.00 0.00804829 
P30041 
EILRVVISLQLTAEKR
VATPV 2316.39 2317.37 0.98 0.047330765 
P04264 
EINKRTNAENEFVTIK
K 2015.08 2015.08 0.00 0.015540016 




P04264 YQELMNTKLAL 1322.69 1322.70 0.01 0.065106816 
Q9Y4Y9 KEIVGTLLGF 1075.63 1075.63 0.00 0.09823911 
Q14103 GKMFIGGLSW 1094.56 1095.56 1.01 0.00804829 
Q14103 YFSKFGEVV 1074.54 1074.54 0.00 0.021094265 
Q14103 YFSKFGEVVD 1189.57 1189.57 0.00 0.015540016 
P13010 MVAIVRYAY 1084.57 1084.57 0.00 0.062854199 
P13010 TNETPYFMKSI 1329.63 1329.63 0.00 0.031572556 
P46781 YILGLKIE 947.57 947.57 0.00 0.031572556 
P08708 TKEMLKLL 974.58 974.58 0.00 0.082444229 
P49773 
LGLNKGYRMVVNEG
S 1635.84 1635.84 0.00 0.011100833 
O75821 VSMTFITSKE 1141.57 1141.57 0.00 0.021094265 
P17987 GATILKLL 827.55 827.55 0.00 0.083855422 
P40926 
VVVIPAGVPRKPGMT
R 1675.99 1675.99 0.00 0.058001036 
P40926 IVRANTFVAELKGL 1529.89 1529.90 0.01 0.015540016 
P42330 SFASHPNYPYS 1268.55 1268.55 0.00 0.012173913 
P28066 EKGPQLFHM 1067.52 1067.52 0.00 0.00804829 
Q9NYA
4 FTCLKESD 941.42 941.50 0.08 0.042261565 
P14174 PMFIVNTNVPRASVP 1640.87 1640.87 0.00 0.098585121 
P14174 
PMFIVNTNVPRASVP
D 1755.90 1756.93 1.03 0.052462527 
P14174 RVYINYY 989.50 989.50 0.00 0.015540016 
P14174 MNAANVGWNNSTFA 1495.65 1496.64 0.99 0 
Q92804 TGKPKGEATVSFD 1335.67 1333.89 -1.78 0.064516129 
P14867 
NRLRPGLGERVTEVK
T 1824.03 1824.98 0.95 0.077832512 
P07954 PKIANAIMKAA 1126.65 1126.65 0.00 0.00804829 
P00813 PLIFKSTL 917.56 917.56 0.00 0.048727666 
Q04446 VPELARLLEI 1151.69 1152.69 1.00 0.024065864 
Q04446 PYLKPYAV 949.53 949.53 0.00 0.042261565 
P46100 DFLELASREKTE 1436.71 1436.78 0.07 0.090995261 
Q8N7X4 
DVSVPQESQGASPTG
SP 1641.75 1640.88 -0.87 0.08 
O14980 QGEVVREFMK 1204.59 1204.59 0.00 0.011100833 
Q9UQ80 AMPFTLRAFE 1181.59 1181.59 0.00 0.00804829 
Q9UQ80 AMPFTLRAFED 1296.62 1297.62 1.01 0.048727666 
P33993 PGVAKSQLLSYI 1274.72 1273.71 -1.01 0.00804829 
Q9H089 QAEISHSESEHLPAR 1672.78 1672.78 0.00 0.00804829 
Q15393 
PSGQLNEYTERKEMS
A 1838.85 1838.85 0.00 0.011100833 
Q15393 NTVRIISL 914.55 914.56 0.00 0.065922921 
Q9HAU
5 DLELELENLEIN 1442.71 1443.76 1.05 0.058001036 
P42126 VQNFVSFISK 1167.63 1167.63 0.00 0.042261565 
Q7L5Y1 MRRCQIIR 1074.59 1076.02 1.43 0.08708134 
Q15424 
SGAAGAAALSSASSE
TGTRRLS 2007.00 2007.00 0.01 0.016768293 





Q01105 ETSEKEQQEAIEHI 1651.77 1651.77 0.00 0.00804829 
Q01105 ETSEKEQQEAIEHID 1766.80 1766.80 0.00 0 
Q01105 
ENPYFENKVLSKEFH
LNESG 2362.12 2362.10 -0.02 0.094348435 
P62995 LREVFSKYGPIA 1378.76 1378.76 0.00 0.011100833 
P06576 LYHEMIESGVINLK 1644.85 1644.86 0.00 0.090995261 
P06576 PAPATTFAHL 1024.53 1024.53 0.00 0.015540016 
P06576 PAPATTFAHLD 1139.56 1137.65 -1.91 0.041498559 
Q9GZL7 
NKLYSYRYSPTTSHV
GA 1942.95 1943.96 1.01 0.064516129 
Q5T0W
9 METSSMLSSLND 1329.54 1328.69 -0.86 0.082444229 
P08107 
AAKNQVALNPQNTV
F 1613.85 1612.85 -1.00 0.053219798 
P08107 LFRSTLEPVEKALR 1657.95 1657.96 0.01 0.020319303 
P08107 KCQEVISWL 1104.56 1104.56 0.00 0.028117359 
P31040 
AIHYMTEQAPAAVVE








PLTFPTL 3756.95 3757.65 0.69 0.099316629 
O43776 IPEAPERLMT 1155.60 1155.60 0.00 0.011100833 
O43776 SEEILAGYKREGI 1463.76 1463.76 0.00 0.00804829 
P27338 
VVVVGGGISGMAAA
KLLH 1677.96 1675.99 -1.97 0.047330765 
Q9UBL3 DGRRSPPWEP 1195.57 1196.71 1.13 0.053219798 
Q86UP2 EEQMNTMKAVLEEK 1694.79 1695.92 1.14 0.098585121 
Q86UU0 RPLLPPPPP 982.60 984.46 1.86 0.017830609 
Q86V81 GRPMNIQLVTSQI 1455.79 1456.79 1.00 0.02318094 
Q16851 WGKIQRPPE 1109.60 1107.61 -1.99 0.09762901 
Q99729 AGKMFVGGLSW 1151.58 1151.59 0.01 0.013125513 
Q99729 AGKMFVGGLSWD 1266.61 1266.61 0.00 0 
Q99729 YFTKFGEVV 1088.55 1088.56 0.00 0.028117359 
Q99729 PNTGRSRGFGFILFK 1695.92 1695.92 0.00 0.047330765 
P62837 PLVPEIARIYKT 1398.82 1398.82 0.00 0.015540016 
P62837 PLVPEIARIYKTD 1513.85 1513.84 -0.01 0.00804829 
P60660 YVEGLRVF 981.53 981.53 0.00 0.024065864 
Q96EL1 SFLSQLRWELLCGRD 1821.92 1821.83 -0.09 0.036556604 
Q6ZRP7 CMEEKNQAVCHD 1388.52 1388.75 0.23 0.078392945 




SVATEESTEPLSED 5284.67 5286.24 1.57 0.06676783 
Q86TV4 DSSASASQVAGIT 1192.56 1192.61 0.05 0.083855422 
Q76NI1 GQGPLPGLSSTSRD 1370.68 1370.80 0.12 0.086289549 
Q14697 EPGAWEETFKTHS 1499.67 1499.67 0.00 0.021094265 




Q14697 ISSNTAGKTLFGKMM 1584.80 1584.80 0.00 0.00804829 
Q14697 VRWMSETGII 1190.61 1190.61 0.00 0.070858283 
Q14697 
MNEPSVFNGPEVTML
K 1791.85 1791.86 0.00 0.012173913 
Q9UL46 LTSLRAPL 869.53 869.53 0.00 0.011100833 
Q86UT5 DPGLPAKKAGMQAG 1339.69 1337.77 -1.92 0.08 
P50542 QNAPLVSRAPQTFKM 1686.89 1685.00 -1.89 0.064516129 
Q9HB71 PSEGLMNVLKKIYE 1619.86 1619.86 0.00 0.015540016 
P22626 YFEEYGKI 1047.49 1047.49 0.00 0.00804829 
P22626 YFEEYGKID 1162.52 1162.52 0.00 0 
P22626 
SRGGGGNFGPGPGSN
FRGGS 1820.83 1820.83 0.00 0.012173913 
P68104 
SGKSTTTGHLIYKCG
GI 1721.88 1721.89 0.01 0.024065864 
P68104 FIKNMITGTSQA 1309.67 1309.67 0.00 0.00804829 
P68104 FIKNMITGTSQAD 1424.70 1424.70 0.00 0 
P68104 TVAFVPISGWNG 1246.63 1246.64 0.00 0.028117359 
P68104 GNASGTTLLEAL 1145.59 1145.59 0.00 0.00804829 
P68104 GNASGTTLLEALD 1260.62 1260.62 0.00 0.094348435 
P68104 NVGFNVKNVSVK 1303.72 1303.73 0.00 0.00804829 
P68104 MVPGKPMCVESFS 1410.63 1410.64 0.00 0.011100833 
P68104 MVPGKPMCVESFSD 1525.66 1525.66 0.00 0.00804829 
P68104 YPPLGRFAVR 1174.66 1174.66 0.00 0.024065864 
P68104 MRQTVAVGVIKAV 1370.81 1370.81 0.00 0.024065864 
P68104 MRQTVAVGVIKAVD 1485.83 1485.84 0.00 0 
O14787 
SAFRGICMMIGVNPG
GVVQD 2065.97 2066.41 0.43 0.058001036 
Q8NC51 
QSNVTEETPEGEEHH
PVA 1971.84 1971.85 0.01 0.00804829 
P15121 YPFHEEF 967.41 967.41 0.00 0.017830609 
P08238 IIPNPQERTLTLV 1492.86 1492.87 0.01 0.048727666 
P08238 IIPNPQERTLTLVD 1607.89 1607.88 -0.01 0.057621792 
P08238 QEELNKTKPIWTRNP 1835.95 1835.96 0.01 0.00804829 
P08238 
QEELNKTKPIWTRNP
D 1950.98 1951.99 1.01 0.00804829 
P08238 ITQEEYGEFYKSLTN 1820.85 1822.84 1.99 0.016768293 
P08238 ITQEEYGEFYKSLTND 1935.87 1935.88 0.01 0 
Q6ZSZ6 
EEDLDDSPKGGLDIL
K 1742.86 1740.93 -1.93 0.098585121 
P25788 IREEAEKYAKESLKEE 1950.99 1950.99 0.00 0.065922921 
P51991 SLREHFEKWGTLT 1602.82 1602.82 0.00 0.021094265 
Q9NY15 QLLEPPGLGARCD 1367.69 1367.79 0.10 0.082444229 
P62937 GEPLGRVSFELFA 1420.74 1420.74 0.00 0.013125513 
P62937 
FTRHNGTGGKSIYGE
KFE 2026.99 2026.99 0.00 0.012173913 
P62937 
FTRHNGTGGKSIYGE




GGSGR 1403.58 1403.73 0.15 0.058001036 
P61247 GYEPPVQESV 1103.51 1103.50 -0.01 0.048727666 




Q13263 IVENYFMR 1070.52 1070.52 0.00 0.015540016 
P25705 VPVGEELLGRVV 1265.73 1265.74 0.01 0.00804829 
P25705 VPVGEELLGRVVD 1380.76 1380.76 0.00 0.093484419 
Q6ZVP2 MMPGMATLMA 1100.44 1100.56 0.12 0.064516129 
P62805 
VVYALKRQGRTLYG
FGG 1884.04 1884.03 0.00 0.011100833 
Q1KMD
3 LAQRLQEAL 1040.60 1040.60 0.00 0.065106816 
Q1KMD
3 LGVAFWISK 1019.58 1020.59 1.01 0.00804829 
Q1KMD
3 RYYRNYYGYQGYR 1820.84 1820.84 0.00 0.028117359 
Q6XQN
6 PAFFEHLRAL 1199.65 1200.64 1.00 0.012173913 
P06733 
LFTSKGLFRAAVPSG
ASTGIYEALELR 2853.54 2853.53 -0.01 0.042261565 
P06733 VAASEFFRSGKY 1360.68 1360.68 0.00 0.00804829 
P06733 VAASEFFRSGKYD 1475.70 1475.70 0.00 0 
P99999 LIAYLKKATNE 1262.72 1262.73 0.00 0 
P04075 
PYQYPALTPEQKKEL
SD 2006.00 2005.99 -0.01 0.052462527 
P04075 IAHRIVAPGKGILAA 1485.91 1485.92 0.01 0.054082715 
P04075 IAHRIVAPGKGILAAD 1600.94 1600.94 -0.01 0 
P04075 
GRPFPQVIKSKGGVV
GIKV 1965.19 1966.19 1.00 0.00804829 
P04075 
KGVVPLAGTNGETTT
QGL 1741.92 1741.93 0.00 0.00804829 
P14618 TFLEHMCRL 1148.55 1148.55 0.00 0.00804829 
P14618 PILYRPVAVAL 1210.74 1210.74 0.00 0.00804829 
P14618 PILYRPVAVALD 1325.77 1325.77 0.00 0.00804829 
P14618 DGLISLQVKQKGA 1355.78 1355.77 0.00 0.013125513 
P14618 GLISLQVKQKGA 1240.75 1240.75 0.00 0.00804829 
P14618 GLISLQVKQKGAD 1355.78 1355.78 0.00 0.055818852 
P14618 
FLVTEVENGGSLGSK
KGVNLPGAAV 2442.31 2443.33 1.02 0.016768293 
P14618 LPAVSEKDIQD 1213.62 1213.62 0.00 0.098585121 
P14618 MVFASFIRKAS 1255.67 1255.68 0.00 0.00804829 
P14618 MVFASFIRKASD 1370.70 1370.70 0.00 0.021094265 
O94911 DVCQNPEEPEGE 1344.51 1342.65 -1.86 0.075098814 
P06748 
ENEHQLSLRTVSLGA
GAK 1890.99 1891.00 0.01 0.00804829 
P06748 
ENEHQLSLRTVSLGA
GAKD 2006.02 2007.02 1.00 0.00804829 
P06748 LWQWRKSL 1115.62 1115.62 0.00 0.00804829 
Q9UNM
6 ALRFLGCV 877.48 877.48 0.00 0.057621792 
P37802 
VGRPQPGRENFQNW
LK 1925.00 1925.00 0.00 0.035756853 
P37802 
PNWFPKKSKENPRNF
S 1975.01 1975.01 0.00 0.041498559 




P28070 IAHMISGFE 1003.48 1003.48 0.00 0.015540016 
P49589 NELAQSEAYFEN 1413.60 1413.80 0.20 0.094348435 
P19338 
EIEPAAMKAAAAAPA
SE 1608.78 1608.78 0.00 0.00804829 
P19338 ARTLLAKNLPYKVTQ 1715.01 1716.01 1.00 0.025157233 
P19338 GKSKGIAYIEFKTEA 1640.88 1640.88 0.00 0.047330765 
P19338 
GRSISLYYTGEKGQN
Q 1799.88 1799.88 0.00 0.00804829 
P19338 
GRSISLYYTGEKGQN
QD 1914.91 1915.91 1.00 0.00804829 
P19338 TTEETLKESF 1183.56 1183.56 0.00 0.021094265 
A0M8Q
6 FYPGAVTVAWKA 1308.69 1308.69 0.00 0.00804829 
A0M8Q
6 FYPGAVTVAWKAD 1423.71 1423.71 0.00 0.00804829 
 DPGEKGGASAAGCV 1217.53 1217.56 0.03 0.046718576 
P62826 
VTSRVTYKNVPNWH
R 1855.98 1855.98 0.00 0.09823911 
P41252 PVSIIQKYGA 1074.61 1074.61 0.00 0.021094265 
Q96JG9 
PKEALAGCLLQGEGS
PLED 1925.94 1925.00 -0.94 0.065922921 
P12956 LLAVVFYGTEK 1238.69 1238.70 0.01 0.026022305 
Q15084 VIELTPSNFNREVIQS 1844.96 1844.96 0.00 0.017830609 
Q15084 AALSALRQLVK 1168.73 1168.73 0.00 0.036556604 
Q15084 AALSALRQLVKD 1283.76 1283.75 0.00 0.065106816 
P22314 LSSQFYLREE 1270.62 1270.62 0.00 0.017830609 
P22314 
SNGEQPLSAMVSMVT
K 1677.81 1677.81 0.00 0.00804829 
P22314 SRLEELKATLPSP 1439.80 1440.71 0.91 0.021094265 
P22314 FIVAASNLRAENY 1466.75 1466.75 0.00 0.00804829 
P22314 VEVPYVRYTIR 1393.77 1393.77 0.00 0.094348435 
P23284 GTGGKSIYGERFP 1367.68 1367.69 0.00 0.038596491 
Q8IZP6 MAAPPSPGRTAD 1169.55 1167.57 -1.98 0.058001036 
A5A3E0 ESGPSIVHRKCL 1306.68 1306.68 0.00 0.028117359 
Q5JTN6 FSPTVNCLATGSW 1381.63 1380.77 -0.87 0.058001036 
Q9NP58 EVEAAAQAAGIHD 1280.60 1278.73 -1.87 0.090995261 
P15289 AAVTFGPSQVARGE 1388.70 1389.73 1.03 0.048727666 
Q9UBU
7 MSQSPAVHLM 1115.51 1115.52 0.01 0.090995261 
Q9Y262 QKVYELQASRVSS 1476.76 1476.76 0.00 0.00804829 




SVALLTINEASAE 3182.52 3183.88 1.36 0.094348435 
P42704 MENAENILTVMR 1419.69 1419.68 -0.01 0.00804829 
P42704 TYLALLNAYAEKG 1425.75 1426.76 1.01 0.012173913 
Q96L91 
EQALAGSLVAGAGST
VETD 1774.86 1774.88 0.02 0.083212385 
P50990 
QIIMAKPAGGPKPPSG
KK 1787.01 1787.02 0.00 0.044117647 






LQVVAVKAPGFG 2735.61 2736.60 1.00 0.070351759 
P10809 FVNMVEKGII 1148.63 1148.63 0.00 0.013125513 
P10809 FVNMVEKGIID 1263.65 1263.65 0.00 0.00804829 
P10809 
TALLDAAGVASLLTT
AEVVVTEIPK 2481.39 2482.41 1.01 0.098585121 
P10809 
AAGVASLLTTAEVVV
TEIPKEEK 2354.29 2354.29 0.00 0.081632653 
P10809 
PGMGAMGGMGGGM
GGGMF 1558.59 1559.60 1.01 0 
P07900 SGKELHINLIPNKQ 1589.89 1589.89 0.00 0.065106816 
P07900 
ISMIGQFGVGFYSAYL
VAEKVTVITKHN 3071.62 3071.63 0.02 0.00804829 
P07900 
ISMIGQFGVGFYSAYL
VAEKVTVITKHND 3186.64 3185.62 -1.02 0.013125513 
P07900 ITNEEYGEFYKSLTN 1806.83 1808.83 1.99 0.044117647 
O76037 TSSVSTGHTTPLLVTD 1614.81 1613.39 -1.42 0.09762901 
Q6ECI4 LECSTLGKNWKCED 1624.72 1624.90 0.17 0.064516129 
 FNIQEGQRAMLD 1420.68 1420.67 0.00 0.047330765 
P60174 TEVVCAPPTAYI 1262.62 1262.62 0.00 0.012173913 
P60174 
EREAGITEKVVFEQT
KVIA 2128.15 2128.15 0.00 0.098585121 
P60174 
AVAQSTRIIYGGSVTG
ATCKELASQP 2607.33 2608.33 1.00 0.020319303 
P60174 GFLVGGASLKPEFV 1419.78 1419.77 0.00 0.011100833 
P60174 GFLVGGASLKPEFVD 1534.80 1534.80 0.00 0.00804829 
Q96RL7 
TVGSHGAVKCKGLK
M 1530.80 1529.80 -1.01 0.083212385 
P15311 NAMLEYLKIAQ 1292.68 1292.68 0.00 0.083855422 
P15311 ALGLNIYEK 1019.57 1019.56 0.00 0.021094265 
Q08211 FLLVVLR 858.57 860.45 1.88 0.042261565 
Q08211 AVIEAEHTLREL 1379.74 1379.74 0.00 0.00804829 
B3KWE
3 DSGTMNIF 883.37 882.47 -0.90 0.078392945 
O15050 WSTQEIEACLQ 1306.59 1306.66 0.07 0.020319303 
P63244 KTIIMWKLTR 1288.77 1288.77 0.00 0.021094265 
P63244 NLVRVWQVTIGTR 1540.88 1540.88 0.00 0.020319303 
Q6IS14 FQLIGIQ 817.47 817.47 0.00 0.041498559 
Q01844 PPTAKAAVEWF 1215.63 1215.62 -0.01 0.024065864 
P62942 VELLKLE 842.51 843.52 1.01 0 
 MFRCSTSCCED 1296.42 1296.26 -0.16 0.083212385 
Q00839 
DEEAGGRPAMEPGN




K 1799.85 1800.86 1.01 0.098585121 
Q5T1H1 DQGPKQTGIVKH 1306.70 1305.73 -0.97 0.071713147 
P0C7T9 LEAVAKFL 889.53 889.52 0.00 0.013125513 
P26641 YESYTWRKL 1244.62 1244.62 0.00 0.00804829 
Q92598 PFIQKEKENLSY 1494.77 1495.78 1.01 0.052462527 
P50395 FTGHALALYRT 1248.66 1248.66 0.00 0.013125513 






KK 1972.94 1973.96 1.02 0.021094265 
P25205 TEEEMPQVHTPKTA 1596.75 1596.75 0.01 0.021094265 
P06865 TIIQVWRE 1043.58 1043.58 0.00 0.016768293 
P27824 MTPPVNPSREIE 1368.67 1368.68 0.00 0.081632653 
O43852 AFLGAEEAKTF 1182.59 1182.59 0.00 0.054881266 
Q8NCW
5 AIFGFSFKG 972.51 973.51 1.00 0.00804829 
Q13126 PEILEGRTEKYV 1432.76 1432.75 -0.01 0.086289549 
Q13126 ALILGKIKNV 1067.71 1066.53 -1.18 0.038596491 
P29401 LAMFRSVPTSTVFYPS 1801.91 1802.90 0.99 0.021094265 
P29401 FQVGQAKVVLKSK 1430.86 1430.86 0.00 0.058001036 
P29401 PFTIKPL 814.50 814.50 0.00 0.054881266 
P29401 AIAQAVRGLITKA 1310.80 1310.80 0.00 0 
P14314 GTVSVTELQTHPEL 1509.77 1509.75 -0.02 0.00804829 
P14314 GTVSVTELQTHPELD 1624.79 1624.80 0.01 0 
P14314 GALSEAEAQALLSG 1315.66 1316.66 1.00 0.035756853 
P14314 
AAQEARNKFEEAERS
LK 1976.01 1976.01 0.00 0.036556604 
P02765 TLETTCHVL 1015.50 1015.50 0.00 0.013125513 
 
Appendix Table 5. All peptides identified using the high throughput middle down 
strategy for human ribosomes. 
 




Diff  E Value 
P08865 VLQMKEEDVLKFLAAG
THLGGTNL 
2583.37 2583.37 0 1.56E-24 
P08865 VLKFLAAGTHLGGTNL 1610.91 1610.92 0.01 1.33E-26 
P08865 VLKFLAAGTHLGGTNL
DFQMEQYIYKRKS 
3327.74 3328.73 0.99 2.12E-08 






5486.01 5485.92 -0.09 1.28E-18 
P08865 PRADHQPLTEASYVNLP
TIALCNT 












4415.1 4415.16 0.06 3.26E-16 
P15880 KEWMPVTKLGRLVK 1683.99 1684 0.01 3.42E-14 







2737.49 2737.51 0.02 0.000351 




4050.27 4050.35 0.08 8.54E-16 
P15880 HLVKTHTRVSVQRTQA
PAVATT 
2400.33 2400.31 -0.02 8.42E-09 
P23396 AVQISKKRKFVA 1415.86 1416.87 1.01 7.77E-20 
P23396 GIFKAELNEFLTRELAE 1979.04 1979.02 -0.02 5.37E-22 
P23396 TAVRHVLLRQGVLGIK
VKIMLPW 
2626.6 2626.61 0.01 9.57E-11 
P23396 PTGKIGPKKPLPDHVSIV
EPK 
2236.29 2235.35 -0.94 6.36E-11 
P61247 VKAPAMFNIRNIGKTLV
TRTQGTKIAS 
2914.65 2914.68 0.03 2.53E-19 
P61247 GLKGRVFEVSLA 1274.73 1274.73 0 1.52E-08 
P61247 LQNDEVAFRKFKLITE 1950.06 1950.06 0 3.33E-09 
P61247 EVAFRKFKLITE 1479.84 1479.85 0.01 0.0000233 
P61247 VQGKNCLTNFHGM 1447.67 1448.65 0.98 2.2E-14 
P61247 LKEVVNKLIPD 1266.75 1266.76 0.01 5.14E-10 
P61247 LKEVVNKLIPDSIGK 1651.99 1652 0.01 1.54E-14 
P61247 SIGKDIEKACQSIYPLH 1900.97 1900.95 -0.02 6.74E-25 








4772.58 4772.63 0.05 6.63E-23 
P62701 ARGPKKHLKRVAAPKH
WML 
2223.31 2223.32 0.01 1.46E-15 
P62701 ARGPKKHLKRVAAPKH
WMLD 




4175.4 4175.45 0.05 3.9E-09 









4472.51 4472.48 -0.03 0.0000005
12 
P62701 LETGKITDFIKF 1410.78 1410.79 0.01 0.0000432 
P62701 TGNLCMVTGGANLGRI
GVITNRERHPGSF 
3026.53 3026.5 -0.03 0.000276 
P62701 TGNLCMVTGGANLGRI
GVITNRERHPGSFD 













P46782 IKLFGKWST 1078.62 1078.61 -0.01 2.91E-18 
P46782 STRIGRAGTVRRQAVD 1741.97 1741.97 0 0.000178 
P62753 MKLNISFPATGCQKLIE
V 
1991.06 1991.05 -0.01 9.85E-13 
P62753 ANLSVLNLVIVKKGEK 1724.06 1724.07 0.01 2.23E-22 
P62753 ANLSVLNLVIVKKGEKD 1839.08 1839.08 0 5.19E-13 
P62753 ANLSVLNLVIVKKGEKD
IPGLT 
2320.37 2320.33 -0.04 0.0000004
78 
P62081 MFSSSAKIVKPNGEKP 1760.91 1761.93 1.02 7.91E-10 
P62081 MFSSSAKIVKPNGEKPD 1875.94 1877.03 1.09 1.01E-09 
P62081 MFSSSAKIVKPNGEKPD
EFESGISQALLELEMNS 
3753.81 3753.77 -0.04 3.39E-20 
P62081 AILEDLVFPSEIVGKRIR
VKL 
2394.44 2394.45 0.01 3.29E-16 
P62081 LVFPSEIVGKRIRVKL 1853.16 1853.16 0 3.89E-13 
P62081 LVFPSEIVGKRIRVKLD 1968.19 1968.19 0 0.000515 
P62081 GSRLIKVHL 1021.64 1021.64 0 7.25E-10 
P62081 KAQQNNVEHKVETFSG
VYKKLTGK 
2732.46 2732.44 -0.02 8.07E-27 
P62081 KAQQNNVEHKVETFSG
VYKKLTGKD 




4098.09 4098.15 0.06 1.74E-10 
P62081 VNFEFPEFQL 1268.61 1268.62 0.01 1.23E-15 
P62241 VVYNASNNELVRTKTL
VKNCIVLI 
2702.52 2702.54 0.02 1.31E-15 
P62241 VVYNASNNELVRTKTL
VKNCIVLID 








2624.52 2624.53 0.01 3.27E-20 
P46781 PRRLFEGNALLRRLVRI
GVL 
2347.44 2347.41 -0.03 1.8E-15 
P46781 PRRLFEGNALLRRLVRI
GVLD 
2462.47 2462.52 0.05 0.0000902 
P46781 PRRLFEGNALLRRLVRI
GVLDEGKMKL 
3148.85 3148.88 0.03 0.000307 














2949.67 2950.77 1.1 4.75E-31 
P46783 MLMPKKNRIAIYELLFK
EGVMVAKKD 




4204.29 4206.28 1.99 1.83E-19 
P46783 KNVPNLHVMKAMQSL
KSRGYVKEQFAWRHFY






























6298.43 6298.46 0.03 3.03E-14 
P62280 YLHYIRKYNRFEKRHK
NMSVHLSPCFR 
3521.82 3521.83 0.01 4.31E-14 
P62280 YLHYIRKYNRFEKRHK
NMSVHLSPCFRD 
3636.85 3636.82 -0.03 0.0000146 
P62280 YLHYIRKYNRFEKRHK
NMSVHLSPCFRDVQIG 









3821.19 3821.15 -0.04 1.77E-25 
P25398 VNTALQEVLKTALIH 1648.95 1648.97 0.02 1.85E-26 




2539.35 2539.31 -0.04 0.0000115 
P25398 NKKLGEWVGLCKI 1486.83 1486.86 0.03 1.62E-08 
P25398 YGKESQAKDVIEEYFKC
KK 
2292.15 2292.13 -0.02 7.55E-16 
P25398 VIEEYFKCKK 1285.67 1285.67 0 0.0000153 
P62277 GRMHAPGKGLSQSALP
YRRSVPTWLKLTS 
3193.73 3193.79 0.06 3.05E-13 
P62277 GRMHAPGKGLSQSALP
YRRSVPTWLKLTSD 
3308.76 3308.79 0.03 3.3E-09 
P62277 DVKEQIYKLAKKGLTPS
QIGVILR 
2696.6 2696.56 -0.04 4.03E-24 
P62277 VKEQIYKLAKKGLTPSQ
IGVILR 
2581.57 2581.54 -0.03 2.87E-37 
P62277 VKEQIYKLAKKGLTPSQ
IGVILRD 
2696.6 2696.62 0.02 7.19E-16 
P62277 SHGVAQVRFVTGNKILR
ILKSKGLAP 
2788.66 2789.7 1.04 4.15E-17 
P62277 SHGVAQVRFVTGNKILR
ILKSKGLAPD 
2903.68 2903.64 -0.04 1.24E-11 
P62277 LPEDLYHLIKKAVAVRK
HLERNRK 










2471.51 2471.51 0 2.46E-11 
P62277 LYHLIKKAVAVRKHLE
RNRKD 




4844.74 4844.74 0 3.76E-08 
P62263 TFVHVTDLSGKETICRV
TGGMKVKA 
2676.41 2676.42 0.01 9.98E-15 
P62263 LSGKETICRVTGGMKV
KA 




5251.95 5251.91 -0.04 1.62E-17 
P62841 AEVEQKKKRTFRKFTY
RGV 
2412.34 2412.32 -0.02 1.23E-15 
P62841 AEVEQKKKRTFRKFTY
RGVD 

















2749.53 2749.52 -0.01 0.000188 
P62244 HRAGKIVVNLTGRLNK
CGVISPRF 




5188.72 5189.81 1.09 1.36E-17 
P62244 HEEARRKHTGGKILGFF
F 





7136.03 7136.11 0.08 3.96E-14 
P62249 IRVRVKGGGHVAQIYAI
RQSISKALVAYYQKYV 




3849.15 3849.19 0.04 6.74E-12 
P62249 PRRCESKKFGGPGARAR
YQKSYR 
2697.41 2697.36 -0.05 1.04E-10 
P08708 GRVRTKTVKKAARVIIE
KYYTRLGN 
2919.72 2920.66 0.94 0.0000702 
P08708 GRVRTKTVKKAARVIIE
KYYTRLGND 
3034.75 3034.75 0 1.83E-08 
P08708 TKEMLKLL 974.583 974.593 0.01 9.37E-20 




3745.99 3745.99 0 3.58E-16 
P08708 FGSLSNLQVTQPTVGM
NFKTPRGPV 






2275.31 2275.3 -0.01 4.21E-30 
P62269 SLVIPEKFQHILRVLNTN
ID 
2390.33 2390.37 0.04 4.88E-14 
P62269 GRRKIAFAITAIKGVGR
RYAHVVLRKA 
3006.83 3007.84 1.01 3.23E-18 
P62269 GRRKIAFAITAIKGVGR
RYAHVVLRKAD 
3121.86 3121.86 0 0.0000010
4 













2984.7 2984.7 0 1.73E-23 
P39019 VNQQEFVRALAAFLKK
SGKLKVPEWVD 




4578.58 4578.54 -0.04 1.64E-11 
P39019 TVKLAKHKELAPY 1496.87 1496.87 0 1.4E-17 
P39019 TVKLAKHKELAPYD 1611.9 1611.9 0 4.65E-10 
P39019 GGRKLTPQGQRDLDRIA
GQVAAANKKH 
2884.59 2884.59 0 0.0000094 




4048.23 4047.23 -1 0.0000032
4 
P60866 RFQMRIHKRLI 1496.89 1496.9 0.01 2.38E-10 
P60866 RFQMRIHKRLID 1611.91 1611.92 0.01 0.0000086
7 
P63220 LYVPRKCSASNRIIGAK 1875.05 1875.05 0 1E-10 
P63220 LYVPRKCSASNRIIGAK
D 








2630.29 2630.26 -0.03 1.95E-19 
P62266 EVLVAGFGRKGHAVGD 1610.85 1611.92 1.07 0.000421 
P62266 IPGVRFKVVKVANVSLL
ALYKGKKERPRS 
3251.97 3252.04 0.07 8.38E-37 
P62847 TVTIRTRKFMTNRLLQR
KQMVID 




2935.67 2935.67 0 5.34E-15 
P62847 VLHPGKATVPKTEIREK
LAKMYKTTPD 




5570.97 5572.01 1.04 0.000264 
P62847 VIFVFGFRTHFGGGKTT
GFGMIY 














6654.88 6655 0.12 6.54E-28 
P62854 KAIKKFVIRNIVEAAAV
R 
2025.26 2025.23 -0.03 9.21E-37 
P62854 KAIKKFVIRNIVEAAAV
RD 
2140.28 2140.26 -0.02 5.23E-29 
P62854 KAIKKFVIRNIVEAAAV
RDISEASVF 
2873.65 2873.69 0.04 8.09E-09 
P62854 AYVLPKLYVKLHYCVS
CAIHSKVVRNRSREARK 




4001.17 4001.13 -0.04 0.0000363 
P62854 RTPPPRFRPAGAAPRPPP
KPM 
2293.27 2293.25 -0.02 1.47E-11 
P42677 LLHPSPEEEKRKHKKKR
LVQSPNSYFM 








3673 3673.03 0.03 1.58E-14 
P62857 DTSRSIIRNVKGPVREG 1883.03 1883.02 -0.01 0.0000014
9 
P62857 TSRSIIRNVKGPVREG 1768.01 1768.03 0.02 1.07E-15 




3705.09 3705.15 0.06 4.22E-27 
P62857 VLTLLESEREARRLR 1840.06 1840.07 0.01 1.52E-17 
P39023 SHRKFSAPRHGSLGFLP
RKRSSRHRGKVKSFPK 
3828.16 3828.1 -0.06 3.74E-14 
P39023 PSKPVHLTAFLGYKAG
MTHIVREV 
2650.44 2650.43 -0.01 8.35E-37 
P39023 PSKPVHLTAFLGYKAG
MTHIVREVD 
































3852.98 3853.97 0.99 1.96E-20 
P36578 ACARPLISVYSEKGESS
GKNVTLPAVFKAPIRP 
3526.9 3526.9 0 3.14E-31 
P36578 ACARPLISVYSEKGESS
GKNVTLPAVFKAPIRPD 
3641.92 3641.95 0.03 9.28E-26 
P36578 KVEGYKKTKEAVLLLK
KLKAWN 
2586.56 2588.59 2.03 0.0000487 
P36578 KVEGYKKTKEAVLLLK
KLKAWND 















6308.84 6308.82 -0.02 0.0000118 
P46777 GFVKVVKNKAYFKRYQ
VKFRRRREGKT 
3387.96 3387.93 -0.03 3.05E-12 
P46777 GFVKVVKNKAYFKRYQ
VKFRRRREGKTD 
3502.99 3503 0.01 1.57E-08 
P46777 KNKYNTPKYRMIVRVT
NR 




1931.1 1931.1 0 4.32E-23 
P46777 AGLARTTTGNKVFGAL
KGAVD 
2046.12 2046.11 -0.01 3.55E-22 
P46777 GGLSIPHSTKRFPGY 1615.85 1615.83 -0.02 1.97E-10 
P46777 SESKEFNAEVHRKHIMG
QNVA 
2410.18 2410.19 0.01 0.000132 
P46777 YMRYLMEE 1133.49 1133.49 0 9.83E-10 
P46777 AYKKQFSQYIKNSVTP 1901 1900.98 -0.02 0.00027 
P46777 AYKKQFSQYIKNSVTPD 2016.03 2016 -0.03 0.00023 
P46777 RVAQKKASFLRAQERA
AES 
2145.18 2145.16 -0.02 3.47E-12 
Q02878 KNGGTRVVKLRKMPRY
YPTE 













9174.51 9174.39 -0.12 0.0000082
2 
Q02878 ISNVKIPKHLT 1248.76 1248.75 -0.01 1.16E-19 






3748.14 3748.08 -0.06 4.23E-13 
Q02878 AYFKKKKLRKPRHQEG
EIF 
2402.37 2402.35 -0.02 6.23E-13 
Q02878 AYFKKKKLRKPRHQEG
EIFD 
2517.4 2517.41 0.01 0.00036 
Q02878 AYFKKKKLRKPRHQEG
EIFDTEKEKYEITEQRKI 
4293.34 4293.35 0.01 2.97E-24 
Q02878 TEKEKYEITEQRKID 1908.98 1908.95 -0.03 1.04E-11 
Q02878 SQILPKIKAIPQLQGYLR
SVFALTNGIYPHKLVF 
3852.22 3852.23 0.01 7.04E-23 





























4487.57 4487.54 -0.03 3.41E-18 
P62424 VPTKRPPVLRAGVNTVT
TLVENKKAQLVVIAH 
3448.04 3448.01 -0.03 1.43E-22 
P62424 VPTKRPPVLRAGVNTVT
TLVENKKAQLVVIAHD 












5469.98 5470.06 0.08 0.000181 
P62424 KGALAKLVEAIRTNYN 1759.99 1760.99 1 7.73E-21 
P62424 KGALAKLVEAIRTNYN
D 
1875.02 1875.02 0 8.99E-09 
P62424 KGALAKLVEAIRTNYN
DRY 
2194.19 2194.2 0.01 1.38E-12 
P62917 GRVIRGQRKGAGSVFR
AHVKHRKGAARLRAV 
3394.01 3394.04 0.03 1.59E-10 
P62917 GRVIRGQRKGAGSVFR
AHVKHRKGAARLRAVD 




5007.88 5007.92 0.04 0.0000036
8 




P62917 FAERHGYIKGIVKD 1631.88 1631.88 0 6.02E-12 
P62917 FAERHGYIKGIVKDIIH 1995.11 1995.11 0 6.83E-40 
P62917 FAERHGYIKGIVKDIIHD 2110.13 2110.14 0.01 2.58E-24 
P62917 PGRGAPLAKVVFR 1366.82 1366.82 0 1.8E-25 















5557.12 5557.07 -0.05 3.11E-29 
P32969 MKTILSNQTV 1133.61 1133.61 0 3.91E-27 
P32969 IPENVDITLKGRTVIVKG
PRGTLRR 
2787.66 2787.62 -0.04 0.0000176 
P32969 ITLKGRTVIVKGPRGTL
RR 
2120.34 2120.35 0.01 9.72E-15 
P32969 FNHINVELSLLGKKKKR
LRV 
2391.46 2391.44 -0.02 3.1E-20 
P32969 FNHINVELSLLGKKKKR
LRVD 




2127.19 2127.18 -0.01 7.6E-15 
P32969 IELVSNSAALIQQATTV
KNKDIRKFL 
2899.65 2899.65 0 0.000081 
P32969 GIYVSEKGTVQQA 1378.71 1378.71 0 1.63E-10 
 GRRPARCYRYCKNKPY
PKSRFCRGVP 
3157.62 3157.59 -0.03 0.000641 
 GRRPARCYRYCKNKPY
PKSRFCRGVPD 
3272.65 3273.67 1.02 0.000539 
 AKIRIFDLGRKKAKV 1742.1 1743.09 0.99 2.79E-16 
 AKIRIFDLGRKKAKVD 1857.13 1857.1 -0.03 3.79E-15 




4030.22 4030.18 -0.04 1.07E-12 
P62906 IPHMDIEALKKLNKNKK
LVKKLAKKY 
3090.88 3091.71 0.83 3.4E-12 
P62906 IEALKKLNKNKKLVKK
LAKKY 
2497.62 2497.63 0.01 5.77E-24 
P62906 IEALKKLNKNKKLVKK
LAKKYD 








4416.44 4416.44 0 3.12E-13 
P62913 TGNFGFGIQEHI 1318.63 1318.63 0 9.27E-21 
P62913 TGNFGFGIQEHID 1433.66 1433.66 0 5.91E-16 












3834.11 3835.22 1.11 0.0000001
77 
P26373 APSRNGMVLKPHFHK 1717.92 1718.91 0.99 0.0000000
26 













7545.11 7545.16 0.05 2.01E-17 
P40429 KYTEVLKTHGLLV 1499.87 1499.88 0.01 3.84E-20 
P50914 VFRRFVEVGRVAYVSF
GPHAGKLVAIV 
2972.69 2972.68 -0.01 4.93E-13 
P50914 VFRRFVEVGRVAYVSF
GPHAGKLVAIVD 
3087.71 3087.71 0 1.62E-09 
P50914 VFRRFVEVGRVAYVSF
GPHAGKLVAIVDVI 




4096.28 4096.25 -0.03 2.88E-16 
P50914 FILKFPHSAHQKYVRQA
WQKA 
2582.4 2582.39 -0.01 1.83E-16 
P50914 FILKFPHSAHQKYVRQA
WQKAD 
2697.43 2697.39 -0.04 0.0000285 
P50914 INTKWAATRWAKKIEA
RERKAKMT 




3001.64 3001.62 -0.02 0.0000477 
P61313 GAYKYIQELWRKKQS 1897.02 1897.02 0 9.23E-13 
P61313 GAYKYIQELWRKKQSD 2012.05 2012.03 -0.02 1.38E-08 
P61313 STYKFFEVILI 1358.75 1358.76 0.01 4.77E-13 
P61313 PFHKAIRRNP 1234.7 1234.69 -0.01 0.0000191 

























3820.29 3820.35 0.06 0.0000001
9 








4027.12 4027.02 -0.1 4.12E-17 
Q02543 SKIKFPLPHRVLRRQHK
PRFTTKRPNTFF 
3632.1 3632.12 0.02 2.71E-12 
P84098 SMLRLQKRLASSVLRCG
KKKVWL 
2741.6 2741.62 0.02 3.08E-16 
P84098 SMLRLQKRLASSVLRCG
KKKVWLD 




2436.32 2436.32 0 0.000866 
P84098 PNETNEIANANSRQQIR
KLIKD 













6854.84 6854.78 -0.06 3.64E-13 
P35268 APVKKLVVKGGKKKKQ
VLKFTL 
2436.6 2436.61 0.01 1.06E-27 
P35268 APVKKLVVKGGKKKKQ
VLKFTLD 





7056.95 7058 1.05 0.000626 
P62829 SKRGRGGSSGAKFRISL
GLPVGAVINCA 
2799.53 2799.53 0 7.77E-14 
P62829 SKRGRGGSSGAKFRISL
GLPVGAVINCAD 
2914.56 2916.61 2.05 0.000192 
P62829 NTGAKNLYIISVKGIKG
RLNRLPAAGVG 








3932.3 3932.24 -0.06 1.41E-09 
P62829 NAGVIVNNKGEMKGSA
ITGPVAKECA 
2557.3 2557.28 -0.02 1.64E-27 
P62829 LWPRIASNAGSIA 1354.74 1354.74 0 2.88E-10 
P62750 VKANKHQIKQAVKKLY 1895.15 1895.13 -0.02 8.2E-16 
P62750 VKANKHQIKQAVKKLY
DI 
2123.26 2123.24 -0.02 0.00068 
P62750 IDVAKVNTLIRP 1337.8 1337.8 0 0.0000125 
P62750 ALDVANKIGII 1125.68 1125.7 0.02 2.52E-21 












7354.34 7355.3 0.96 1.46E-21 
P61254 MKFNPFVTS 1069.53 1069.53 0 1.28E-18 





6838.88 6837.98 -0.9 0.0000417 
P61254 RKKILERKAKSRQVGKE
KGKYKEETIEKMQE 
3775.13 3775.11 -0.02 8.23E-17 
P61353 GKFMKPGKVVLVLAGR
YSGRKAVIVKNI 
3027.83 3027.83 0 3.06E-19 
P61353 GKFMKPGKVVLVLAGR
YSGRKAVIVKNID 
3142.85 3142.79 -0.06 4.45E-17 













4871.7 4871.69 -0.01 1.01E-10 




4183.39 4183.42 0.03 4.25E-21 
P46776 KYHPGYFGKVGMKHY
HLKRNQSFCPTVNL 
3448.74 3448.72 -0.02 5.55E-09 
P46776 KLWTLVSEQTRVNAAK
NKTGAAPII 
2708.53 2708.56 0.03 2.15E-20 
P46776 KLWTLVSEQTRVNAAK
NKTGAAPIID 









6271.25 6271.2 -0.05 1.08E-09 
P46779 LRMAAIRRASAILRSQK
PVMVKRKRTRPTKSS 










6565.82 6566.7 0.88 9.01E-15 






3549.09 3549.07 -0.02 0.0000804 
P62899 SPNKLYTLVTYVPVTTF
KNLQTVNV 
2838.55 2838.56 0.01 3.54E-16 
P62899 SPNKLYTLVTYVPVTTF
KNLQTVNVD 
2953.58 2953.54 -0.04 4.47E-15 
P62910 AALRPLVKPKIVKKRTK
KFIRHQS 
2841.8 2841.79 -0.01 1.71E-30 
P62910 AALRPLVKPKIVKKRTK
KFIRHQSD 
2956.83 2956.83 0 2.19E-18 
P62910 RYVKIKRNWRKPRGI 1969.2 1969.2 0 0.000455 
P49207 RIKRAFLIEEQKIVVKVL
KAQAQSQKAK 
3249.98 3250.94 0.96 2.17E-38 
P42766 AKIKARDLRGKKKEELL
KQL 
2364.47 2364.46 -0.01 2.69E-11 

























4794.73 4794.73 0 3.52E-17 
Q9Y3U8 MIREVCGFAPYERRAM
ELLKVSK 
2725.42 2725.41 -0.01 3.13E-10 
Q9Y3U8 MIREVCGFAPYERRAM
ELLKVSKD 




4400.69 4400.7 0.01 4.58E-13 
P83881 VNVPKTRRTFCKKCGK
HQPHKVTQYKKGK 
3423.9 3423.89 -0.01 1.04E-22 
P83881 VNVPKTRRTFCKKCGK
HQPHKVTQYKKGKD 




4761.58 4761.63 0.05 1.96E-15 
P83881 KKRKGQVIQF 1230.76 1230.76 0 0.000113 
P63173 PRKIEEIKDFLLTARRK 2112.25 2112.26 0.01 2.56E-27 








2333.4 2333.43 0.03 1.01E-23 








5722.1 5723.06 0.96 1.47E-10 
P05388 YTFPLAEKVKAFLA 1596.89 1596.93 0.04 3.32E-25 
P05387 MRYVASYLLAALGGNS
SPSAK 
2155.11 2155.1 -0.01 2.44E-25 
P05387 MRYVASYLLAALGGNS
SPSAKDIKKIL 
2865.58 2865.56 -0.02 3.99E-14 
P05387 RLNKVISELNGKNIE 1725.97 1725.98 0.01 2.98E-17 










Appendix Table 6. Table of all peptides identified from combined analyses of ECVs 
using microwave-supported acid hydrolysis. 
	  





P60710 DIAALVV 699.42 698.88 -0.53 0.067385443 
P14069 AEIARLM 802.44 802.43 0.00 0.047413793 
Q99N16 GLLMSTGD 808.36 808.46 0.10 0.023866348 
P06801 GERILGLG 813.47 813.47 0.00 0.067385443 
P40142 PFTIKPL 814.50 814.50 0.01 0.052910052 
P52480 LRVNLAM 815.47 815.47 0.00 0.032986112 
Q8BTM8 VTSLRPF 818.47 818.47 0.00 0.056155507 
P52480 LKFGVEQ 819.45 819.45 0.00 0.099357098 
A2AR02 SSSSSSSSD 829.29 830.41 1.11 0.052313883 
P06745 IINIGIGGS 842.49 842.49 0.01 0.015968064 
Q8BRV5 GPEGPPPSD 851.37 849.60 -1.77 0.088724584 
P11983 AVLAVKYT 863.51 863.51 0.00 0.015968064 
P97324 AYERLIL 876.51 875.18 -1.32 0.069645204 
P27773 ASVVGFFR 881.48 881.48 0.00 0.015968064 
P30101 PNIVIAKM 884.52 884.51 0.00 0.0064 
Q64727 PGLQKSFL 888.51 888.50 0.00 0.0345679 
P51437 TNLYRLL 891.52 891.52 0.00 0.025341131 
P25911 FGLARVIE 903.52 903.52 0.00 0.015968064 
Q8CH25 EKSSSRSAG 907.44 908.66 1.23 0.086206898 
Q04750 GYFAPPKE 907.44 907.44 0.00 0.015968064 
P31146 AGPLLISLK 910.59 910.58 0.00 0.0098 




Q3UP87 AFAPVAEFA 921.46 922.28 0.82 0.030195381 
Q9D6I9 SVSIGSFLD 923.46 924.44 0.98 0.053691275 
O09172 LTAFAKQF 924.51 924.51 0.00 0.030195381 
Q8CGZ0 NLLQPIID 924.53 922.68 -1.85 0.088724584 
Q9JHK5 PAYLHYY 925.43 926.48 1.05 0.015968064 
Q8BK64 DGNVTGEFT 938.40 939.00 0.60 0.053691275 
P80318 VVITEKGIS 944.55 944.56 0.00 0.015968064 
P10630 EMLSRGFK 948.48 948.48 0.00 0.033500839 
O88342 YSGQGVVKL 949.52 951.16 1.64 0.051515151 
Q9R111 ALLINPRAS 953.57 953.57 0.00 0.025341131 
P42932 IEAEVPAVK 954.54 954.54 0.00 0.0345679 
P63017 ANGILNVSAV 956.53 956.53 0.00 0.015968064 
Q9D2V7 TGLVLLTGKG 957.59 957.59 0.00 0.015968064 
O88845 DVMQQAHH 964.42 964.54 0.12 0.04989605 
P27037 AFAVFLISC 969.50 969.51 0.01 0.047 
O89053 VRVSQTTW 975.51 975.50 -0.01 0.033500839 
Q4VAA2 MQISEKED 978.43 979.56 1.13 0.015968064 
P39054 LPGITKVPVG 979.61 979.61 0.00 0.015968064 
Q60605 YVEGLRVF 981.53 982.54 1.02 0.015968064 
P34884 RVYINYY 989.50 989.50 0.00 0.054834057 
P97324 AYERLILD 991.53 991.53 0.00 0.081063963 
Q9JHK5 LGALYLSMK 994.55 994.55 0.00 0.015968064 
P62826 PALAAQYEH 998.48 998.48 0.00 0.0016 
A0M8Q6 PGAVTVAWKA 998.55 998.55 0.00 0.0084 
Q8BTM8 LSKIKVSGLG 1000.63 1000.63 0.00 0.086206898 
P99026 IAHMISGFE 1003.48 1003.48 0.00 0.008264462 
P63017 GIFEVKSTAG 1007.53 1008.52 1.00 0.015968064 
P26443 TYASTIGHY 1011.47 1011.47 0.00 0.015968064 
Q05144 SKPVNLGLW 1012.57 1012.57 0.00 0.015968064 
P56480 PAPATTFAHL 1024.53 1024.53 0.00 0.046656299 
O89053 AGPLLISLKD 1025.61 1025.61 0.00 0.008264462 
Q6A037 DLNALSALVL 1027.59 1027.54 -0.05 0.067385443 
P19096 IMLATGKLSP 1029.59 1031.48 1.89 0.050613496 
Q3THE2 MLASLGKNPT 1030.55 1030.55 0.00 0.015968064 
P11276 LRFTNIGPD 1031.54 1031.54 0.00 0.015564202 
Q3TRM8 GSLGTLSTRF 1037.55 1037.55 0.00 0.015968064 
Q68FD5 LLMVLSPRL 1040.64 1040.64 0.00 0.005988024 
P16858 LMAYMASKE 1042.48 1042.48 0.00 0.008264462 
Q7TSE6 MMTLLMKK 1042.52 1042.59 0.07 0.086206898 
P62746 GKQVELALW 1042.58 1042.58 0.00 0.025341131 
Q9D2V7 LVQSAVWSR 1044.57 1044.57 0.00 0.015968064 
O88569 YFEEYGKI 1047.49 1047.49 0.00 0.015968064 
Q9ET01 IINMLFYH 1049.54 1049.54 0.00 0.015968064 
O89053 VGTGAAVLTLGP 1054.60 1054.60 0.00 0.015968064 
P06745 VMPEVNRVL 1055.58 1055.58 0.00 0.09041591 




O89053 TNIVYLCGKG 1066.55 1066.55 0.00 0.015968064 
P84096 VPILLVGTKK 1066.71 1066.71 0.00 0.043921567 
Q9Z2U1 EKGPQLFHM 1067.52 1067.52 0.00 0.015968064 
P26039 ILNGSHPVSF 1069.56 1069.56 0.00 0.015968064 
P20029 VNGILRVTAE 1070.61 1070.61 0.00 0.015968064 
P35527 LTVGNNKTLL 1071.63 1071.63 0.00 0.039 
O70456 STLIMQLLR 1073.63 1073.62 0.00 0.005988024 
Q8VDD5 NIATLLHQSS 1082.57 1082.56 -0.01 0.015968064 
Q61598 SQIFISRAY 1083.57 1083.57 0.00 0.015968064 
P09411 KIQLINNML 1085.63 1085.62 0.00 0.015968064 
P62334 PLVYNMSHE 1088.50 1088.50 0.00 0.015968064 
P51150 VTAPNTFKTL 1090.60 1090.60 0.00 0.015968064 
P20357 MTRSTELGSD 1095.49 1095.54 0.06 0.008264462 
P60710 NGSGMCKAGFAG 1098.46 1098.46 0.00 0.094441123 
P01895 MELVETRPAG 1101.55 1101.55 0.00 0.057061341 
P61204 AVLLVFANKQ 1101.65 1101.65 0.00 0.0018 
O15355 FIQSKISQR 1105.62 1105.62 0.00 0.018 
O88342 ASKVVTVFSVA 1106.63 1106.63 0.00 0.015968064 
P26039 VVKLGAASLGAE 1113.64 1113.64 0.00 0.005988024 
O89053 SSIRYFEIT 1114.57 1114.56 0.00 0.057061341 
P18085 AVLLLFANKQ 1115.67 1115.67 0.00 0.011 
P10126 GSASGTTLLEAL 1118.58 1118.58 0.00 0.015968064 
P63017 GIFEVKSTAGD 1122.56 1122.56 0.01 0.008264462 
P35175 NYELHGYQT 1123.49 1123.50 0.00 0.054014597 
P07954 PKIANAIMKAA 1126.65 1126.65 -0.01 0.013 
Q05144 SKPVNLGLWD 1127.60 1127.58 -0.01 0.015968064 
Q8CEZ4 DKFQVFNIQ 1137.58 1136.63 -0.95 0.077120826 
P35527 VNVEINVAPGK 1138.63 1138.63 0.00 0.03 
P28063 LLYKYGEAAL 1139.62 1139.62 0.00 0.008264462 
P10809 LGKVGEVIVTK 1141.71 1141.70 -0.01 0.033 
P0CG49 TIENVKAKIQ 1142.67 1143.65 0.99 0.015968064 
Q6PE87 DTIKMQVYF 1143.56 1142.55 -1.02 0.039936103 
Q9Z1Q9 EAIALFQKML 1144.63 1144.63 0.00 0.04989605 
P26041 AVLEYLKIAQ 1146.66 1146.66 0.00 0.015968064 
Q9ET01 MEELEEIEE 1149.47 1149.48 0.01 0.032986112 
Q14566 PGAGSQHLEVR 1149.59 1149.59 0.00 0.026 
P08905 LSQYIRNCGV 1151.58 1151.58 0.00 0.008264462 
Q99729 AGKMFVGGLSW 1151.58 1151.57 -0.01 0.033 
Q8VCM7 YAMFRVGPES 1155.54 1155.55 0.01 0.015968064 
P68372 LVSEYQQYQ 1156.54 1157.43 0.89 0.053097345 
P35908 LEEALQQAKE 1157.59 1157.59 0.00 0.044 
P20591 PAAASHPLLLNG 1159.63 1159.63 0.00 0.0021 
Q8CIH5 MLLTKPTEASA 1160.61 1160.61 0.00 0.067385443 
O88569 YFEEYGKID 1162.52 1162.52 0.00 0.008264462 
P08071 KVEVLQQVLL 1167.72 1167.72 0.00 0.015968064 




P0CG49 QQRLIFAGKQ 1170.65 1170.65 0.00 0.033500839 
P36578 KAAAAAAALQAKS 1170.67 1170.67 0.00 0.0055 
P50990 TGANVVVTGGKVA 1171.66 1171.65 -0.01 0.0098 
P62310 GVVLVAPPLRVG 1175.74 1175.74 0.00 0.05 
P60710 IKEKLCYVAL 1178.67 1178.67 0.00 0.025341131 
P08030 ALEPGQRVVIV 1179.70 1179.70 0.00 0.054014597 
P19338 TTEETLKESF 1183.56 1183.56 -0.01 0.009 
P26039 SALSVVQNLEK 1186.66 1186.66 0.00 0.015968064 
Q01853 NSVVSLSQPKM 1188.62 1188.62 0.00 0.015968064 
Q3ULZ2 VQMLAKTGTED 1191.58 1193.32 1.74 0.074742265 
O88342 ASVKEWTITY 1196.61 1197.61 1.00 0.015564202 
P40124 VVGIVEIINSR 1197.71 1197.71 0.00 0.015968064 
P16858 NEYGYSNRVV 1199.56 1199.56 0.00 0.015968064 
P11276 EEVQIGHVPRG 1201.62 1201.62 0.00 0.015968064 
Q6P5F9 QGEVVREFMK 1204.59 1204.59 -0.01 0.044247788 
P17141 HRKSLSHSASD 1205.59 1206.50 0.92 0.083281539 
P29351 MLMESISTKGL 1208.61 1209.61 1.00 0.005988024 
P14618 PILYRPVAVAL 1210.74 1212.76 2.01 0.0079 
P62835 TAGTEQFTAMR 1211.56 1211.56 0.00 0.015968064 
P62314 PVQLETLSIRG 1211.69 1211.69 0.00 0.019 
P61226 TAGTEQFASMR 1213.54 1215.42 1.88 0.015968064 
P06732 VSPLLLASGMAR 1213.69 1213.68 -0.01 0.031 
Q8VHX6 SPFVVPVASLSD 1216.63 1218.34 1.71 0.069645204 
P06454 AAVDTSSEITTK 1221.61 1221.61 0.00 0.017 
P60709 GYALPHAILRL 1222.72 1222.71 -0.01 0.046 
P27870 QSLANYGRPKI 1228.66 1228.65 0.00 0.010309278 
P00505 PILGVTEAFKR 1229.71 1229.71 -0.01 0.00011 
P29351 QVTHIRIQNSG 1234.64 1235.64 1.00 0.015968064 
P06733 LLKTAIGKAGYT 1234.73 1234.72 -0.01 0.03 
O70566 ERSLLLLARAI 1235.77 1236.77 1.00 0.04989605 
Q8BZW8 DGAVKHLVGGER 1236.66 1236.71 0.05 0.066115702 
O75821 AARAIAGVSGFGY 1238.64 1238.64 -0.01 0.0011 
P52480 MVFASFIRKAA 1239.68 1239.68 0.00 0.040089087 
P0CG49 DTIENVKAKIQ 1239.68 1240.70 1.02 0.015968064 
P0CG49 TIENVKAKIQD 1239.68 1240.67 0.99 0.008264462 
P14618 GLISLQVKQKGA 1240.75 1240.74 -0.01 0.015 
Q68FD5 NAIITMMNHPT 1241.59 1241.59 0.00 0.015968064 
P52480 GLISLQVKEKGA 1241.73 1241.74 0.01 0.015968064 
P02538 AELSQMQTHIS 1243.59 1243.58 0.00 0.02 
P10126 TVAFVPISGWNG 1246.63 1246.64 0.00 0.027958993 
P04264 SIIAEVKAQYE 1249.66 1249.65 0.00 0.038 
P60842 VLEVTKKFMR 1249.72 1249.71 -0.01 0.044 
O54865 MMEIAGQVQVD 1251.55 1250.51 -1.03 0.054834057 
P00558 PVAVELKSLLGK 1252.78 1252.77 -0.01 0.00073 
P47738 SKYGLAAAVFTK 1254.70 1254.70 0.00 0.015968064 




P70399 DSQPESQVLEE 1259.55 1259.65 0.10 0.030195381 
P10809 KYKNIGAKLVQ 1260.76 1260.75 -0.01 0.025 
Q91VH6 SSVSYAAGALTVH 1261.63 1261.62 -0.01 0.015968064 
P25705 VPVGEELLGRVV 1265.73 1265.73 0.00 0.00042 
Q02053 LSSQFYLREE 1270.62 1270.62 0.00 0.015968064 
P19338 RETGSSKGFGFV 1270.63 1270.64 0.01 0.047 
Q9JKF1 VGRTLSALRSPD 1270.70 1270.70 0.00 0.096755162 
Q4VA53 PVLPARFFTQP 1271.70 1272.70 1.00 0.069498069 
Q9JHU4 EYEKLQVLLR 1271.72 1272.74 1.02 0.005988024 
P28838 PPLVFVGKGITF 1273.74 1273.74 0.00 0.01 
P40142 AIVQAVKGLVTKG 1282.80 1282.80 0.00 0.008264462 
P13010 IESKIQPGSQQA 1284.67 1284.67 0.00 0.038 
O35286 PLLERYGVIIL 1284.78 1284.78 0.00 0.04989605 
Q68FD5 AILGNQMFTHY 1293.62 1293.61 0.00 0.005988024 
P60710 IKEKLCYVALD 1293.70 1293.70 0.00 0.015968064 
Q641P0 ITYFIQQLLR 1293.74 1294.75 1.01 0.005988024 
P08030 ALEPGQRVVIVD 1294.72 1294.75 0.02 0.015968064 
Q3UZZ4 LVFLQTPRQPV 1296.76 1296.76 0.00 0.008264462 
P31146 PALTAEEWLGGR 1298.66 1298.67 0.01 0.000031 
P13020 ENPFAQGALRSE 1299.62 1300.62 1.00 0.015968064 
Q99KE1 PFYMGLYQKR 1301.66 1302.66 1.00 0.052313883 
P68104 NVGFNVKNVSVK 1303.72 1303.72 -0.01 0.018 
P60174 GAFTGEISPGMIK 1306.66 1306.66 0.00 0.044 
P10126 FIKNMITGTSQA 1309.67 1310.67 1.00 0.005988024 
Q9Y490 PETQVVLINAVK 1309.76 1309.76 0.00 0.0064 
P29401 AIAQAVRGLITKA 1310.80 1310.80 -0.01 0.034 
P28838 SVVLVGLGKKAAGI 1310.83 1310.82 -0.01 0.047 
Q8BV57 HLTQGPTPNHNP 1311.63 1309.63 -2.00 0.015968064 
P16858 NEYGYSNRVVD 1314.58 1315.70 1.12 0.008264462 
O08602 DESGVIMNKWK 1321.63 1319.66 -1.97 0.086294416 
P52480 PILYRPVAVALD 1325.77 1325.77 0.00 0.008264462 
P19096 PGSPELQQVLKH 1331.72 1332.72 1.00 0.005988024 
Q7TPV2 DSHGKSVSRLTF 1332.68 1333.62 0.94 0.044247788 
P60710 ESGPSIVHRKCF 1340.67 1340.67 0.00 0.008264462 
P39054 IEQSYINTNHE 1346.61 1346.62 0.01 0.015968064 
P40124 SPSKGAVPYVQAF 1349.70 1349.70 0.00 0.053097345 
Q4G5Y1 VPPSMSGSCAVCVD 1350.56 1349.84 -0.72 0.053691275 
P53396 VLINFASLRSAY 1352.75 1352.75 0.00 0.023 
Q9R111 SEIGNFEVGKEF 1354.64 1354.65 0.01 0.015968064 
P14174 PMFIVNTNVPRA 1357.72 1357.72 0.00 0.0097 
Q9D8N0 ECEQALAAEPKAK 1368.67 1368.67 0.00 0.015968064 
P10126 MRQTVAVGVIKAV 1370.81 1370.81 0.00 0.025341131 
P17182 VAASEFYRSGKY 1376.67 1376.66 -0.01 0.015968064 
P13645 ALEESNYELEGK 1380.64 1380.64 0.00 0.000018 
P62805 GVLKVFLENVIR 1385.84 1385.84 0.00 0.015 




P06745 NMFSGSKINYTE 1389.62 1389.62 0.00 0.015968064 
Q9CW03 QVSHRGALTGGYY 1390.66 1390.66 0.00 0.010309278 
P11276 VRSYTITGLQPGT 1391.74 1391.74 0.00 0.027958993 
P14625 RIMKAQAYQTGK 1393.75 1393.75 0.00 0.029 
Q9EQK5 PFPLYPGELLEK 1401.75 1401.75 0.00 0.052313883 
Q9WV04 EKYITSKINLVD 1403.77 1405.70 1.94 0.083281539 
P40240 EVIKELQEFYK 1406.74 1406.74 0.00 0.005988024 
P10126 MVPGKPMCVESFS 1410.63 1410.64 0.00 0.025341131 
P0CG49 QQRLIFAGKQLE 1412.78 1412.76 -0.01 0.005988024 
P26039 PVQLNLLYVQAR 1412.81 1412.80 -0.02 0.005988024 
Q99PI8 TPPGNGSGPRHIND 1417.67 1416.67 -1.00 0.084262699 
Q14697 PSVFNGPEVTMLK 1417.73 1418.73 1.01 0.0045 
P63017 QGNRTTPSYVAFT 1423.67 1423.68 0.00 0.088861838 
Q8VDM4 ELEMLVERLGEK 1426.75 1426.75 0.00 0.005988024 
Q9WV32 WAPESNRIVTCGT 1432.68 1432.69 0.01 0.082070708 
P02538 AAYMNKVELQAKA 1435.75 1435.75 0.00 0.019 
P27797 FGKFVLSSGKFYG 1435.75 1435.74 -0.01 0.022 
P25398 TALQEVLKTALIH 1435.84 1435.84 0.00 0.04 
P61978 LGGPIITTQVTIPK 1436.86 1436.86 0.00 0.000071 
Q8K0E8 PYKKGFGNIATNE 1437.73 1437.73 0.00 0.067385443 
P05386 KINALIKAAGVNVE 1438.85 1438.85 0.00 0.0076 
Q571I9 IAPLFPAGLVSVVTG 1439.84 1440.84 1.01 0.005988024 
P54577 LKNSVEVALNKLL 1439.87 1439.86 -0.01 0.025 
P30086 LSKWSGPLSLQEV 1442.78 1442.77 0.00 0.013 
Q8BTM8 QHIPGSPFTARVTG 1449.74 1449.73 0.00 0.040089087 
Q8VCZ7 SFQPGSPGHLGVIR 1450.77 1452.74 1.98 0.005988024 
P00558 GAKSVVLMSHLGRP 1450.81 1450.81 0.00 0.04 
P49720 AVSGMGVIVHIIEK 1451.82 1451.81 0.00 0.0074 
P31948 PAMRLILEQMQK 1456.79 1456.78 -0.01 0.03 
P31254 FIVAASNLRAENY 1466.75 1467.73 0.98 0.005988024 
P04264 VKKQISNLQQSIS 1471.84 1471.84 0.00 0.014 
Q8QZY1 QKVYELQASRVSS 1476.76 1476.76 0.01 0.015968064 
P62316 SVIVVLRNPLIAGK 1477.93 1477.93 0.00 0.00017 
P14866 SVQSAQRAKASLNGA 1486.79 1486.78 0.00 0.03 
P62880 IETGQQTVGFAGHSG 1487.70 1487.71 0.01 0.015968064 
Q80XK6 MGLLELTITAVKSD 1487.79 1487.81 0.02 0.008264462 
P17182 VAASEFYRSGKYD 1491.70 1491.71 0.01 0.008264462 
Q9DCD0 MQLICEAYHLMK 1494.70 1494.75 0.05 0.099357098 
Q8VDD5 LIEKPAGPPGILALL 1500.93 1500.92 0.00 0.010309278 
P55884 PPVPAQGEAPGEQAR 1502.75 1503.75 1.01 0.0053 
P06733 GAVEKGVPLYRHIA 1508.85 1508.84 -0.01 0.042 
Q3TEI4 FVPQTLGFPYARD 1509.76 1511.10 1.34 0.094441123 
P10809 AMKKVGRKGVITVK 1513.95 1514.95 1.00 0.0023 
P97384 VQELYAAGENRLGT 1519.76 1519.76 0.00 0.015968064 
P16858 APMFVMGVNHEKY 1521.71 1521.71 0.00 0.015968064 




Q8K557 GGGAGGGGAGGAGAAGAAGGGPD 1525.65 1526.56 0.91 0.040089087 
P0CG49 QQRLIFAGKQLED 1527.80 1528.79 0.99 0.008264462 
P38646 IKNVPFKIVRASNG 1541.90 1541.90 -0.01 0.019 
P35527 HKEEMSQLTGQNSG 1544.69 1544.69 0.00 0.031 
Q61830 FCKAIGGELASIKSK 1550.85 1550.86 0.01 0.040089087 
Q5RKZ7 DAPSGPGPTSNQLTHV 1558.74 1557.75 -0.99 0.015968064 
P49588 PVRVVSIGVPVSELL 1562.94 1562.94 0.00 0.019 
Q5SUA5 EALVGYVAKLTATPR 1569.89 1569.88 -0.01 0.005988024 
P11021 AGTIAGLNVMRIINE 1570.85 1570.85 0.00 0.0047 
P22626 GGGGNFGPGPGSNFRGGS 1577.70 1577.69 -0.01 0.017 
P62874 IETGQQTTTFTGHTG 1577.73 1577.75 0.02 0.015968064 
Q13148 AGWGNLVYVVNYPK 1578.82 1578.82 0.00 0.00079 
P30046 SWQIGKIGTVMTFL 1579.84 1580.85 1.01 0.019 
P00558 SLEPVAVELKSLLGK 1581.93 1581.93 0.00 0.0039 
Q96AB3 SGLLGLFQGQNSLLH 1582.85 1582.85 0.00 0.013 
P00558 PAKIEAFRASLSKLG 1586.91 1586.91 -0.01 0.00045 
Q9CQC9 ETIANVPILILGNKI 1588.95 1588.95 -0.01 0.005988024 
P60228 LVKVIQQESYTYK 1597.87 1598.87 1.00 0.022 
P23284 NFVALATGEKGFGYK 1600.82 1600.82 -0.01 0.0013 
P27797 DEFTHLYTLIVRP 1602.84 1604.85 2.01 0.0084 
P36536 ETISNVPILILGNKI 1604.95 1604.95 0.01 0.005988024 
O75531 KAYVVLGQFLVLKK 1605.00 1606.00 1.00 0.0036 
O08582 AGKSTLLGVLTHGELD 1609.87 1610.89 1.02 0.052313883 
P08865 VLKFLAAGTHLGGTNL 1610.91 1610.91 -0.01 0.0037 
Q9JHU4 PSGQATEFIMNEYK 1613.74 1612.88 -0.86 0.015968064 
P52597 PPLKFMSVQRPGPY 1615.85 1616.86 1.00 0.0013 
P40240 EPQRETLKAIHMAL 1617.87 1617.87 0.00 0.005988024 
P63017 AAKNQVAMNPTNTVF 1620.79 1620.80 0.01 0.015968064 
P06745 QYMHRFAAYFQQG 1628.72 1629.73 1.01 0.005988024 
P11276 AIPANGQTPVQRSISP 1634.87 1634.88 0.00 0.015968064 
P04264 LEIATYRTLLEGEE 1635.84 1635.83 0.00 0.047 
P49773 LGLNKGYRMVVNEGS 1635.84 1635.84 0.00 0.05 
P14174 PMFIVNTNVPRASVP 1640.87 1640.87 0.00 0.009 
P35527 AAIQKNYSPYYNTI 1644.81 1644.81 0.00 0.026 
P25398 VNTALQEVLKTALIH 1648.95 1648.95 0.00 0.046 
P28658 IVIAKLVGEEQLTKD 1654.95 1654.93 -0.02 0.066115702 
Q8BTM8 PTGQKGTVEPQLEARG 1666.86 1667.85 0.99 0.040089087 
Q07021 PELTSTPNFVVEVIK 1671.91 1671.90 0.00 0.028 
Q18PE0 MTEAALVEGQVKLRD 1674.86 1673.80 -1.06 0.010309278 
Q9Z2U1 PGAMSRPFGVALLFGGV 1674.89 1675.88 0.99 0.010309278 
P22314 SNGEQPLSAMVSMVTK 1677.81 1677.80 -0.01 0.011 
P62258 LVYQAKLAEQAERY 1680.88 1681.88 1.00 0.000068 
Q6NZK8 PYSTLVNSSGHAAHMD 1683.73 1681.76 -1.97 0.051515151 
Q9CR30 SRLNPHRSLLGTGNY 1683.88 1684.98 1.10 0.053097345 





P10853 TGISSKAMGIMNSFVN 1687.79 1688.78 0.99 0.015968064 
P42859 DPVPSLLPATTGALISH 1687.91 1688.84 0.92 0.062992126 
P70696 TGISSKAMSIMNSFVT 1688.81 1688.78 -0.03 0.067385443 
Q924K8 QFLVVARAVGTFARAL 1700.97 1700.99 0.02 0.005988024 
Q969H8 VRPGGVVHSFSHNVGPG 1701.87 1701.87 0.00 0.013 
P13796 SKAYYHLLEQVAPKG 1702.90 1702.90 0.00 0.022 
Q00610 VNTSAVQVLIEHIGNL 1705.94 1705.93 -0.01 0.019 
P68363 PYNSILTTHTTLEHS 1712.84 1712.83 -0.01 0.0022 
Q8VDW
0 EEPQAPQESTPAPPKK 1714.85 1714.86 0.01 0.069645204 
Q4VA53 QFAAPLKSLVATFIVK 1715.00 1716.00 1.00 0.005988024 
P10809 VQPHDLGKVGEVIVTK 1717.97 1717.96 -0.01 0.000093 
P53634 LLGTWVFQVGSSGSQR 1720.89 1720.89 0.00 0.000012 
Q62101 TEMALAEGQSGGAEMQD 1723.70 1723.82 0.12 0.094441123 
Q8BTM8 QATPTSPIRVKVEPSH 1728.92 1729.92 1.00 0.062992126 
Q8VDM4 EELRPLPVSVRVGQAV 1729.98 1729.98 0.00 0.005988024 
Q8BYH8 DLLRRGAYGAIMEEE 1737.84 1736.76 -1.07 0.096028455 
P35527 PAAIQKNYSPYYNTI 1741.87 1741.86 0.00 0.016 
P04075 KGVVPLAGTNGETTTQGL 1741.92 1741.91 -0.01 0.00096 
P68104 AAGAGKVTKSAQKAQKAK 1742.02 1742.01 0.00 0.0095 
Q9Z1Q5 EEIELAYEQVARALK 1742.92 1742.90 -0.02 0 
P11276 AIPANGQTPVQRSISPD 1749.90 1749.91 0.01 0.053097345 
P06454 LKEKKEVVEEAENGR 1756.93 1757.94 1.01 0.000064 
P62158 GQVNYEEFVQMMTAK 1773.81 1774.82 1.02 0.000031 
P17182 LYKSFVQNYPVVSIE 1784.93 1784.95 0.01 0.005988024 
P10853 TGISSKAMGIMNSFVND 1802.82 1802.82 0.01 0.008264462 
P62806 AVTYTEHAKRKTVTAM 1805.95 1805.93 -0.01 0.005988024 
P53396 LYFTYLEINPLVVTK 1812.01 1813.01 1.00 0.0052 
P23284 TNGSQFFITTVKTAWL 1812.94 1812.94 0.00 0.05 
P23284 VGRVIFGLFGKTVPKTV 1817.09 1817.09 0.00 0.032 
Q8BTM8 SLTKVATVPQHATSGPGPA 1817.96 1817.96 0.00 0.027958993 
O88569 SRGGGGNFGPGPGSNFRGGS 1820.83 1820.84 0.01 0.015968064 
A2BH40 GAESNGGGGGGGAGSGGGPGAEPD 1827.73 1827.88 0.15 0.058238637 
P60710 LYANTVLSGGTTMYPGIA 1827.91 1827.91 0.00 0.005988024 
Q8BFY9 QFPLPLKERLAAFYGV 1831.00 1832.01 1.00 0 
P40142 LAMFRSVPMSTVFYPS 1831.90 1832.90 1.00 0.005988024 
Q15056 PPYTAYVGNLPFNTVQG 1836.90 1836.90 0.00 0.0031 
P10809 KAQIEKRIQEIIEQL 1838.06 1838.06 0.00 0.037 
P62737 LYANNVLSGGTTMYPGIA 1840.90 1839.91 -0.99 0.005988024 
P56480 ATTVLSRAIAELGIYPAV 1844.04 1845.03 0.99 0.005988024 




O60361 GLNVVKTGRVMLGETNPA 1855.00 1856.00 1.00 0.005 
P68363 VNAAIATIKTKRSIQFV 1859.10 1859.09 -0.01 0.012 
P05387 YVASYLLAALGGNSSPSAK 1867.97 1867.97 0.00 0.00073 
P00558 KYSLEPVAVELKSLLGK 1873.09 1873.08 -0.01 0.00059 
Q99832 SVVAGGGAIEMELSKYLR 1878.99 1878.99 0.00 0.00019 
P23528 TLAEKLGGSAVISLEGKPL 1882.08 1882.08 0.00 0.000034 
P62806 VVYALKRQGRTLYGFGG 1884.04 1885.02 0.98 0.053691275 
P32969 IELVSNSAALIQQATTVK 1885.05 1886.05 1.00 0.00017 
P11672 STQNLIPAPSLLTVPLQP 1888.07 1889.07 1.00 0.005988024 
P28665 IVTVNSTGLAEVEMTVPD 1889.93 1889.96 0.03 0.053691275 
P35908 GLTAERTSQNSELNNMQ 1891.87 1892.87 1.00 0.015 
Q8BSN3 DATGVAESHAVVRRFLAQ 1908.00 1906.24 -1.76 0.081063963 
Q9NVP2 SVLVGPVPAGRHMFVFQA 1911.02 1911.02 0.00 0.021 
P26638 EKYLIATSEQPIAALHR 1921.04 1921.04 0.00 0.010309278 
P60709 TVPIYEGYALPHAILRL 1925.08 1925.07 -0.01 0.00022 
P09651 PEQLRKLFIGGLSFETT 1935.05 1936.04 0.99 0.035 
P62827 PNLEFVAMPALAPPEVVM 1939.98 1941.98 2.00 0.005988024 
P60710 LYANTVLSGGTTMYPGIAD 1942.93 1942.94 0.00 0.008264462 
Q9Z0U1 EAIYGPNTKMVRFKKGD 1951.00 1949.76 -1.23 0.083281539 
P43308 VVIGSTSAPGQGGILAQREF 1986.05 1986.04 -0.01 0.0044 
Q80TR8 AEIQKSALQIIINCVCGPD 1996.01 1996.07 0.06 0.053097345 
P68104 KKAAGAGKVTKSAQKAQKAK 1998.21 1998.21 0.00 0.00091 
Q99757 LAIEYEVSAVPTVLAMKNG 2004.06 2005.07 1.01 0.013 
P07237 GAAAESLVESSEVAVIGFFK 2010.03 2012.04 2.00 0.0022 
P04104 EINKRTNAENEFVTIKK 2015.08 2015.09 0.01 0.005988024 
P60174 GRKQSLGELIGTLNAAKVPA 2022.16 2022.16 0.00 0.0025 








P31948 PTNMTYITNQAAVYFEKG 2046.97 2047.97 1.00 0.000021 
C8YR32 DSNATLKNFRYHISVKTG 2050.06 2050.10 0.04 0.04989605 
P04406 GIVEGLMTTVHAITATQKTV 2069.12 2069.12 0.00 0.00063 




P09622 TKNILIATGSEVTPFPGITI 2071.16 2072.16 1.00 0.034 
P07858 IMAEIYKNGPVEGAFSVYS 2074.01 2074.01 0.00 0.003 
Q7TPD0 DLIRYICGVVHPSNEVLSS 2082.06 2080.57 -1.49 0.078255288 
P35527 LEMQYETLQEELMALKK 2096.05 2097.05 0.99 0.0052 
P10809 AAGVASLLTTAEVVVTEIPKE 2097.16 2098.15 0.99 0.026 
P07437 TVVEPYNATLSVHQLVENT 2113.07 2115.06 1.99 0.042 
P61088 ALQIRTVLLSIQALLSAPNP 2117.26 2118.26 1.01 0.00095 
P32969 IELVSNSAALIQQATTVKNK 2127.19 2127.19 0.00 0.000013 
P42765 LVEVNEAFAPQYLAVERSL 2147.13 2149.14 2.01 0.000002 
P06733 GNSEVILPVPAFNVINGGSHAG 2148.10 2148.09 -0.01 0.019 
P09104 GNSDLILPVPAFNVINGGSHAG 2148.10 2148.09 -0.01 0.014 
P05387 MRYVASYLLAALGGNSSPSAK 2155.11 2156.11 1.00 0.0000053 
P07737 AAVPGKTFVNITPAEVGVLVGK 2166.24 2166.24 0.00 0.00021 
Q14974 VVMASLLRMFQSTAGSGGVQE 2167.08 2168.09 1.02 0.014 
Q8VDP3 QLLGKANVVPEALQRFARAAA 2205.24 2206.23 0.99 0.052313883 
Q3V0Q1 DPKVLAATSLTGLLEKLQNCN 2209.18 2210.38 1.20 0.033500839 
P0CG49 MQIFVKTLTGKTITLEVEPS 2234.22 2250.22 16.00 1.67E-20 
Q9NSE4 KVASVASTLETTFETISTLSGV 2240.18 2241.18 1.00 0.0011 
Q61464 DILVLSSHKKAYIEINKKSA 2256.28 2254.54 -1.75 0.069645204 
Q9Z2I8 DATQVEVNPFGETPEGQVVCF 2265.03 2264.20 -0.83 0.075471698 








Q12905 LAPNSAEQASILSLVTKINNVI 2294.28 2294.27 -0.01 0.036 
P60710 FEQEMATAASSSSLEKSYELP 2304.05 2304.05 0.00 0.005988024 
P62737 FENEMATAASSSSLEKSYELP 2306.03 2305.05 -0.97 0.079155673 
P60709 GVTHTVPIYEGYALPHAILRL 2319.27 2320.27 0.99 0.0013 
P04406 NFGIVEGLMTTVHAITATQKTV 2330.23 2331.22 0.99 0.000024 











P10809 AAGVASLLTTAEVVVTEIPKEEK 2354.29 2355.29 0.99 0.000087 
Q99NB5 SIPIQKGSVLAYKKQQLVIED 2356.34 2355.13 -1.21 0.051515151 
P07437 RISVYYNEATGGKYVPRAILV 2368.29 2368.28 -0.01 0.018 
P97504 DVWAFGILMWEVFSLGKQPY 2383.17 2382.92 -0.25 0.074742265 
A7XUY5 RIHSILKSSSVQKETKNLLLD 2390.36 2390.30 -0.06 0.059154928 
P60710 FEQEMATAASSSSLEKSYELPD 2419.07 2419.08 0.01 0.015968064 
P60710 GVTHTVPIYEGYALPHAILRLD 2434.30 2435.31 1.00 0.066115702 
P60709 DGVTHTVPIYEGYALPHAILRL 2434.30 2434.29 -0.01 0.021 
P14649 VMRALGQNPTNAEVLKVLGNPKS 2435.33 2435.33 0.00 0.033 
P52480 FLVTEVENGGSLGSKKGVNLPGAAV 2442.31 2443.31 1.00 0.005988024 
P06744 PSAVAKHFVALSTNTTKVKEFGI 2444.34 2444.33 -0.01 0.0086 








Q9ES18 GGAVAAGAPGQESTEGAPPLYNTNHD 2462.11 2462.52 0.41 0.025341131 
P97311 EFSPRAVYTSGKASSAAGLTAAVVR 2477.30 2478.32 1.02 0.005988024 
P08107 AGVIAGLNVLRIINEPTAAAIAYGL 2479.42 2479.41 0.00 0.031 
P35527 GGILTANEKSTMQELNSRLASYL 2495.27 2495.26 -0.01 0.00052 
P38646 AGQISGLNVLRVINEPTAAALAYGL 2510.39 2510.38 -0.01 0.026 
P07737 SVWAAVPGKTFVNITPAEVGVLVGK 2538.42 2538.42 -0.01 0.0012 
P47857 MTHEEHHAAKTLGIGKAIAVLTSGG 2544.31 2544.44 0.13 0.040089087 
Q60592 DFGLSKIGLMSLTTNLYEGHIEK 2581.31 2580.11 -1.20 0.047413793 
P84244 LRFQSAAIGALQEASEAYLVGLFE 2582.34 2582.33 -0.01 0.005988024 
O76021 SASASLSSAAATGTSTSTPAAPTARKQL 2590.32 2591.32 1.00 0.000017 
P62249 PRTLQYKLLEPVLLLGKERFAGV 2639.55 2639.56 0.01 0.0098 
P14866 NQIYIAGHPAFVNYSTSQKISRPG 2647.35 2647.34 -0.01 0.019 
P62737 EAQSKRGILTLKYPIEHGIITNW 2648.44 2648.44 -0.01 0.005988024 
P84228 LRFQSSAVMALQEASEAYLVGLFE 2658.34 2658.34 0.01 0.005988024 
B1AUH1 MVNASQHAPGQRAHIIFQTLSEND 2663.29 2662.31 -0.98 0.053691275 
P08708 FGSLSNLQVTQPTVGMNFKTPRGPV 2674.39 2674.39 0.00 0.0014 




Q9D2G5 FGVFAKGENVSPRFQKGTLRMNCL 2714.38 2714.96 0.59 0.079233229 
P68104 GQTREHALLAYTLGVKQLIVGVNKM 2738.53 2738.52 -0.01 0.0000051 
P04264 KVRFLEQQNQVLQTKWELLQQV 2754.52 2754.52 0.00 0.013 








P06733 LFTSKGLFRAAVPSGASTGIYEALELR 2853.54 2853.53 -0.01 0.033 
P04908 VGAGAPVYLAAVLEYLTAEILELAGNAAR 2914.58 2915.59 1.01 0.00000011 
P04264 FLEQQNQVLQTKWELLQQVDTSTR 2931.51 2932.50 0.99 0.01 
Q16777 VGAGAPVYMAAVLEYLTAEILELAGNAAR 2932.54 2932.53 -0.01 0.0018 








P62266 GVRFKVVKVANVSLLALYKGKKERPRS 3041.83 3041.83 -0.01 0.0029 
Q61171 SQFTHLAWINTPRKEGGLGPLNIPLLAD 3057.64 3056.95 -0.69 0.005988024 
P04264 IAQKSKAEAESLYQSKYEELQITAGRHG 3134.60 3135.60 1.00 0.0042 
P31949 GYNYTLSKTEFLSFMNTELAAFTKNQK 3145.54 3146.55 1.01 0.012 
P24752 VMVAGGMESMSNVPYVMNRGSTPYGGVKLE 3159.49 3161.48 1.99 0.0026 
Q8CGP0 DGKKRKRGRKESYSIYV
YKVLKQVHP 








P14618 TKGPEIRTGLIKGSGTAEVELKKGATLKITL 3208.88 3208.86 -0.02 0.017 





























3667.99 3668.97 0.98 0.0029 
P06745 MAALTRNPQFQKLLEW
HRANSANLKLRELFEA 



































































1.  Wilkins, M., Proteomics data mining. Expert Review of Proteomics 2009, 6 (6), 
599-603. 
2.  Geiger, T.; Wehner, A.; Schaab, C.; Cox, J.; Mann, M., Comparative Proteomic 
Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression 
of Most Proteins. Molecular & Cellular Proteomics 2012, 11 (3), M111.014050–1- 
M111.014050–11. 
3.  Whitehouse, C. M.; Dreyer, R. N.; Yamashita, M.; Fenn, J. B., Electrospray 
interface for liquid chromatographs and mass spectrometers. Analytical Chemistry 
1985, 57 (3), 675-679. 
4.  Tanaka, K.; Waki, H.; Ido, Y.; Akita, S.; Yoshida, Y.; Yoshida, T.; Matsuo, T., 
Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight 
mass spectrometry. Rapid Communications in Mass Spectrometry 1988, 2 (8), 151-
153. 
5.  The Nobel Prize in Chemistry 2002 at www.Nobelprize.org. 
6.  Dobo, A.; Kaltashov, I. A., Detection of Multiple Protein Conformational 
Ensembles in Solution via Deconvolution of Charge-State Distributions in ESI MS. 
Analytical Chemistry 2001, 73 (20), 4763-4773. 
7.  Paul, W.; Steinwedel, H., Ein neues Massenspektrometer ohne Magnetfeld. 
Zeitschrift Naturforschung A 1953, 8 (7), 448-450. 




9.  Stafford Jr, G. C.; Kelley, P. E.; Syka, J. E. P.; Reynolds, W. E.; Todd, J. F. J., 
Recent improvements in and analytical applications of advanced ion trap technology. 
International Journal of Mass Spectrometry and Ion Processes 1984, 60 (1), 85-98. 
10.  McLuckey, S.; Mentinova, M., Ion/Neutral, Ion/Electron, Ion/Photon, and 
Ion/Ion Interactions in Tandem Mass Spectrometry: Do We Need Them All? Are 
They Enough? Journal of the American Society for Mass Spectrometry 2011, 22 (1), 
3-12. 
11.  Hunt, D. F.; Yates, J. R.; Shabanowitz, J.; Winston, S.; Hauer, C. R., Protein 
sequencing by tandem mass spectrometry. Proceedings of the National Academy of 
Sciences 1986, 83 (17), 6233-6237. 
12.  Makarov, A., Electrostatic Axially Harmonic Orbital Trapping: A High-
Performance Technique of Mass Analysis. Analytical Chemistry 2000, 72 (6), 1156-
1162. 
13.  Perry, R. H.; Cooks, R. G.; Noll, R. J., Orbitrap mass spectrometry: 
Instrumentation, ion motion and applications. Mass Spectrometry Reviews 2008, 27 
(6), 661-699. 
14.  Gucinski, A. C.; Dodds, E. D.; Li, W.; Wysocki, V. H.; Hubbard, S. J.; Jones, A. 
R., Understanding and Exploiting Peptide Fragment Ion Intensities Using 
Experimental and Informatic Approaches 
Proteome Bioinformatics. Walker, J. M., Ed. Humana Press: 2010; Vol. 604, 73-94. 
15.  Wysocki, V. H.; Tsaprailis, G.; Smith, L. L.; Breci, L. A., Mobile and localized 
protons: a framework for understanding peptide dissociation. Journal of Mass 




16.  Kelleher, N. L.; Lin, H. Y.; Valaskovic, G. A.; Aaserud, D. J.; Fridriksson, E. K.; 
McLafferty, F. W., Top Down versus Bottom Up Protein Characterization by Tandem 
High-Resolution Mass Spectrometry. Journal of the American Chemical Society 
1999, 121 (4), 806-812. 
17.  Ge, Y.; Lawhorn, B. G.; ElNaggar, M.; Strauss, E.; Park, J.-H.; Begley, T. P.; 
McLafferty, F. W., Top Down Characterization of Larger Proteins (45 kDa) by 
Electron Capture Dissociation Mass Spectrometry. Journal of the American Chemical 
Society 2002, 124 (4), 672-678. 
18.  Compton, P. D.; Zamdborg, L.; Thomas, P. M.; Kelleher, N. L., On the 
Scalability and Requirements of Whole Protein Mass Spectrometry. Analytical 
Chemistry 2011, 83 (17), 6868-6874. 
19.  Wynne, C.; Fenselau, C.; Demirev, P. A.; Edwards, N., Top-Down Identification 
of Protein Biomarkers in Bacteria with Unsequenced Genomes. Analytical Chemistry 
2009, 81 (23), 9633-9642. 
20.  Tran, J. C.; Zamdborg, L.; Ahlf, D. R.; Lee, J. E.; Catherman, A. D.; Durbin, K. 
R.; Tipton, J. D.; Vellaichamy, A.; Kellie, J. F.; Li, M.; Wu, C.; Sweet, S. M. M.; 
Early, B. P.; Siuti, N.; LeDuc, R. D.; Compton, P. D.; Thomas, P. M.; Kelleher, N. L., 
Mapping intact protein isoforms in discovery mode using top-down proteomics. 
Nature 2011, 480 (7376), 254-258. 
21.  Wu, C.; Tran, J. C.; Zamdborg, L.; Durbin, K. R.; Li, M.; Ahlf, D. R.; Early, B. 
P.; Thomas, P. M.; Sweedler, J. V.; Kelleher, N. L., A protease for 'middle-down' 




22.  Cannon, J.; Lohnes, K.; Wynne, C.; Wang, Y.; Edwards, N.; Fenselau, C., High-
throughput middle-down analysis using an orbitrap. Journal of Proteome Research 
2010, 9 (8), 3886-3890. 
23.  Yates, J. R.; Eng, J. K.; McCormack, A. L., Mining Genomes: Correlating 
Tandem Mass Spectra of Modified and Unmodified Peptides to Sequences in 
Nucleotide Databases. Analytical Chemistry 1995, 67 (18), 3202-3210. 
24.  Yates, J. R.; Eng, J. K.; McCormack, A. L.; Schieltz, D., Method to Correlate 
Tandem Mass Spectra of Modified Peptides to Amino Acid Sequences in the Protein 
Database. Analytical Chemistry 1995, 67 (8), 1426-1436. 
25.  Perkins, D. N.; Pappin, D. J. C.; Creasy, D. M.; Cottrell, J. S., Probability-based 
protein identification by searching sequence databases using mass spectrometry data. 
Electrophoresis 1999, 20 (18), 3551-3567. 
26.  Senko, M.; Beu, S.; McLafferty, F., Automated assignment of charge states from 
resolved isotopic peaks for multiply charged ions. Journal of the American Society 
for Mass Spectrometry 1995, 6 (1), 52-56. 
27.  Wynne, C.; Edwards, N. J.; Fenselau, C., Phyloproteomic classification of 
unsequenced organisms by top-down identification of bacterial proteins using capLC-
MS/MS on an Orbitrap. Proteomics 2010, 10 (20), 3631-3643. 
28.  Lee, J.-E.; Kwon, J.; Baek, M.-C., A combination method of chemical with 
enzyme reactions for identification of membrane proteins. Biochimica et Biophysica 




29.  Drapeau, G. R., Substrate specificity of a proteolytic enzyme isolated from a 
mutant of Pseudomonas fragi. Journal of Biological Chemistry 1980, 255 (3), 839-
840. 
30.  Alam, A.; Mataj, A.; Yang, Y.; Boysen, R. I.; Bowden, D. K.; Hearn, M. T., 
Rapid Microwave-Assisted Chemical Cleavage - Mass Spectrometric Method for the 
Identification of Hemoglobin Variants in Blood. Analytical Chemistry 2010, 82 (21), 
8922-8930. 
31.  Wu, S. L.; Kim, J.; Bandle, R. W.; Liotta, L.; Petricoin, E.; Karger, B. L., 
Dynamic profiling of the post-translational modifications and interaction partners of 
epidermal growth factor receptor signaling after stimulation by epidermal growth 
factor using Extended Range Proteomic Analysis (ERPA). Molecular & Cellular 
Proteomics 2006, 5 (9), 1610-1627. 
32.  Wu, S. L.; Kim, J.; Hancock, W. S.; Karger, B., Extended Range Proteomic 
Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage 
of complex proteins with extensive post-translational modifications-comprehensive 
analysis of beta-casein and epidermal growth factor receptor (EGFR). Journal of 
Proteome Research 2005, 4 (4), 1155-1170. 
33.  Zhang, J.; Wu, S. L.; Kim, J.; Karger, B. L., Ultratrace liquid 
chromatography/mass spectrometry analysis of large peptides with post-translational 
modifications using narrow-bore poly(styrene-divinylbenzene) monolithic columns 





34.  Kocher, T.; Swart, R.; Mechtler, K., Ultra-High-Pressure RPLC Hyphenated to 
an LTQ-Orbitrap Velos Reveals a Linear Relation between Peak Capacity and 
Number of Identified Peptides. Analytical Chemistry 2011, 83 (7), 2699-2704. 
35.  Swatkoski, S.; Gutierrez, P.; Wynne, C.; Petrov, A.; Dinman, J. D.; Edwards, N.; 
Fenselau, C., Evaluation of microwave-accelerated residue-specific acid cleavage for 
proteomic applications. Journal of Proteome Research 2008, 7 (2), 579-586. 
36.  Schultz, J.; Allison, H.; Grice, M., Specificity of the Cleavage of Proteins by 
Dilute Acid. I. Release of Aspartic Acid from Insulin, Ribonuclease, and Glucagon*. 
Biochemistry 1962, 1 (4), 694-698. 
37.  Inglis, A. S.; C.H.W. Hirs, S. N. T., Cleavage at aspartic acid. In Methods in 
Enzymology, Academic Press: 1983; Vol. Volume 91, pp 324-332. 
38.  Li, A.; Sowder, R. C.; Henderson, L. E.; Moore, S. P.; Garfinkel, D. J.; Fisher, R. 
J., Chemical cleavage at aspartyl residues for protein identification. Analytical 
Chemistry 2001, 73 (22), 5395-5402. 
39.  Swatkoski, S.; Russell, S. C.; Edwards, N.; Fenselau, C., Rapid chemical 
digestion of small acid-soluble spore proteins for analysis of Bacillus spores. 
Analytical Chemistry 2006, 78 (1), 181-188. 
40.  Hua, L.; Low, T. Y.; Sze, S. K., Microwave-assisted specific chemical digestion 
for rapid protein identification. Proteomics 2006, 6 (2), 586-591. 
41.  Bruice, T. C.; Pandit, U. K., The Effect of Geminal Substitution Ring Size and 
Rotamer Distribution on the Intramolecular Nucleophilic Catalysis of the Hydrolysis 
of Monophenyl Esters of Dibasic Acids and the Solvolysis of the Intermediate 




42.  Xie, M.; Vander Velde, D.; Morton, M.; Borchardt, R. T.; Schowen, R. L., pH-
Induced Change in the Rate-Determining Step for the Hydrolysis of the Asp/Asn-
Derived Cyclic-Imide Intermediate in Protein Degradation. Journal of the American 
Chemical Society 1996, 118 (37), 8955-8956. 
43.  Swatkoski, S.; Gutierrez, P.; Ginter, J.; Petrov, A.; Dinman, J. D.; Edwards, N.; 
Fenselau, C., Integration of residue-specific acid cleavage into proteomic workflows. 
Journal of Proteome Research 2007, 6 (11), 4525-4527. 
44.  Hauser, N. J.; Basile, F., Online microwave D-cleavage LC-ESI-MS/MS of intact 
proteins: site-specific cleavages at aspartic acid residues and disulfide bonds. Journal 
of Proteome Research 2008, 7 (3), 1012-1026. 
45.  Tsugita, A.; Miyazaki, K.; Nabetani, T.; Nozawa, T.; Kamo, M.; Kawakami, T., 
Application of chemical selective cleavage methods to analyze post-translational 
modification in proteins. Proteomics 2001, 1 (9), 1082-1091. 
46.  Basile, F.; Hauser, N., Rapid online nonenzymatic protein digestion combining 
microwave heating acid hydrolysis and electrochemical oxidation. Analytical 
Chemistry 2011, 83 (1), 359-367. 
47.  Fenselau, C.; Laine, O.; Swatkoski, S., Microwave assisted acid cleavage for 
denaturation and proteolysis of intact human adenovirus. International Journal of 
Mass Spectrometry 2011, 301 (1-3), 7-11. 
48.  Hauser, N. J.; Han, H.; McLuckey, S. A.; Basile, F., Electron transfer 
dissociation of peptides generated by microwave D-cleavage digestion of proteins. 




49.  Li, J.; Shefcheck, K.; Callahan, J.; Fenselau, C., Extension of microwave-
accelerated residue-specific acid cleavage to proteins with carbohydrate side chains 
and disulfide linkages. International Journal of mass Spectrometry 2008, 278 (2-3), 
109-113. 
50.  Osula, O.; Swatkoski, S.; Cotter, R. J., Identification of protein SUMOylation 
sites by mass spectrometry using combined microwave-assisted aspartic acid 
cleavage and tryptic digestion. Journal of Mass Spectrometry 2012, 47 (5), 644-654. 
51.  Swatkoski, S.; Russell, S.; Edwards, N.; Fenselau, C., Analysis of a model virus 
using residue-specific chemical cleavage and MALDI-TOF mass spectrometry. 
Analytical Chemistry 2007, 79 (2), 654-658. 
52.  Remily-Wood, E.; Dirscherl, H.; Koomen, J., Acid hydrolysis of proteins in 
matrix assisted laser desorption ionization matrices. Journal of the American Society 
for Mass Spectrometry 2009, 20 (11), 2106-2115. 
53.  Yassine, M. M.; Guo, N.; Zhong, H.; Li, L.; Lucy, C. A., Off-line coupling of 
preparative capillary zone electrophoresis with microwave-assisted acid hydrolysis 
and matrix-assisted laser desorption ionization mass spectrometry for protein 
sequencing. Analytica Chimica Acta 2007, 597 (1), 41-49. 
54.  Zhong, H.; Marcus, S.; Li, L., Microwave-assisted acid hydrolysis of proteins 
combined with liquid chromatography MALDI MS/MS for protein identification. 
Journal of the American Society for Mass Spectrometry 2005, 16 (4), 471-481. 
55.  Lidstrom, P.; Tierney, J.; Wathey, B.; Westman, J., Microwave assisted organic 




56.  Choksawangkarn, W.; Edwards, N.; Wang, Y.; Gutierrez, P.; Fenselau, C., 
Comparative Study of Workflows Optimized for In-gel, In-solution, and On-filter 
Proteolysis in the Analysis of Plasma Membrane Proteins. Journal of Proteome 
Research 2012, 11 (5), 3030-3034. 
57.  Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M., Universal sample 
preparation method for proteome analysis. Nat Meth 2009, 6 (5), 359-362. 
58.  Wessel, D.; Flugge, U. I., A method for the quantitative recovery of protein in 
dilute solution in the presence of detergents and lipids. Analytical Biochemistry 1984, 
138 (1), 141-143. 
59.  Shevchenko, A.; Tomas, H.; Havlis, J.; Olsen, J. V.; Mann, M., In-gel digestion 
for mass spectrometric characterization of proteins and proteomes. Nat. Protocols 
2007, 1 (6), 2856-2860. 
60.  Edwards, N.; Wu, X.; Tseng, C.-W., An Unsupervised, Model-Free, Machine-
Learning Combiner for Peptide Identifications from Tandem Mass Spectra. Clinical 
Proteomics 2009, 5 (1), 23-36. 
61.  Fenselau, C.; Havey, C.; Teerakulkittipong, N.; Swatkoski, S.; Laine, O.; 
Edwards, N., Identification of beta-lactamase in antibiotic-resistant Bacillus cereus 
spores. Applied and Environmental Microbiology 2008, 74 (3), 904-906. 
62.  Mirza, U. A.; Liu, Y.-H.; Tang, J. T.; Porter, F.; Bondoc, L.; Chen, G.; Pramanik, 
B. N.; Nagabhushan, T. L., Extraction and characterization of adenovirus proteins 
from sodium dodecylsulfate polyacrylamide gel electrophoresis by matrix-assisted 
laser desorption/ionization mass spectrometry. Journal of the American Society for 




63.  Cannon, J.; Edwards, N.; Fenselau, C., Middle-out proteomic analysis using site-
selective acid cleavage and mass biased partitioning. Submitted 2012. 
64.  Meyer, B.; Papasotiriou, D.; Karas, M., 100% protein sequence coverage: a 
modern form of surrealism in proteomics. Amino Acids 2011, 41 (2), 291-310. 
65.  Boyne, M. T.; Garcia, B. A.; Li, M.; Zamdborg, L.; Wenger, C. D.; Babai, S.; 
Kelleher, N. L., Tandem Mass Spectrometry with Ultrahigh Mass Accuracy Clarifies 
Peptide Identification by Database Retrieval. Journal of Proteome Research 2008, 8 
(1), 374-379. 
66.  Syka, J. E. P.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt, D. F., Peptide 
and protein sequence analysis by electron transfer dissociation mass spectrometry. 
Proceedings of the National Academy of Sciences of the United States of America 
2004, 101 (26), 9528-9533. 
67.  Taouatas, N.; Heck, A. J. R.; Mohammed, S., Evaluation of 
Metalloendopeptidase Lys-N Protease Performance under Different Sample Handling 
Conditions. Journal of Proteome Research 2010, 9 (8), 4282-4288. 
68.  Rahbar, A. M.; Fenselau, C., Integration of Jacobson's Pellicle Method into 
Proteomic Strategies for Plasma Membrane Proteins. Journal of Proteome Research 
2004, 3 (6), 1267-1277. 
69.  Scherl, A.; Shaffer, S. A.; Taylor, G. K.; Kulasekara, H. D.; Miller, S. I.; 
Goodlett, D. R., Genome-specific gas-phase fractionation strategy for improved 





70.  Yi, E. C.; Marelli, M.; Lee, H.; Purvine, S. O.; Aebersold, R.; Aitchison, J. D.; 
Goodlett, D. R., Approaching complete peroxisome characterization by gas-phase 
fractionation. Electrophoresis 2002, 23 (18), 3205-3216. 
71.  Lee, J.; Kellie, J.; Tran, J.; Tipton, J.; Catherman, A.; Thomas, H.; Ahlf, D.; 
Durbin, K.; Vellaichamy, A.; Ntai, I.; Marshall, A.; Kelleher, N., A robust two-
dimensional separation for top-down tandem mass spectrometry of the low-mass 
proteome. Journal of the American Society for Mass Spectrometry 2009, 20 (12), 
2183-2191. 
72.  Han, X.; Jin, M.; Breuker, K.; McLafferty, F. W., Extending Top-Down Mass 
Spectrometry to Proteins with Masses Greater Than 200 Kilodaltons. Science 2006, 
314 (5796), 109-112. 
73.  Bondarenko, P.; Second, T.; Zabrouskov, V.; Makarov, A.; Zhang, Z., Mass 
measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a 
hybrid linear quadrupole ion trap-orbitrap mass spectrometer. Journal of the 
American Society for Mass Spectrometry 2009, 20 (8), 1415-1424. 
74.  Garcia, B. A.; Pesavento, J. J.; Mizzen, C. A.; Kelleher, N. L., Pervasive 
combinatorial modification of histone H3 in human cells. Nat Meth 2007, 4 (6), 487-
489. 
75.  Taverna, S. D.; Ueberheide, B. M.; Liu, Y.; Tackett, A. J.; Diaz, R. L.; 
Shabanowitz, J.; Chait, B. T.; Hunt, D. F.; Allis, C. D., Long-distance combinatorial 
linkage between methylation and acetylation on histone H3 N termini. Proceedings of 




76.  Chi, A.; Bai, D. L.; Geer, L. Y.; Shabanowitz, J.; Hunt, D. F., Analysis of intact 
proteins on a chromatographic time scale by electron transfer dissociation tandem 
mass spectrometry. International Journal of Mass Spectrometry 2007, 259 (1), 197-
203. 
77.  Hohmann, L.; Sherwood, C.; Eastham, A.; Peterson, A.; Eng, J. K.; Eddes, J. S.; 
Shteynberg, D.; Martin, D. B., Proteomic Analyses Using Grifola frondosa 
Metalloendoprotease Lys-N. Journal of Proteome Research 2009, 8 (3), 1415-1422. 
78.  Vestling, M. M.; Fenselau, C., Poly(vinylidene difluoride) membranes as the 
interface between laser desorption mass spectrometry, gel electrophoresis, and in situ 
proteolysis. Analytical Chemistry 1994, 66 (4), 471-477. 
79.  The Nobel Prize in Chemistry 2009 at www.Nobelprize.org. 
80.  Dinman, J. D., University of Maryland private communication. 2008. 
81.  Hardy, S. J. S.; Kurland, C. G.; Voynow, P.; Mora, G., The ribosomal proteins of 
Escherichia coli. I. Purification of the 30s ribosomal proteins. Biochemistry 1969, 8 
(7), 2897-2905. 
82.  Nakao, A.; Yoshihama, M.; Kenmochi, N., RPG: the Ribosomal Protein Gene 
database. Nucleic Acids Research 2004, 32 (suppl 1), D168-D170. 
83.  Kenmochi, N.; Kawaguchi, T.; Rozen, S.; Davis, E.; Goodman, N.; Hudson, T. 
J.; Tanaka, T.; Page, D. C., A Map of 75 Human Ribosomal Protein Genes. Genome 
Research 1998, 8 (5), 509-523. 
84.  Li, W.; Ye, Y., Polyubiquitin chains: functions, structures, and mechanisms. Cell 




85.  Xu, G.; Paige, J. S.; Jaffrey, S. R., Global analysis of lysine ubiquitination by 
ubiquitin remnant immunoaffinity profiling. Nat Biotech 2010, 28 (8), 868-873. 
86.  Mirzaei, H.; Rogers, R. S.; Grimes, B.; Eng, J.; Aderem, A.; Aebersold, R., 
Characterizing the connectivity of poly-ubiquitin chains by selected reaction 
monitoring mass spectrometry. Molecular BioSystems 2010, 6 (10), 2004-2014. 
87.  Kim, H. T.; Kim, K. P.; Lledias, F.; Kisselev, A. F.; Scaglione, K. M.; Skowyra, 
D.; Gygi, S. P.; Goldberg, A. L., Certain pairs of ubiquitin-conjugating enzymes 
(E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin 
chains containing all possible isopeptide linkages. J Biol Chem 2007, 282 (24), 
17375-17386. 
88.  Jung, J.; Pierson, N.; Marquardt, A.; Scheffner, M.; Przybylski, M.; Clemmer, D., 
Differentiation of Compact and Extended Conformations of Di-Ubiquitin Conjugates 
with Lysine-Specific Isopeptide Linkages by Ion Mobility-Mass Spectrometry. 
Journal of the American Society for Mass Spectrometry 2011, 22 (8), 1463-1471. 
89.  Strachan, J.; Roach, L.; Sokratous, K.; Tooth, D.; Long, J.; Garner, T. P.; Searle, 
M. S.; Oldham, N. J.; Layfield, R., Insights into the Molecular Composition of 
Endogenous Unanchored Polyubiquitin Chains. Journal of Proteome Research 2012, 
11 (3), 1969-1980. 
90.  Pickart, C. M.; Raasi, S.; Raymond, J. D., Controlled Synthesis of Polyubiquitin 
Chains. In Methods in Enzymology, Academic Press: 2005; Vol. Volume 399, pp 21-
36. 
91.  Dong, K. C.; Helgason, E.; Yu, C.; Phu, L.; Arnott, D. P.; Bosanac, I.; Compaan, 




E. C., Preparation of Distinct Ubiquitin Chain Reagents of High Purity and Yield. 
Structure 2011, 19 (8), 1053-1063. 
92.  Johnston, S. C.; Riddle, S. M.; Cohen, R. E.; Hill, C. P., Structural basis for the 
specificity of ubiquitin C-terminal hydrolases. EMBO J 1999, 18 (14), 3877-3887. 
93.  Cornilescu, G.; Marquardt, J. L.; Ottiger, M.; Bax, A., Validation of Protein 
Structure from Anisotropic Carbonyl Chemical Shifts in a Dilute Liquid Crystalline 
Phase. Journal of the American Chemical Society 1998, 120 (27), 6836-6837. 
94.  Saville, M. K.; Sparks, A.; Xirodimas, D. P.; Wardrop, J.; Stevenson, L. F.; 
Bourdon, J. C.; Woods, Y. L.; Lane, D. P., Regulation of p53 by the ubiquitin-
conjugating enzymes UbcH5B/C in vivo. J Biol Chem 2004, 279 (40), 42169-42181. 
95.  Li, W.; Ye, Y., Polyubiquitin chains: functions, structures, and mechanisms. 
Cellular and Molecular Life Sciences 2008, 65 (15), 2397-2406. 
96.  Mathivanan, S.; Ji, H.; Simpson, R. J., Exosomes: Extracellular organelles 
important in intercellular communication. Journal of Proteomics 2010, 73 (10), 1907-
1920. 
97.  Raimondo, F.; Morosi, L.; Chinello, C.; Magni, F.; Pitto, M., Advances in 
membranous vesicle and exosome proteomics improving biological understanding 
and biomarker discovery. Proteomics 2011, 11 (4), 709-720. 
98.  Dennis, G.; Sherman, B.; Hosack, D.; Yang, J.; Gao, W.; Lane, H.; Lempicki, R., 
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome 




99.  Nicklay, J. J.; Shechter, D.; Chitta, R. K.; Garcia, B. A.; Shabanowitz, J.; Allis, 
C. D.; Hunt, D. F., Analysis of Histones in Xenopus laevis. Journal of Biological 
Chemistry 2009, 284 (2), 1075-1085. 
100.  Grazini, U.; Zanardi, F.; Citterio, E.; Casola, S.; Goding, C. R.; McBlane, F., 
The RING Domain of RAG1 Ubiquitylates Histone H3: A Novel Activity in 
Chromatin-Mediated Regulation of V(D)J Joining. Molecular cell 2010, 37 (2), 282-
293. 
101.  Schatz, D. G.; Swanson, P. C., V(D)J Recombination: Mechanisms of Initiation. 
Annual Review of Genetics 2011, 45 (1), 167-202. 
102.  Mombaerts, P.; Iacomini, J.; Johnson, R. S.; Herrup, K.; Tonegawa, S.; 
Papaioannou, V. E., RAG-1-deficient mice have no mature B and T lymphocytes. 
Cell 1992, 68 (5), 869-877. 
103.  Huang, J.; Chen, J., VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase 
complex for degradation. Oncogene 2008, 27 (29), 4056-4064. 
 
 
